Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.230831420507856,0.00467099986213927,-0.239986580237649,-0.221676260778063,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,39858,-0.186809614987439,0.00391062618674263,-0.194474442313455,-0.179144787661423,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.0920994603795343,0.00258988559919466,0.0870232846051128,0.0971756361539559,1.0753294748641e-266
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0999702732550539,0.00295113185873704,0.0941860548119293,0.105754491698178,5.09099762073649e-243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40058,-0.162598554766103,0.00494744216560226,-0.172295541410684,-0.152901568121523,2.20119644104073e-229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,39477,-0.352722286005617,0.0114164439321573,-0.375098516112645,-0.330346055898588,1.70588049113538e-203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0827517107129114,0.00267945383438701,-0.08800344022831,-0.0774999811975129,1.79235755051734e-203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,39868,0.103793033301033,0.00344305343124481,0.0970446485757936,0.110541418026273,3.1444194672681e-194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,39868,0.131282650168077,0.00439309901106595,0.122672176106388,0.139893124229767,5.39401403763988e-191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.140452350935609,0.00474613684547569,-0.149754779152741,-0.131149922718476,2.59018490895614e-187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,39908,0.0723268105897372,0.00248338077336775,0.0674593842739364,0.077194236905538,9.14065567174748e-182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,39976,0.0959622684629948,0.00334621879212427,0.0894036796304313,0.102520857295558,1.88959620294346e-176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.107031261516672,0.00376234381353595,-0.114405455391203,-0.099657067642142,5.79530574742955e-173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.17348205297416,0.0062076591599264,-0.185649064927615,-0.161315041020704,7.93029962931421e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40030,-0.171215536796952,0.00618717239360426,-0.183342394688417,-0.159088678905488,1.00132967857621e-164
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.137802475014904,0.00499060882326079,-0.147584068308495,-0.128020881721313,5.510382331996e-164
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.108847802615461,0.00396184120292216,-0.116613011373189,-0.101082593857734,1.86331989664647e-162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0814619943683678,0.00305787763186407,-0.0874554345268214,-0.0754685542099143,4.60799917609381e-153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.146419189289335,0.00550349304509984,-0.157206035657731,-0.135632342920939,1.14516904978323e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.158976302642906,0.00600434247054337,-0.170744813885171,-0.147207791400641,3.61155730649531e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0717081045167282,0.00272005748092839,-0.0770394171793479,-0.0663767918541086,6.04244828379817e-150
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,39758,-0.184903517543269,0.00714779576217507,-0.198913197237132,-0.170893837849406,1.44840268293404e-144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37437,-0.198463291538975,0.00773804741282342,-0.213629864468109,-0.183296718609841,1.03340966898095e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,39868,-0.149710371814411,0.00584940959395998,-0.161175214618572,-0.138245529010249,1.23350802243049e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37445,0.0622281054957259,0.00243386116110195,0.057457737619966,0.0669984733714857,7.29737883222821e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,39805,-0.0941717117825999,0.00375600972960181,-0.101533490852619,-0.0868099327125803,4.26215493151893e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.128458386726162,0.00513401492439228,-0.138521055977971,-0.118395717474353,1.59206503896782e-135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,37453,0.154807822223306,0.00621822414056763,0.142620102907793,0.166995541538818,8.02962578682579e-134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.145585197902447,0.00586917449093652,-0.157088779904682,-0.134081615900211,2.95969185604191e-133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.106484290162046,0.0043571871016233,-0.115024376881227,-0.0979442034428642,1.64819076251716e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0687483941923325,0.00283219227508027,0.0631972973331752,0.0742994910514898,2.17674015409457e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,37453,0.0621610826828284,0.00257277004752166,0.0571184533896859,0.0672037119759708,2.57940977018935e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0809726824209535,0.00336839769082652,-0.0875747418949734,-0.0743706229469335,1.87540676428909e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37039,-0.180770437891719,0.00752802361958932,-0.195525364186114,-0.166015511597324,9.539719026128e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0918754082931929,0.00386252900080845,-0.0994459651347775,-0.0843048514516084,6.10798275228633e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.105384946080514,0.00443764625227854,-0.11408273273498,-0.0966871594260481,1.46942069963089e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0705427854013238,0.00297614833697732,-0.0763760361417993,-0.0647095346608482,4.40438474966239e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,40058,-0.0569968666725747,0.00241751619978329,-0.06173519842415,-0.0522585349209995,7.21123682276064e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0576913942034757,0.00246119868865102,-0.0625153436332317,-0.0528674447737197,1.66351281550527e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0871192620049233,0.00372612381779758,-0.0944224646878066,-0.0798160593220401,7.10620563335194e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.0667068677085461,0.00286194926444402,0.0610974471502359,0.0723162882668564,3.38626687002362e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,39862,-0.114701052917487,0.00495537992687525,-0.124413597574163,-0.104988508260812,1.28051120806374e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,37021,-0.201632061348842,0.00870298431081823,-0.218689910598046,-0.184574212099638,2.00627308004072e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0786472275918757,0.00341322414861634,-0.0853371469231637,-0.0719573082605877,1.27289404951195e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0836908143484182,0.00364726233955549,-0.0908394485339469,-0.0765421801628894,2.70447002190773e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0889388408814974,0.00393774940336083,-0.0966568297120846,-0.0812208520509102,3.45156479467267e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40058,-0.0717862277391791,0.00319768089085693,-0.0780536822852587,-0.0655187731930995,6.12306608317146e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0728240683091347,0.00327884988812111,-0.0792506140898521,-0.0663975225284173,1.13832193618571e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,37124,0.0467000107776799,0.00209961986857268,0.0425847558352774,0.0508152657200823,1.23403675369821e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,39839,-0.100196335506445,0.00456657690576456,-0.109146826241743,-0.0912458447711464,3.72840083247998e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0656399500790628,0.00299236894540132,-0.0715049932120494,-0.0597749069460762,4.14676288772335e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.111433603104157,0.00508619776875353,-0.121402550730914,-0.1014646554774,7.55956410514436e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0678000592897038,0.00309582849604933,-0.0738678831419605,-0.0617322354374471,8.58705028152271e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0563288222780063,0.00258539533526867,-0.0613961971351329,-0.0512614474208797,9.81334366658858e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,39854,-0.162936505339489,0.00749037807132558,-0.177617646359288,-0.148255364319691,2.04183202771032e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0613887048580986,0.00283655288194076,-0.0669483485067025,-0.0558290612094947,2.14796356873284e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,39859,-0.0636725423196281,0.00296413392205795,-0.0694822448068617,-0.0578628398323946,6.22208444626362e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.109959615276172,0.00513353153910822,-0.120021337092824,-0.0998978934595196,2.35849204692561e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,39866,0.0683128464957181,0.00320389428775189,0.0620332136917244,0.0745924792997118,1.71698467629681e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.162667613344191,0.00766644072671149,-0.177693837168546,-0.147641389519837,1.49524365618498e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.066183760731625,0.00312423870069715,-0.0723072685849914,-0.0600602528782586,2.89425734466612e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0673466551267671,0.00319291944805897,-0.0736047772449627,-0.0610885330085715,1.91473920570758e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0446696840095335,0.00212661856068025,-0.0488378563884668,-0.0405015116306002,1.17839993594612e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,39788,-0.110142856541752,0.00527813404531242,-0.120487999270564,-0.0997977138129397,1.98211334767591e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0887639544948269,0.00426221902843402,0.0804100051990963,0.0971179037905576,4.61438353071592e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.283255494026743,0.0136583491906069,-0.310025858440332,-0.256485129613153,2.82696412835532e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.052264439308496,0.00252581807701211,-0.0572150427394398,-0.0473138358775523,7.02503254759517e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0583357227115363,0.00281867828627706,-0.0638603321526393,-0.0528111132704333,1.08644941098145e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40030,0.032190264576521,0.00156026137525241,0.0291321522810263,0.0352483768720157,2.28315401031668e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,39897,-0.0516519587260694,0.00250833897012359,-0.0565683031075116,-0.0467356143446271,5.14335156416463e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0839687106886973,0.00409070145762286,-0.0919864855456381,-0.0759509358317565,1.86254080865698e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0497754992147073,0.00242446955830714,0.0450235388804253,0.0545274595489893,2.8757082202748e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.114128222108478,0.00558998032569612,-0.125084583546842,-0.103171860670114,1.70672919384559e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.137144397144453,0.00672801302593036,-0.150331302675276,-0.123957491613629,5.29914261118056e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0667442995746882,0.00328324641467291,-0.0731794625474471,-0.0603091366019294,9.99817875745283e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0578528862421985,0.00284660036754187,-0.0634322229625805,-0.0522735495218164,1.10790981740856e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0695735525506679,0.00343107827707043,-0.0762984659737259,-0.0628486391276098,2.84864833025348e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,37411,-0.0822574762729179,0.00407216234057794,-0.0902389144604507,-0.0742760380853851,2.02045781642889e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,38721,-0.0745448252468243,0.0036964706954114,-0.0817899078098306,-0.0672997426838179,3.0051612765809e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40052,-0.0990265699634588,0.00492159829751922,-0.108672902626596,-0.0893802373003212,5.91792652692521e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,39913,-0.0642072497827734,0.00319716558633421,-0.0704736943319885,-0.0579408052335584,1.28246961802224e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,39931,-0.0615521217376391,0.00307829948748038,-0.0675855887331006,-0.0555186547421775,7.04481529935523e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,39587,-0.148754496366172,0.00747456434543406,-0.163404642483223,-0.134104350249121,4.6523261373675e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0859260235709159,0.00433141831339148,-0.0944156034651632,-0.0774364436766686,1.53491095054887e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.060935093917097,0.00307379275949806,-0.0669597277257132,-0.0549104601084808,1.95023574010721e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,39788,-0.166449066728816,0.0084142376441953,-0.182940972511439,-0.149957160946194,4.59827771586211e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,39720,-0.0516490613437708,0.00261270246433505,-0.0567699581738675,-0.0465281645136741,6.01841831146655e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,39868,-0.114531419388198,0.0058233225301212,-0.125945131547236,-0.103117707229161,4.11530954328146e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.156280954538383,0.00796900918321164,-0.171900212537477,-0.140661696539288,1.27281546625307e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.121044687985044,0.0062235953446716,-0.1332429348606,-0.108846441109488,2.67400590097238e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.09019987284996,0.00464738121850937,-0.0993087400382384,-0.0810910056616817,9.11162305999796e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0527177463904796,0.00272112417789201,-0.0580511497791479,-0.0473843430018113,1.20117488634497e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0504598891680554,0.00260673824326679,-0.0555690961248583,-0.0453506822112525,1.58100158289477e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.1549175059933,0.00800631705861476,-0.170609887428185,-0.139225124558415,2.66989037711377e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0992129557698145,0.00513840714597401,-0.109284233775924,-0.0891416777637054,3.97832455383371e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0631717259449228,0.00328247615550943,0.0567380726801243,0.0696053792097213,1.29358236474635e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37437,-0.168018441035646,0.00872990637546256,-0.185129057531553,-0.15090782453974,1.8375171748805e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0642637693617685,0.00334829930943531,-0.0708264360082617,-0.0577011027152753,3.49212432814637e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.153603377082118,0.00801949038495006,-0.16932157823662,-0.137885175927616,7.24501697912135e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0384550390205586,0.00201521736463103,0.0345052129858818,0.0424048650552354,2.70571288684269e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.129702880944688,0.0068012867356225,-0.143033402946508,-0.116372358942868,3.51432937987931e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,39974,-0.0458268205112314,0.00240970569328059,-0.0505498436700613,-0.0411037973524014,9.10587821189443e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0681913665804547,0.0035984274597265,-0.0752442844015186,-0.0611384487593907,3.24303121689605e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0645427231954475,0.00341308221271803,-0.0712323643323748,-0.0578530820585201,6.62268808605988e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0605607990382593,0.0032040131743213,-0.0668406648599291,-0.0542809332165896,7.82984536746343e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,39919,-0.104736571161448,0.00554977181287288,-0.115614123914679,-0.0938590184082171,1.3659120488685e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,39868,-0.044998745047792,0.00241133587068918,-0.0497249633543428,-0.0402725267412412,6.67884652900405e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.160529749288357,0.00860189859223807,-0.177389470529144,-0.143670028047571,6.80517022938066e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,40058,-0.052824911664234,0.00283110120282989,-0.0583738700217806,-0.0472759533066875,6.84771105880728e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,39913,-0.0686372751721798,0.00367893212318388,-0.0758479821336202,-0.0614265682107394,7.21337402160676e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0644922948806912,0.00346223630852037,0.0577063117159913,0.0712782780453912,1.24532191984293e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.067657615715484,0.00363712017892921,-0.0747863712661852,-0.0605288601647827,1.95038195125378e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,36780,0.0766582198470972,0.00412600857920156,0.0685712430318621,0.0847451966623323,4.6167704683612e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0493134395817647,0.00265908573563911,-0.0545252476236173,-0.044101631539912,5.46291540311779e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.051868495200097,0.00279718469444691,-0.0573509772012129,-0.046386013198981,5.74438606425386e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0377538640128605,0.00203957253951048,-0.041751426190301,-0.03375630183542,1.03836568348734e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.0870848523653819,0.00470972351143046,-0.0963159104477856,-0.0778537942829782,1.55644876251486e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37051,-0.0456409909332976,0.00247313821476407,-0.0504883418342351,-0.04079364003236,4.20402910074888e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0670600987891629,0.00365000383856859,-0.0742141063127573,-0.0599060912655684,1.74871967867524e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.149846601352152,0.0082136785822825,-0.165945411373425,-0.133747791330878,1.30712625624832e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0463271021129032,0.00254461579756184,-0.0513145490761244,-0.041339655149682,2.50424728758095e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0615203356675329,0.00337894642615166,-0.0681430706627901,-0.0548976006722756,2.74218743835875e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,39846,-0.0485356898372483,0.00266688393168049,-0.053762782343342,-0.0433085973311545,2.86334544877795e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37386,-0.0476648977353424,0.00262938348031372,-0.0528184893567573,-0.0425113061139275,1.38786032026697e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,40003,-0.0331041362194899,0.00182815034458174,-0.0366873108948701,-0.0295209615441097,1.43927809293242e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0691991054053678,0.00382361915579354,-0.0766933989507231,-0.0617048118600125,1.74969993288451e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0531656818674317,0.00294149005015481,-0.0589310023657351,-0.0474003613691283,2.63026872757485e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,39868,-0.0598865127812053,0.0033177079959158,-0.0663892204532003,-0.0533838051092103,4.04890532517141e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0928953938223786,0.00516558377260371,-0.103019938016682,-0.0827708496280753,1.39040006071058e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0498096264735567,0.00277410156298232,-0.055246865537002,-0.0443723874101113,2.18509573504282e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.065731012284863,0.00367009025050688,-0.0729243891758564,-0.0585376353938695,4.92410384104302e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.13053955284778,0.00729018015248296,-0.144828305946646,-0.116250799748913,6.9257817598919e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0448865484335804,0.00251569641598963,-0.0498173134089201,-0.0399557834582407,1.59097071696621e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.100217897875158,0.00561659606806246,-0.111226426168561,-0.0892093695817558,1.63563856944922e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0453321350396679,0.0025424864372608,-0.050315408456699,-0.0403488616226367,1.97582725578513e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0700832532455521,0.00394813377519048,-0.0778215954449254,-0.0623449110461787,1.08139725388061e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.109333267420907,0.0061662180447961,-0.121419054788708,-0.0972474800531071,1.11319542161393e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0800305348256213,0.00451060926820766,-0.0888713289913083,-0.0711897406599343,1.24993251419476e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_E,,39866,-0.0458553088773216,0.00259100681014126,-0.0509336822251985,-0.0407769355294447,1.99547681162313e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0534561920846059,0.00301872274428718,-0.0593728886634088,-0.047539495505803,2.18058010724377e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0626388656499268,0.00353945025132978,-0.0695761881425331,-0.0557015431573204,2.74534493022687e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0831872189302369,0.0047199102646289,-0.0924382430489095,-0.0739361948115642,7.18958242062948e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0559967724540149,0.00318195504009947,-0.0622334043326098,-0.0497601405754199,1.12692659343704e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0544645179829452,0.00310470580619255,-0.0605497413630826,-0.0483792946028078,2.94848626730294e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,37437,-0.0559904826965802,0.00319243687939171,-0.0622476589801879,-0.0497333064129724,4.09925809522236e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0925422210504106,0.00528569474374933,-0.102902182748159,-0.0821822593526619,5.34813089004755e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,39555,-0.0623738391717569,0.00359213510056107,-0.0694144239688566,-0.0553332543746572,6.51883509460387e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,40058,-0.0453468712250228,0.00262338474345253,-0.0504887053221897,-0.0402050371278558,2.37585634167996e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40058,-0.0672132224343583,0.00390049583489947,-0.0748581942707613,-0.0595682505979553,5.91730632534922e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.045506550945042,0.00265368008429281,-0.0507077639102559,-0.040305337979828,2.45975420310742e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0826830810882374,0.00482751410230222,-0.0921450087287497,-0.073221153447725,3.64366748737554e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,39788,-0.0754200780563089,0.00443029192747602,-0.0841034502341619,-0.0667367058784559,2.0329077741994e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0527408803179505,0.00310024164281347,0.0466644066980361,0.0588173539378649,2.45214627155211e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0846477679507312,0.00497623194502641,-0.094401182562983,-0.0748943533384794,2.52707828911942e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,39489,-0.0815250388616475,0.00479495823973349,-0.0909231570115251,-0.0721269207117698,2.98726420482715e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0515623072952656,0.00304217273016805,-0.0575249658463949,-0.0455996487441362,9.45334566040666e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,40058,-0.0541540248972707,0.00320369129137885,-0.0604332598283732,-0.0478747899661681,1.48265732133915e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0683363440826867,0.00404508064649477,-0.0762647021498165,-0.060407986015557,1.75613340042554e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.122697117473935,0.00726213951231191,-0.136930910918066,-0.108463324029803,1.77930659500984e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.220738498253581,0.0131335385004197,-0.246480233714404,-0.194996762792758,7.3882767832596e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0587834213685058,0.00349984254945009,-0.065643112765428,-0.0519237299715836,9.0837411058936e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0846709284111448,0.00505279115853354,-0.0945743990818706,-0.0747674577404191,1.70800363777703e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0582707536303045,0.00348383385201676,-0.0650990679802573,-0.0514424392803517,2.85981829369264e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,39788,-0.0807071669343852,0.0048433265784616,-0.09020008702817,-0.0712142468406005,8.04575591774567e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0442221373883243,0.00265534282332899,-0.0494266093220491,-0.0390176654545994,9.36269226571185e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0659115322236321,0.00396730952901826,-0.0736874589005079,-0.0581356055467563,1.79013909241972e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.0898877200644306,0.0054294440608017,-0.100529430423602,-0.0792460097052593,5.80912399343603e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,39984,-0.0763283626217843,0.00466253272674555,-0.0854669267662055,-0.067189798477363,9.41043951683559e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0496122932449509,0.00303474881073333,-0.0555604009139882,-0.0436641855759136,1.34740790850006e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,39858,-0.0367005882313795,0.00224759948393349,-0.0411058832198891,-0.0322952932428698,1.86326446087212e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,39585,-0.0813769932612594,0.00498336733334371,-0.091144393234613,-0.0716095932879057,1.87087293268391e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,39673,-0.0514917856288152,0.00315388572779104,-0.0576734016552857,-0.0453101696023448,1.95965220862698e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0306174765489492,0.00187705378748221,0.026938451125484,0.0342965019724143,2.47566686781874e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.059511052491487,0.00364926193203317,-0.066663605878272,-0.052358499104702,2.58567203416694e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,39826,-0.154338448583934,0.00948499407053165,-0.172929036962176,-0.135747860205692,4.66860385003013e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0519567543814282,0.00319354140804205,-0.0582160955411906,-0.0456974132216658,5.87945370646749e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0419857099973529,0.00258233472390031,-0.0470470860561975,-0.0369243339385083,7.1669533495204e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40030,0.0540550749435889,0.00332833906170717,0.0475315303826429,0.060578619504535,7.57535084510642e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0556812212338237,0.00342902017292578,-0.0624021007727583,-0.0489603416948892,8.09629797457674e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0898886449784674,0.00553916859580647,-0.100745415426248,-0.0790318745306867,9.3494553786175e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,37124,-0.0637896284073246,0.0039370888852517,-0.0715063226224179,-0.0560729341922313,1.76971411557452e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,40058,-0.0697547395669026,0.00431112783608034,-0.0782045501256201,-0.0613049290081852,1.99837786089217e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,37445,0.0818019955781441,0.00505589801315274,0.0718924354723647,0.0917115556839235,2.46659731879205e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0926278476924228,0.00574234818478013,-0.103882850134592,-0.0813728452502537,4.45826709621086e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.0963159847039892,0.0059991669633158,0.0845576174558903,0.108074351952088,1.49443468767992e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,40052,-0.0757912558481639,0.004721466256202,-0.0850453297103198,-0.066537181986008,1.52665637774945e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.186863479613853,0.0116435414434311,0.164042138384728,0.209684820842978,1.62510068464133e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,40030,-0.0834238725618518,0.0052008648239675,-0.0936175676168281,-0.0732301775068755,1.85202774323348e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0386158207426031,0.00240773997684,-0.0433349910972095,-0.0338966503879967,1.92189390328231e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0754783097380456,0.00471045002617683,-0.0847107917893522,-0.066245827686739,2.4416716766952e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37437,-0.0349777654200397,0.00218229106550839,-0.0392550559084362,-0.0307004749316433,2.73026741391518e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0910343711386722,0.00568747107981571,-0.102181814455111,-0.0798869278222334,3.19127908346012e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,39817,0.0964752906447795,0.00602736232245778,0.0846616604927622,0.108288920796797,3.22391719375664e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0626879505692433,0.00393647682099677,-0.070403445138397,-0.0549724560000896,1.16014909595444e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,39489,-0.0778298708022509,0.00489992119040542,-0.0874337163354455,-0.0682260252690563,2.2612945514052e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,39931,0.0966502672580067,0.00610154647306063,0.0846912361708079,0.108609298345206,4.35839617341798e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0601824518654037,0.00380317797367207,-0.067636680693801,-0.0527282230370065,5.62651181860044e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,39866,-0.068194421165963,0.00433251109745956,-0.0766861429169837,-0.0597026994149423,2.08852133279605e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.123434255504736,0.00785786008656285,-0.138835661274399,-0.108032849735073,3.50413558892854e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0910210206818073,0.00581903838663725,-0.102426335919616,-0.0796157054439983,9.63121958341577e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,39858,-0.0532799243270762,0.00341567386480318,-0.0599746451020904,-0.046585203552062,1.87186285021202e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,39788,-0.116369661037637,0.00746375619533278,-0.130998623180489,-0.101740698894784,2.10521579281322e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,39504,-0.0732704774502324,0.00470080261836639,-0.0824840505822305,-0.0640569043182343,2.29420384924943e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37424,0.0556680073609925,0.00357172523831875,0.0486674258938877,0.0626685888280972,2.68918683653067e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0932090310584194,0.0059937210821977,-0.104956724379527,-0.0814613377373119,3.89191324019751e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0687109130932375,0.00441988629789443,-0.0773738902371106,-0.0600479359493644,4.31548066091111e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0418367806913884,0.00269216155071488,-0.0471134173307896,-0.0365601440519873,4.628802751353e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37124,-0.0941323059105871,0.00605500250742434,-0.106000110825139,-0.0822645009960354,5.05517705666174e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,39908,-0.0496009775768514,0.00319707352600996,-0.0558672416878309,-0.0433347134658719,6.8155553216581e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.11455212844382,0.00738450130469594,-0.129025751001024,-0.100078505886616,6.98749711328428e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0856924454170536,0.00552726415173045,-0.0965258831544453,-0.0748590076796619,8.07536018774289e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,37453,-0.0455199623116876,0.00293579514339311,-0.0512741207927381,-0.0397658038306371,9.23451331967718e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,36543,-0.0357512784407991,0.00230593736839449,-0.0402709156828523,-0.0312316411987459,1.01300912304791e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0382941703727803,0.00247362373838501,-0.0431424729000149,-0.0334458678455457,1.34325823663923e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0649185755531489,0.00419702598087539,-0.0731447464756647,-0.0566924046306331,1.40066521217793e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0612263912828968,0.00396165779290422,-0.068991240556989,-0.0534615420088045,1.70025735333849e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0330816885126549,0.00214308336538003,-0.0372821319087997,-0.02888124511651,2.70234089587606e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0480337551677556,0.00311743859313261,-0.0541439348102955,-0.0419235755252156,3.47851372527294e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0798604666989553,0.00519222396050352,-0.0900372256615422,-0.0696837077363684,5.2730306823128e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.100228362109061,0.00651157248201847,-0.112991044173817,-0.0874656800443045,5.33133287101484e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0620691688224471,0.0040392723029412,-0.0699861425362118,-0.0541521951086823,6.53759707696091e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,39713,-0.0886504624564726,0.00577893050605322,-0.0999771662483369,-0.0773237586646082,9.83950371875004e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.187580560438498,0.0122360499750433,-0.211563218389583,-0.163597902487413,1.12827036625311e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,39899,-0.0435245636218843,0.00284109346955512,-0.0490931068222124,-0.0379560204215563,1.33230368647252e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.0413270708497818,0.00269888605777193,-0.0466168875230148,-0.0360372541765488,1.48779533804812e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0562456280482645,0.00368182748503354,0.0490292461775988,0.0634620099189303,2.56322451458163e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0503779927013622,0.00330075014256466,-0.056847462980789,-0.0439085224219355,3.16514600457821e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.172432623960218,0.0113120357864606,-0.194604214101681,-0.150261033818755,4.2047787923099e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,39995,-0.0542121083081839,0.00355775742852913,-0.061185312868101,-0.0472389037482668,4.57713604471488e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,39866,-0.0474074331960145,0.00311241634096044,-0.0535077692242969,-0.041307097167732,5.04455810715422e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,40012,0.0760060697188217,0.0050007422864191,0.0662046148374403,0.0858075246002032,8.20087358893758e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,40009,-0.0346064442135773,0.0022804139614111,-0.039076055577943,-0.0301368328492115,1.16696895361948e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0553457388184321,0.00365492393275929,-0.0625093897266403,-0.0481820879102239,1.9324235049176e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0380208267793207,0.00251095437167246,-0.0429422973477987,-0.0330993562108427,1.939619134056e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0581455167256443,0.00384094802833725,-0.0656737748611853,-0.0506172585901033,2.08384689854545e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0491868853066649,0.0032540861377372,-0.0555648941366298,-0.0428088764766999,2.95306644421985e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0480698352182405,0.00318253891363559,-0.0543076114889662,-0.0418320589475147,3.44167822540338e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.056193604149521,0.00373210511953982,-0.0635085301838191,-0.048878678115223,6.94347297238098e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0521381230940363,0.00346380839958446,-0.0589271875572218,-0.0453490586308507,7.47937221019841e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0631352644688054,0.00419367321284509,-0.0713548639659818,-0.0549156649716291,8.23981037188897e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,39785,-0.101863896235825,0.00677592348551147,-0.115144706267427,-0.0885830862042221,9.91453079021752e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0399881165985906,0.0026629599254211,-0.045207518052416,-0.0347687151447653,1.26052008235919e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,39790,-0.0580567447619491,0.003868954513373,-0.0656398956081602,-0.050473593915738,1.49028973720126e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0556483810111638,0.00371335727446422,-0.0629265612691137,-0.0483702007532139,1.98592393993215e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0482689049056952,0.00322424733269094,0.041949380133621,0.0545884296777695,2.48155986032917e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0696414490659142,0.00466241161342624,-0.0787797758282296,-0.0605031223035987,4.12314160603047e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0533479511894111,0.00357773237528676,-0.0603603066449731,-0.046335595733849,6.04050250868696e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,39795,-0.0643884168732841,0.00431900188925755,-0.0728536605762289,-0.0559231731703393,6.32859946988428e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,39858,-0.0586120315981764,0.00393252717633604,-0.066319784863795,-0.0509042783325577,6.66894891952234e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37088,-0.0537451285904263,0.00360809425580038,-0.0608169933317951,-0.0466732638490576,8.89332705315707e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,39908,-0.0408668190521973,0.00274693183098144,-0.0462508054409209,-0.0354828326634737,9.93207259300717e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0469282696361918,0.0031572972275993,-0.0531165722022865,-0.0407399670700972,1.21194626256689e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.106036474265253,0.00714100949781062,-0.120032852880962,-0.092040095649544,1.53343427960596e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0466119187352522,0.00314078081634573,-0.0527678491352898,-0.0404559883352145,1.69900173768697e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,39843,-0.0712400066507304,0.00480255242086462,-0.0806530093956251,-0.0618270039058358,1.8893617807794e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0713325190042701,0.00480927816547902,-0.080758704208609,-0.0619063337999312,1.92964421224217e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0811272334177471,0.00547068476903329,-0.0918497755650523,-0.0704046912704418,2.36034300932833e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0535626698501927,0.00361665719224753,-0.0606513179469978,-0.0464740217533875,2.65638020830306e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,39913,-0.039878039720604,0.00269758028460968,-0.045165297078439,-0.034590782362769,3.97382925142419e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.0405474256712323,0.00274905787907813,-0.0459355791142254,-0.0351592722282391,6.43079658574849e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0516323447491648,0.00350250142360578,-0.0584972475394321,-0.0447674419588974,7.38554871435966e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.111105241642018,0.00754128441015246,-0.125886159085917,-0.0963243241981191,8.29929890049178e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0876285489823005,0.00595848369772854,-0.0993071770298484,-0.0759499209347526,1.21579825272324e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,39619,-0.0591875148236141,0.00402581042420736,-0.0670781032550605,-0.0512969263921676,1.31312403855003e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,39788,-0.0987256485447461,0.00672415596866598,-0.111904994243331,-0.0855463028461608,1.73775598994924e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0733250520031005,0.00499275228897704,-0.0831108464894954,-0.0635392575167055,1.86440969823131e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0698674443226587,0.00476581261131815,-0.0792084370408423,-0.0605264516044751,2.42430005532072e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0834943168686907,0.00569834429676195,-0.0946630716903441,-0.0723255620470373,3.04671280910437e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0828281032310051,0.00566524125994246,-0.0939319761004923,-0.0717242303615179,4.26582079814528e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.047118279429439,0.0032263513054342,-0.0534419279880901,-0.040794630870788,5.39424764617582e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0516496367386564,0.00353778052027486,-0.0585836865583951,-0.0447155869189177,5.71767230289812e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.115264404193313,0.00790349871980505,-0.130755261684131,-0.099773546702495,7.33033005976422e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0557606831811674,0.00382988227558371,-0.0632672524413115,-0.0482541139210233,1.16386199067815e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,39984,-0.0325486949707243,0.00223949500113562,-0.0369381051729501,-0.0281592847684985,1.47568106248844e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0221321787109093,0.00152285428433922,0.0191473843136045,0.0251169731082142,1.48402413460335e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0391586375615349,0.00269378364830739,-0.0444384535122173,-0.0338788216108524,1.61366642218466e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,39798,-0.041921884157876,0.00288649675152219,-0.0475794177908595,-0.0362643505248926,1.7303817049713e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0274591558292236,0.00189070749715115,-0.0311649425236399,-0.0237533691348074,1.7347735290774e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0501292222786492,0.00345677874756364,-0.0569045086238739,-0.0433539359334245,2.41083782106225e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0491661072881924,0.00339366626021676,-0.0558176931582172,-0.0425145214181675,2.88908317265088e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40052,-0.0789704040064535,0.00545409661166061,-0.0896604333653083,-0.0682803746475987,3.23924115830387e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0458757090032869,0.00316841083576238,-0.0520857942413812,-0.0396656237651927,3.25978936712983e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0366870708640216,0.00254599246383495,0.0316969256349051,0.0416772160931381,8.81836778086321e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0372136462160165,0.00258282921068571,-0.0422759914689605,-0.0321513009630726,9.17470924131991e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0686123682326254,0.00476803403027345,-0.0779577149319614,-0.0592670215332895,1.16614906237936e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0631799702145987,0.00439269494726366,0.0545702881179619,0.0717896523112355,1.29253916504472e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0623745843872701,0.00433882644521267,-0.0708786842198869,-0.0538704845546533,1.42096189714693e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39464,-0.080731495895124,0.0056151558283349,-0.0917372013186604,-0.0697257904715876,1.42281526887307e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0508507459308818,0.00353570651055064,-0.0577807306915611,-0.0439207611702026,1.47618790994295e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.104766663015162,0.00729091172161894,-0.119056849989535,-0.0904764760407886,1.5541901937285e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.142467147078376,0.00991970055981324,-0.16190976017561,-0.123024533981142,1.74923259111841e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,39908,-0.024775305042495,0.00172886572350239,-0.0281638818605597,-0.0213867282244303,2.72858571284843e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37124,-0.158758310262911,0.0110825962995335,-0.180480199009996,-0.137036421515825,3.3756270375552e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,39933,-0.0874577930446126,0.006119791665526,-0.0994525847090436,-0.0754630013801817,4.76973077786226e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0418075821183427,0.00292432322594621,-0.0475392556411973,-0.0360759085954882,4.9785905176771e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,39865,-0.0421024322527171,0.00294827603701655,-0.0478810532852695,-0.0363238112201646,5.55971435329705e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0626253380845809,0.00438916699766088,-0.0712281053999963,-0.0540225707691656,6.66088294761944e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0997274950101515,0.0069964313520395,-0.113440500460149,-0.0860144895601541,8.0931916742247e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,40058,-0.0605514090213405,0.00426036474768736,-0.0689017239268077,-0.0522010941158733,1.43541269714479e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0882143723838676,0.00620769700405179,-0.100381458511809,-0.0760472862559261,1.49418498906462e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.034218542706727,0.00240892020206774,-0.0389400263027797,-0.0294970591106742,1.61484956548738e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0399256642218937,0.00281035969733282,-0.0454339692286661,-0.0344173592151214,1.80473912500247e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0483426185727298,0.00341544122062289,-0.0550368833651507,-0.0416483537803089,3.27734866180939e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,39931,-0.0691053758973002,0.004882517252128,-0.0786751097114711,-0.0595356420831293,3.31422081240744e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.046360373187726,0.00328360437544879,-0.0527962377636056,-0.0399245086118464,5.41137455810351e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0389861642003404,0.00276192405638135,-0.0443995353508479,-0.033572793049833,6.43518673482427e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0670110002507457,0.00474836265729674,-0.0763177910590473,-0.0577042094424441,6.86391256115671e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40009,-0.0558986537928373,0.00398277015209992,-0.0637048832909532,-0.0480924242947215,1.73498575537711e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0586905298506569,0.00418854640503104,-0.0669000808045177,-0.050480978896796,2.68230222180685e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,39868,-0.0316824054952463,0.00226755929841637,-0.0361268217201424,-0.0272379892703502,4.19315178010906e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0590912736135507,0.00423022256636837,-0.0673825098436327,-0.0508000373834687,4.36069213965951e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0597881202370602,0.00427890185408662,-0.0681747678710699,-0.0514014726030504,4.70693137586361e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.0898510392803314,0.00643937426547123,-0.102472212840655,-0.0772298657200078,5.51101383901726e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40009,-0.0293259436608123,0.00210344096335545,-0.033448687948989,-0.0252031993726356,6.33464616191748e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0357682012581094,0.00256585768191214,-0.0407972823146572,-0.0307391202015616,6.49755365946404e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39489,-0.0806458540214016,0.00578655491247245,-0.0919875016498476,-0.0693042063929556,6.93313372867842e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40002,-0.0355883227096069,0.00255672756301963,-0.0405995087331254,-0.0305771366860884,8.63929100696438e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0416253889973772,0.00298932954835175,-0.0474844749121466,-0.0357663030826077,9.15670518818701e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,39858,-0.0506254486136417,0.00365389947664912,-0.057787091587874,-0.0434638056394094,2.10804066174524e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.094393787769931,0.00684219726712208,-0.10780449441349,-0.0809830811263718,5.27946377907642e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0874827655322138,0.00634625615210299,-0.0999214275903357,-0.075044103474092,5.5002270509853e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.069500347891396,0.00505843455038685,-0.0794148796101542,-0.0595858161726378,1.02386827901203e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0655018473602187,0.00476905666007639,-0.0748491984139684,-0.0561544963064689,1.09111914644844e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0510704935941967,0.0037259506441224,0.0437676303317168,0.0583733568566766,1.60950837546759e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,37453,-0.0261054325990435,0.001907644319193,-0.0298444154646618,-0.0223664497334252,2.39279345129716e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.101069961389963,0.00739473440960548,-0.11556364083279,-0.0865762819471366,2.72992919586016e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0630745719286843,0.00462011063691334,0.0540191550803341,0.0721299887770344,3.72300541782907e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.0828228912644673,0.00607139919939919,-0.0947228336952897,-0.0709229488336449,4.3096542965402e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0440627784397389,0.00323212376371029,-0.0503977410166111,-0.0377278158628667,4.38603010842097e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.121169579555372,0.00889278076306274,-0.138599429850975,-0.103739729259769,4.84038424584075e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0555000647481239,0.0040787863176643,-0.0634944859307459,-0.0475056435655018,6.18630761306826e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0736227985406862,0.00541456495791768,-0.0842353458582049,-0.0630102512231676,7.08038604025005e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,37124,-0.0596241563042512,0.00439234628407559,-0.0682331550210394,-0.0510151575874631,1.07609521565177e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,39858,0.0343649269049096,0.00253450664842363,0.0293972938739993,0.0393325599358199,1.19338661464958e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0619038237610218,0.00457470415925807,-0.0708702439131676,-0.052937403608876,1.73351443755261e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37388,-0.0489031555256506,0.00361445749484157,-0.05598749221554,-0.0418188188357611,1.93789521121091e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0620691001971798,0.00461336650408911,-0.0711112985451944,-0.0530269018491651,4.83354456999682e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0543939404708192,0.00404515412655045,-0.0623224425588581,-0.0464654383827803,5.36354532028355e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0874877186274317,0.0065102724084278,-0.10024785254795,-0.0747275847069132,5.98523123358758e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.082659651446731,0.00616293341120556,-0.0947390009326939,-0.0705803019607681,9.29707053445882e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.072217392051959,0.00539257079380022,-0.0827868308078074,-0.0616479532961106,1.11468876373469e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.0968266420246471,0.00724350468465497,-0.111023911206571,-0.0826293728427233,1.71435958023874e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0321782446784245,0.00241188856311081,0.0274509430947274,0.0369055462621217,2.18434427616622e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.040370864184854,0.00303073090544442,-0.0463110967595251,-0.034430631610183,2.87008155908677e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0454432269533657,0.00341082629596937,-0.0521284464934656,-0.0387580074132657,3.03426197028443e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0448838098587746,0.00337226982713821,-0.0514934587199654,-0.0382741609975837,3.32958763063193e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,39782,-0.0521022652403127,0.003923227625271,-0.0597917913858439,-0.0444127390947815,4.90749342465409e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0411268474590713,0.00309807101893578,-0.0471990666561854,-0.0350546282619572,5.27442808719886e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.033118787973126,0.00249726060541164,-0.0380134187597328,-0.0282241571865192,6.22959651456667e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,39866,-0.0972068509845034,0.00733460867995697,-0.111582683997219,-0.0828310179717877,7.01648827885903e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0659057354964437,0.00497597080002639,-0.0756586382644954,-0.0561528327283919,7.79094521715311e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0360663365168063,0.002737014218823,0.0307017886479132,0.0414308843856994,1.90127514133627e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40009,-0.0360807211097229,0.00274030198473504,-0.0414517129998036,-0.0307097292196423,2.17712386317119e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0319132350423266,0.00242682591145485,-0.0366698138287781,-0.027156656255875,2.7095991758948e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,39788,-0.0361191062466528,0.00276211476780928,-0.041532851191559,-0.0307053613017467,7.10317170964128e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,39868,-0.0491323644543681,0.00377443954396763,-0.0565302659605447,-0.0417344629481916,1.53426410523889e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0544896278815226,0.00418795741074865,-0.06269802440659,-0.0462812313564553,1.66416406846353e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.0505889731521344,0.0038929084708015,-0.0582190737549053,-0.0429588725493634,2.03164252156987e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.131629198216282,0.0101295170319283,-0.151483051598861,-0.111775344833702,2.05790843967346e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,39908,-0.0703778766913667,0.00542314795393737,-0.081007246681084,-0.0597485067016495,2.56526015086632e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.055329111719134,0.00427262922260114,-0.0637034649954322,-0.0469547584428357,3.67711322895841e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,39866,-0.109618490574613,0.00846548638927504,-0.126210843897592,-0.0930261372516337,3.70692000101666e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0706702263655797,0.00547052041198959,-0.0813924463730793,-0.0599480063580801,5.47299068796328e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.0909047392176661,0.00704054083131625,-0.104704199247046,-0.0771052791882862,6.00734180438684e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.0361655495948708,0.00280278361643469,-0.0416590054830828,-0.0306720937066589,6.65100530804729e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,39885,0.0476405863023433,0.0036962129395376,0.0403960089408496,0.054885163663837,7.99943678406698e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.048045128843697,0.00373109366902301,-0.0553580724349821,-0.0407321852524119,9.37760817180961e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,37043,-0.0742532660485442,0.0057689159988899,-0.0855603414063684,-0.06294619069072,1.10134470862157e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,37437,-0.0323096923458952,0.00251519303308442,-0.0372394706907407,-0.0273799140010497,1.50206808115135e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.0557504867269758,0.0043448795152998,-0.0642664505769635,-0.0472345228769882,1.66754737507807e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0314039734153026,0.00244635293157155,-0.0361988251611828,-0.0266091216694223,1.6910670452083e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0458250716895251,0.0035743949615689,-0.0528308858142001,-0.03881925756485,1.9275493607619e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,39868,-0.042509174156458,0.00332273770562214,-0.0490217400594774,-0.0359966082534386,2.71754460076383e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.068614881107581,0.00536246888076301,-0.0791253201138765,-0.0581044421012855,2.90055995097814e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39455,-0.0478568645655725,0.00374543425511913,-0.055197915705606,-0.040515813425539,3.36980346555376e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0941585889670472,0.00739611254404755,-0.10865496955338,-0.079662208380714,6.49073254330013e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0301429940635398,0.00237359451557141,-0.0347952393140597,-0.0254907488130198,8.96158292127445e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0700244476109424,0.00551455554331244,-0.0808329764758348,-0.05921591874605,9.07971124401377e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.120694099410916,0.00952043077196725,-0.139354143723972,-0.10203405509786,1.19979698530631e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0606027718083421,0.0047846632024241,-0.0699807116850933,-0.0512248319315908,1.37258583305328e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.0629480223204761,0.00497420157579503,-0.0726974574090343,-0.0531985872319178,1.56703139161598e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0352224043324588,0.0027930894172581,-0.0406968595902846,-0.0297479490746329,2.79180693222683e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.0331647787387935,0.00263497153511283,-0.0383293229476146,-0.0280002345299723,3.99039335408412e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0672513907633569,0.00534600609997389,-0.0777295627193058,-0.0567732188074081,4.37798300654198e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,39749,-0.0773693733500329,0.00617608439035849,-0.0894744987551356,-0.0652642479449303,7.82181558588726e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REN,Renin,39868,-0.0784434701139254,0.00626499555679753,-0.0907228614052485,-0.0661640788226022,8.44146874389497e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,37437,-0.0364437778174828,0.00291027041723765,-0.0421479078352686,-0.030739647799697,8.86740531477812e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.13115550489057,0.0105036173623566,-0.151742594920789,-0.110568414860352,1.30529938314577e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0353383090787751,0.00283418434094893,-0.040893310387035,-0.0297833077705152,1.61761380553065e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0418325673340472,0.00335874378066424,-0.0484157051441492,-0.0352494295239453,1.93962741897736e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0331266846269395,0.00266881515699594,-0.0383575623346515,-0.0278958069192274,3.24646757697685e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0557034622194576,0.00448787976449156,-0.064499706557861,-0.0469072178810541,3.26724747976732e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37437,-0.0814188886964729,0.00656192824267019,-0.0942802680521065,-0.0685575093408394,3.67804890395083e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0458924856247834,0.00370140148939455,-0.0531472325439967,-0.03863773870557,3.85413565031735e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0496731330253292,0.00400765838968757,-0.0575281434691168,-0.0418181225815415,4.33965420317859e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0544425406566627,0.00439754876078309,-0.0630617362277975,-0.0458233450855278,5.23463475857838e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,37043,-0.076616806621347,0.00618931430417264,-0.0887478626575254,-0.0644857505851686,5.3202508659862e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,39862,-0.0291590801707902,0.00236119840025175,-0.0337870290352836,-0.0245311313062968,7.08637348184459e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0491738609971315,0.00398865072798469,-0.0569916164239815,-0.0413561055702815,9.13520591631665e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0608712005146876,0.00494642039555131,-0.0705661844899681,-0.051176216539407,1.29978894462325e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0608645650677353,0.00494948362321008,0.0511635771662435,0.070565552969227,1.3445027915976e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37124,-0.0342889755653153,0.0027873257129433,-0.0397521339626842,-0.0288258171679464,1.36809519583812e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0325006233871169,0.00264572490642229,-0.0376862442037046,-0.0273150025705292,1.68633665608777e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,39809,-0.0318686459081106,0.00260742869964504,-0.0369792061594148,-0.0267580856568063,3.36298465692434e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.0307434863185162,0.00251748154555012,-0.0356777501477944,-0.0258092224892379,3.80589832686011e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0656568560018978,0.00537982894916499,-0.0762013207422612,-0.0551123912615344,4.18144301989683e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37445,0.0600829212297632,0.0049351247595264,0.0504100767010915,0.0697557657584349,6.37936735863257e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0712149523805612,0.00586379913965618,-0.0827079986942873,-0.059721906066835,9.25907427985081e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,39949,-0.0359068945168726,0.00296027661685648,-0.0417090366859113,-0.0301047523478339,1.033295191793e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,39868,-0.0730126002455718,0.00602226917887473,-0.0848162478361663,-0.0612089526549774,1.11035623136375e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,39955,-0.0397237564813803,0.00327675629763848,-0.0461461988247518,-0.0333013141380089,1.12017395579943e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,37388,-0.13438233022571,0.0111070936541971,-0.156152233787936,-0.112612426663484,1.59665813032916e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0246306451584037,0.00204393591066491,-0.0286367595433069,-0.0206245307735005,2.67329371226055e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0660580761389223,0.00549551590712586,-0.0768292873168889,-0.0552868649609556,3.88078764435442e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0599094403853987,0.00498205541136358,-0.0696742689916713,-0.050144611779126,3.91165053168867e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.117868971281547,0.00981057284391727,-0.137097694055625,-0.0986402485074693,4.39505354188201e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.12488302356211,0.010403157423282,0.104492835012477,0.145273212111743,5.08162917945514e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,37437,-0.0321637487183646,0.00268056647071329,-0.0374176590009626,-0.0269098384357665,5.28980492670859e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0446060375536309,0.00372181608018163,0.0373112780364749,0.0519007970707869,5.92511166244391e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.03289477956794,0.00274524966297809,-0.0382754689073771,-0.027514090228503,6.44554671779677e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,39789,-0.0856068976814982,0.00715488740017676,-0.0996304769858447,-0.0715833183771518,7.51183083648754e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0641699548013869,0.00538050735507452,-0.074715749217333,-0.0536241603854409,1.18619919031768e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0370130019282243,0.00310546392356521,-0.0430997112184121,-0.0309262926380364,1.29984913272159e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39489,-0.0392406015969025,0.00329265743184156,-0.045694210163312,-0.0327869930304931,1.32649623876382e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0519826391189261,0.0043666770739867,-0.06054132618394,-0.0434239520539122,1.53548795573011e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40052,-0.066969485204454,0.00562832674594898,-0.078001005626514,-0.055937964782394,1.64322805300237e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,39866,0.0482975304174476,0.00407329007850458,0.0403138818635786,0.0562811789713165,2.69806283987003e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0319517989545243,0.00269713539264148,-0.0372381843241016,-0.026665413584947,3.23153356547429e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.046745275094549,0.00395162625740402,-0.0544904625590609,-0.0390000876300372,3.74125563838463e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,40030,-0.0450882704416314,0.00381274048584101,-0.0525612417938798,-0.037615299089383,3.90062427669068e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.068441594377298,0.00578880738864191,0.0570955318955598,0.0797876568590361,4.30734064881886e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.02175000180664,0.00184083634144951,-0.025358041035881,-0.018141962577399,4.67245247274353e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.029803641285488,0.00252793354097529,-0.0347583910257995,-0.0248488915451764,5.95971483586179e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0557286589215989,0.00472719285000524,-0.0649939569076092,-0.0464633609355886,6.0375571594966e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0609411863962258,0.00517062784238172,-0.0710756169672939,-0.0508067558251576,6.22239941914515e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0252282560594901,0.00214429748094564,-0.0294310791221435,-0.0210254329968366,8.40710387334585e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0667217304348928,0.00568317527465123,-0.0778607539732092,-0.0555827068965764,1.06660957924311e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0848063002853108,0.00723685819095704,-0.0989905423395866,-0.070622058231035,1.45125331680852e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.0813035272337905,0.00694328752737986,-0.094912370787455,-0.067694683680126,1.53172339067157e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0333646022161719,0.00285387241007401,-0.038958192139917,-0.0277710122924268,1.9044826220009e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,37383,0.0208606061555794,0.00178591126661201,0.0173602200730199,0.024360992238139,2.26427408166669e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0521334420874657,0.00446949012497772,-0.060893642732422,-0.0433732414425094,2.59634262070089e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37348,-0.0489691486436065,0.00420432141472133,-0.0572096186164603,-0.0407286786707527,3.3388558211045e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0687475231388151,0.00590624840336036,-0.0803237700094014,-0.0571712762682288,3.4540509175246e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,39985,-0.0791739464429894,0.00682176058469664,-0.0925445971889948,-0.065803295696984,5.09773243795171e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37357,-0.0353832788718546,0.00304862601174703,-0.0413585858548788,-0.0294079718888304,5.37201265699875e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0364927839663582,0.00314893299937704,-0.0426646926451372,-0.0303208752875792,6.21346893341003e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,39826,-0.0289672139500863,0.00250646997712479,-0.0338798951052509,-0.0240545327949217,9.02311961312701e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37388,-0.0301294448251545,0.00261699689417665,-0.0352587587377407,-0.0250001309125682,1.57445069954472e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39489,-0.0707544517120229,0.00617765320932011,-0.0828626520022903,-0.0586462514217554,2.98907560868864e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.0929791921045656,0.0081212302436839,-0.108896803382186,-0.0770615808269452,3.30777539310428e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.0927809866771421,0.00812205791254945,-0.108700220185739,-0.0768617531685452,4.20219591819558e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0487324322348507,0.004266220017897,-0.0570942234699288,-0.0403706409997725,4.45088612789396e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,39868,0.0555927223145226,0.00487073372239182,0.0460460842186347,0.0651393604104106,4.67231776706111e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.0940533978479454,0.00824450095615296,-0.110212619722005,-0.0778941759738856,5.2706939052131e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39477,-0.0565978847774885,0.0049660147469842,-0.0663312736815775,-0.0468644958733995,5.68189110678959e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.0607850140727041,0.00533347141622944,-0.0712386180485138,-0.0503314100968944,5.93745611276832e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0613045622508327,0.00539315712527681,-0.0718751502163753,-0.0507339742852902,7.98730754344495e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0580428820347865,0.00510511962248312,-0.0680489164948534,-0.0480368475747196,8.10118416766635e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0444134954438936,0.00391015979630585,-0.0520774086446531,-0.0367495822431341,8.74184466473057e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.028864186606492,0.00254246231027209,-0.0338474127346253,-0.0238809604783587,9.32313927579196e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39477,-0.0675581366454119,0.00595450361091175,-0.0792289637227989,-0.0558873095680248,1.01808174381402e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0561807288990785,0.00495364916122043,-0.0658898812550705,-0.0464715765430864,1.06301175319494e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,39913,-0.0581646453828149,0.00512925569633851,-0.0682179865476384,-0.0481113042179914,1.08113814478236e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,36763,-0.0255706381476486,0.00225596928341378,-0.0299923379431396,-0.0211489383521576,1.22027970813939e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0300755429983227,0.00265570889958075,-0.0352807324415009,-0.0248703535551444,1.35132288439262e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0683918018072889,0.00604560486931607,-0.0802411873511484,-0.0565424162634294,1.47104009398852e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0403297435076526,0.00356868006767226,-0.0473243564402902,-0.033335130575015,1.67328447157412e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.086129214805211,0.0076200184356938,-0.101064450939171,-0.0711939786712511,1.7321249229223e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0755353743402726,0.00669811266406318,-0.0886636751618364,-0.0624070735187087,2.32001357925994e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,39315,-0.04320479599817,0.00383485188818844,-0.0507211056990194,-0.0356884862973207,2.50313362351985e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0399611005075504,0.00354988739556635,-0.0469188798028605,-0.0330033212122404,2.76846045117439e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40058,-0.0589963284872935,0.00524305241877264,-0.0692727112280879,-0.0487199457464992,2.89765268746517e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0676406415790643,0.00601378025679318,-0.079427650882379,-0.0558536322757497,3.205902197111e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.067711291678138,0.00602747347890032,-0.0795251396967826,-0.0558974436594933,3.57993303902819e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0682110994666441,0.00607690866245686,-0.0801218404450595,-0.0563003584882286,4.18245715004286e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,39788,-0.0382566211533703,0.00341861448842567,-0.0449571055506846,-0.0315561367560559,5.80879861767079e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.0562532505797808,0.00502999241694929,-0.0661120357170014,-0.0463944654425602,6.28245872475004e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,39858,-0.0263680319294797,0.00235941185882718,-0.0309924791727809,-0.0217435846861784,6.86234234249929e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0332371842220409,0.00297653525869334,-0.0390711933290799,-0.027403175115002,7.58971876420755e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37382,-0.117617017257668,0.0105779455323563,-0.138349790501087,-0.0968842440142498,1.3477781167988e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37445,0.0506877930163382,0.00456271127706631,0.0417448789132883,0.0596307071193882,1.50305580077709e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0543909759464387,0.00490782807560416,-0.0640103189746228,-0.0447716329182545,1.94711094359873e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,39563,-0.0520766030729511,0.00469908906272072,-0.0612868176358837,-0.0428663885100185,1.9495888401706e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0875045150039519,0.00789937674981615,-0.102987293433592,-0.0720217365743123,2.04928387022547e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.0721128341538374,0.00651057006235238,-0.0848735514760481,-0.0593521168316267,2.0766746040112e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0412001482513662,0.00372736175825872,-0.0485057772975533,-0.0338945192051791,2.67388870314069e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,37043,-0.0640457778173662,0.00579312505157837,-0.0754003029184598,-0.0526912527162726,2.74553695373428e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0317100049102773,0.00287306169248864,-0.0373412058275551,-0.0260788039929996,3.19628613613687e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0415341602862422,0.00376430227750938,-0.0489121927501606,-0.0341561278223238,3.34104707866966e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,39868,-0.055901292057225,0.00507966131167321,-0.0658574282281045,-0.0459451558863455,4.56141798089372e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0696814039369746,0.00633610276631859,-0.082100165358959,-0.0572626425149901,5.16174154466156e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0625000581244777,0.00568529510910987,-0.0736432365383331,-0.0513568797106224,5.17303210468167e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0743118088620834,0.00676061896624336,-0.0875626220359204,-0.0610609956882464,5.53005631433033e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0521325028236477,0.00474712430883893,-0.061436866468972,-0.0428281391783234,5.85964712241848e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0442817769939233,0.00403326827908797,-0.0521869828209358,-0.0363765711669109,6.31038772213751e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39477,-0.077391959175619,0.00705443404672898,-0.0912186499072078,-0.0635652684440302,6.68459976509467e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.0958269001213363,0.00873316743264408,-0.112943908289319,-0.0787098919533539,6.76747853015742e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,39787,-0.0257679126032273,0.00234975933159316,-0.0303734408931499,-0.0211623843133047,6.99048861411994e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0292337979173448,0.00266764800250047,-0.0344623880022457,-0.0240052078324439,7.5940441917619e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.0242340002210537,0.00221802714981858,-0.0285813334346982,-0.0198866670074093,1.08321032268458e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0533415346536744,0.0048800868847519,-0.0629065049477881,-0.0437765643595607,1.08379680831153e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0286953122082626,0.00262800892317086,-0.0338462096976775,-0.0235444147188478,1.17099093460408e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,36879,-0.0728399462831937,0.00667368168519115,-0.0859203623861683,-0.0597595301802191,1.29414257571032e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.101489574640366,0.00930758356168913,-0.119732438421277,-0.0832467108594558,1.44679626615885e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.041697939077502,0.00383122352691243,-0.0492071371902503,-0.0341887409647536,1.71614808510379e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0582969041462065,0.00536782372216411,-0.0688178386416482,-0.0477759696507648,2.22823202294754e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0323421059613342,0.00298241155522562,-0.0381876326095764,-0.026496579313092,2.74901527089794e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0569780767954043,0.00526111022252053,-0.0672898528315445,-0.046666300759264,3.09941278080265e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0452999202037001,0.00418752461629136,-0.0535074684516312,-0.037092371955769,3.67638760731651e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.0642124150941799,0.00593620038757104,-0.0758473678538191,-0.0525774623345407,3.68612413129211e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,39846,-0.0297946217971921,0.00275541941854984,-0.0351952438575498,-0.0243939997368344,3.70509680023535e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0306218623634445,0.00283217807069189,-0.0361729313820006,-0.0250707933448884,3.73520149496396e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0241333255115726,0.00223723204910333,-0.0285183003278151,-0.0197483506953301,4.89255325696679e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0479959308735615,0.00445422580663902,-0.0567262134545739,-0.039265648292549,5.5686981653346e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40009,-0.118627180460992,0.0110169731875235,-0.140220447908538,-0.0970339130134456,6.03925956827126e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.0315220725748184,0.00293022701811949,-0.0372653175303326,-0.0257788276193042,6.75480858129905e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,37411,-0.0457532464029862,0.00425424517967568,-0.0540915669551505,-0.0374149258508219,7.2265702346309e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.058753661791638,0.00547077387669999,-0.06947637858997,-0.0480309449933061,8.20296142309393e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.0267712566535038,0.00249536120998646,-0.0316621646250772,-0.0218803486819303,9.23216068975279e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0490213505776168,0.00457430355039149,-0.0579869855363841,-0.0400557156188494,1.08724377229329e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40030,-0.0268194806579932,0.00250708779520572,-0.0317333727365964,-0.02190558857939,1.28405399977414e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,39858,-0.0655710011354823,0.00613677744328574,-0.0775990849243224,-0.0535429173466423,1.47178113910465e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.0403976110884891,0.00378352652370971,-0.0478133230749602,-0.0329818991020181,1.6570296282728e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,39713,-0.0327061013096354,0.00306951138191831,-0.0387223436181953,-0.0266898590010755,2.02690486323551e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0412625356203611,0.0038743878035609,-0.0488563357153404,-0.0336687355253817,2.21603413424153e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,39585,-0.050839359958933,0.00478848430426731,-0.0602247891952969,-0.0414539307225691,3.04800393522132e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,40009,-0.0350027655079287,0.00329946044181472,-0.0414697079738855,-0.0285358230419718,3.31394375820884e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0656882901490147,0.00619354455283226,-0.0778276374725659,-0.0535489428254635,3.40969550383127e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.0188429882913063,0.00177675140281518,-0.0223254210408241,-0.0153605555417885,3.56304883783475e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0711691611983669,0.00671953533393526,-0.08433945045288,-0.0579988719438538,3.99301996609969e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0477498872247164,0.00450774807438841,-0.0565850734505177,-0.0389147009989151,4.07074587974172e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,39858,-0.0455946713906222,0.00431419669400167,-0.0540504969108655,-0.0371388458703789,5.08092977588229e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40058,-0.08476914471856,0.00802447814604576,-0.10049712188481,-0.0690411675523103,5.32713020374317e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0440932480995937,0.00417470460503227,-0.0522756691254569,-0.0359108270737304,5.67625013454621e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,39858,-0.0396441900180285,0.0037581407385463,-0.0470101458655793,-0.0322782341704778,6.25386956819915e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0507770636640704,0.00481410921400136,-0.060212717723513,-0.0413414096046277,6.37183747776596e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0399647520138719,0.00378993253006076,-0.047393019772791,-0.0325364842549528,6.7843060114833e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,39885,-0.0236819762324442,0.00224671011753518,-0.0280855280628131,-0.0192784244020752,6.81386892290693e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40052,-0.0194739155326493,0.00184863726840381,-0.0230972445787207,-0.0158505864865778,7.28597813314917e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,37437,-0.0460417269715611,0.0043768637600857,-0.0546203799413291,-0.0374630740017932,8.84082519977985e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,39843,-0.0338355773446267,0.00321854242987763,-0.0401439205071868,-0.0275272341820665,9.16264040831209e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37056,-0.0929584758721257,0.00886950560545501,-0.110342706858818,-0.0755742448854338,1.33575342216395e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0654775062614385,0.00625455317768836,-0.0777364304897077,-0.0532185820331693,1.51504817422889e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,39587,-0.0513554436286914,0.00491074647257634,-0.060980506714941,-0.0417303805424418,1.63689723979469e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0367807594362685,0.00351946475847523,-0.0436789103628799,-0.029882608509657,1.75739032501365e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0440756064352876,0.00423000044210547,-0.0523664073018143,-0.0357848055687608,2.43124427973647e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.086407515385754,0.00829483325429731,-0.102665388564177,-0.0701496422073313,2.51131687434554e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.0328569782659269,0.00315486444895977,-0.0390405125858881,-0.0266734439459658,2.55988369950108e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,40058,-0.0378313379355536,0.00363639706762692,-0.0449586761881024,-0.0307039996830048,2.87006123251919e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0323765855974098,0.00311408724109659,-0.0384801965899591,-0.0262729746048605,3.08747498595356e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0668187419858048,0.00644639223395404,-0.0794536707643547,-0.0541838132072549,4.27318127217209e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,39720,-0.0507602535103071,0.00490173182108871,-0.0603676478796409,-0.0411528591409732,4.74474560401113e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0640741237431369,0.00619107032792774,-0.0762086215858753,-0.0519396259003986,5.04005735319807e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0599670507784969,0.00579862082581169,-0.0713323475970878,-0.0486017539599059,5.47553662149811e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0485099286083333,0.00471113131216854,-0.0577437459801836,-0.039276111236483,8.73620281635456e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39173,-0.0206761988903218,0.00200982246471677,-0.0246154509211667,-0.016736946859477,9.65062184158178e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,39713,-0.0780596921856154,0.00760000589973479,-0.0929557037490956,-0.0631636806221352,1.13760651796965e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,37415,-0.0440156947595214,0.00428456346731055,-0.0524134391554501,-0.0356179503635928,1.14742700831411e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0497582290793983,0.00484443663547714,-0.0592533248849335,-0.0402631332738631,1.17038672765966e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39314,-0.0897619011097023,0.00874598899927812,-0.106904039548287,-0.0726197626711172,1.23831061653555e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,37430,-0.0552995671896866,0.00539679462110079,-0.0658772846470442,-0.0447218497323291,1.5038150101647e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.0391112428922612,0.00381917739105725,-0.0465968305787334,-0.031625655205789,1.55019803274888e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0209039838289865,0.00204135990436269,0.0169029184164356,0.0249050492415374,1.56339910013388e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.0823424925898915,0.00805371007208182,-0.0981277643311718,-0.0665572208486111,1.8392414866464e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,39587,-0.0464513979650497,0.00454388288382016,-0.0553574084173372,-0.0375453875127622,1.86856017019605e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0605427209278333,0.00593073822510065,-0.0721669678490306,-0.0489184740066361,2.16188860556825e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0533354588494386,0.00522639066949871,-0.0635791845616561,-0.0430917331372212,2.24534372722143e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.0887200770158468,0.00869792054842959,-0.105768001290769,-0.0716721527409248,2.34907207640471e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37124,-0.0483261618827464,0.00474186981479772,-0.05762022671975,-0.0390320970457429,2.66291225666447e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.032949534161385,0.0032364249527931,-0.0392929270688595,-0.0266061412539105,2.87499567630508e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.120573150897631,0.0118621356244666,-0.143822936721585,-0.0973233650736764,3.38378990427423e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,37453,-0.0705842034034996,0.00694861908165201,-0.0842034968035376,-0.0569649100034617,3.72269432229372e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,39880,-0.0565745103562377,0.0055720880132327,-0.0674958028621738,-0.0456532178503016,3.79468211000917e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.063210146012012,0.0062371239152753,-0.0754349088859515,-0.0509853831380724,4.73252154602816e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.0273814391947787,0.00270270312811607,-0.0326787373258862,-0.0220841410636712,4.75880528748256e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0268091864324322,0.00264895331911688,-0.0320011349379013,-0.0216172379269631,5.28296105265542e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0493555552456577,0.00487519508441256,-0.0589109376111063,-0.0398001728802091,5.30591115106691e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,37437,0.0384079465724868,0.00379796083366346,0.0309639433385064,0.0458519498064672,5.89489458007847e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0302905512438391,0.00299631512933812,0.0244177735903364,0.0361633288973418,5.93247640265532e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0439443341483909,0.0043489088112084,-0.0524681954183594,-0.0354204728784224,6.43655205998438e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,39739,-0.0557990577269465,0.00553048551978362,-0.0666388093457224,-0.0449593061081706,7.26608237065608e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0286306038744008,0.00284005864386025,-0.0341971188163669,-0.0230640889324347,8.13787240957219e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0347898368176568,0.00345520224897063,-0.0415620332256393,-0.0280176404096744,9.20296782790438e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,39749,-0.0500212856132967,0.00498808451767984,-0.0597979312679492,-0.0402446399586442,1.34743896092301e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0444178363526009,0.00443161365645283,-0.0531037991192484,-0.0357318735859534,1.41963518484438e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,40040,-0.0185733266580503,0.00185336523672646,-0.0222059225220342,-0.0149407307940665,1.43792753948347e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.0220052930877971,0.00219547410656689,-0.0263084223366682,-0.017702163838926,1.46630346068619e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0415710488202489,0.00415800279355353,-0.0497207342956138,-0.033421363344884,1.82650564103311e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0677752791711341,0.00678047126130895,-0.0810650028432997,-0.0544855554989686,1.87281844847989e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,39901,-0.0280171728853605,0.00280625904177681,-0.0335174406072431,-0.022516905163478,2.09994103288477e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.02778668542263,0.00278462475182384,-0.0332445499362048,-0.0223288209090553,2.21858367761722e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0228534566672395,0.00229785774836933,-0.0273572578540434,-0.0183496554804356,3.16642121471193e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0395014470767716,0.0039789835802824,-0.0473002548941251,-0.0317026392594181,3.80556376764874e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0278290252136553,0.00280363059176433,-0.0333241411735134,-0.0223339092537972,3.84464686988709e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0581129758134553,0.00586076420398012,-0.0696000736532563,-0.0466258779736542,4.1675270828116e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.042744100955641,0.00431084117018357,0.0342948522620812,0.0511933496492008,4.2726984179195e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.0241813800520449,0.00244355063528824,-0.0289707392972099,-0.01939202080688,5.18683761622544e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.0365251455207663,0.00369272022190033,-0.043762877155691,-0.0292874138858417,5.29528569736608e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37037,-0.0404905181001401,0.00410043044917068,-0.0485273617805146,-0.0324536744197655,6.43670941640346e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40011,-0.0289372597044498,0.00293353642945175,-0.0346869911061752,-0.0231875283027243,6.90020140780012e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,39931,-0.095004840900505,0.00963150702148297,-0.113882594662612,-0.0761270871383984,6.92774452273206e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0523381591035139,0.00532093567997302,-0.062767193036261,-0.0419091251707668,9.11665327732791e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,39477,-0.0438387972856112,0.00446060843620744,-0.0525815898205778,-0.0350960047506446,9.92923015097747e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0499347906541904,0.00509012984619552,-0.0599114451527336,-0.0399581361556472,1.17990548807656e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0489811296736301,0.00499447974685502,0.0391919493697942,0.0587703099774659,1.21601181464402e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0460588224940382,0.00469780123117606,-0.0552665129071433,-0.0368511320809331,1.28204869759292e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0462742678571743,0.00472259957192001,-0.0555305630181375,-0.0370179726962111,1.3215475630013e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.0342580377054105,0.00349573696416622,-0.0411096821551763,-0.0274063932556447,1.34402143698203e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0197210198467395,0.00201713051817693,-0.0236745956623663,-0.0157674440311127,1.63582087476103e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0503311892130272,0.00514763991668332,-0.0604205634497266,-0.0402418149763279,1.6693941380049e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0631886851567268,0.00646787907081876,-0.0758657281355315,-0.050511642177922,1.75767685705438e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0646571706336682,0.00664302256512618,-0.0776774948613155,-0.0516368464060209,2.57921654387635e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37124,-0.0267572950597215,0.00276007003583648,-0.032167032329961,-0.021347557789482,3.77128980520601e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0367059933747458,0.00378971716948947,-0.0441338390269452,-0.0292781477225464,4.11292767934796e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0705023345659181,0.00728962198486402,-0.0847899936562516,-0.0562146754755846,4.5721384018756e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.0357699778766871,0.00369913020198272,-0.0430202730725732,-0.028519682680801,4.65715095121487e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37056,-0.0784628662927247,0.00811298708668047,-0.0943643209826185,-0.062561411602831,4.72691669918854e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0555731087801951,0.00577126915751227,-0.0668847963289191,-0.044261421231471,6.89767247426872e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.0330200020534004,0.00343899625801313,-0.0397604347191062,-0.0262795693876947,9.00705221595026e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,39913,-0.0505422881551129,0.00527029225679421,-0.0608720609784296,-0.0402125153317962,1.00687978993184e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0546130384476199,0.00569859255025935,-0.0657822798461283,-0.0434437970491116,1.07422645015457e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40058,-0.036634970484286,0.00382341643240676,-0.0441288666918032,-0.0291410742767687,1.08937131612707e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,39973,-0.0489189972216666,0.0051088201378259,-0.0589322846918054,-0.0389057097515278,1.15869495592369e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0359515901599324,0.0037619292958279,-0.043324971579755,-0.0285782087401097,1.38826184392394e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,37043,-0.0682918421093742,0.00714796765744353,-0.0823018587179635,-0.0542818255007848,1.46507191150008e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0523358917558186,0.00549141866089369,-0.0630990723311702,-0.041572711180467,1.7850487032153e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,39419,-0.0623038034752715,0.00653717899835259,-0.0751166743120426,-0.0494909326385004,1.78821899464948e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0883962180606686,0.00928236760897212,-0.106589658574254,-0.0702027775470832,1.91751685290994e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,37056,-0.0292915001618265,0.00307740396659886,-0.0353232119363602,-0.0232597883872927,2.06305692955453e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0217837099544763,0.00228948096329859,0.0172963272664111,0.0262710926425415,2.07487178545926e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39477,-0.0525580875486603,0.00553110034098849,-0.0633990442169978,-0.0417171308803229,2.34516750230097e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,39931,-0.0324743309965922,0.00342152738126046,-0.0391805246638627,-0.0257681373293217,2.59769364582998e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0616796982647018,0.00650490864326557,-0.0744293192055023,-0.0489300773239012,2.83378495313294e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,-0.0306940735374929,0.00323823060674184,-0.0370410055267069,-0.0243471415482789,2.92594073312564e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0363943015857734,0.00383989230055294,-0.0439204904948571,-0.0288681126766896,2.95523096251016e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.0517108284462776,0.00546018621051421,-0.0624127934188854,-0.0410088634736697,3.17457073561447e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0277878420658689,0.0029340313146127,0.022037140689228,0.0335385434425098,3.20676309725766e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,39587,-0.103183292564835,0.0109047787033072,-0.124556658823317,-0.0818099263063533,3.43284524147321e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37021,-0.0425943139851427,0.00450910882226242,-0.051432167276777,-0.0337564606935084,4.09502759513874e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0304005979368333,0.00322565834321425,-0.0367228882895333,-0.0240783075841334,5.02607207288672e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0451553531435237,0.00479722990033029,-0.0545579237481711,-0.0357527825388764,5.47408288926493e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,39913,-0.0510040438829156,0.00541917099658039,-0.0616256190362132,-0.0403824687296181,5.52474420605537e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0297934283451911,0.00316792352556411,0.0235842982350854,0.0360025584552968,5.90769097680948e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0720624269001237,0.00766102444833003,-0.0870780348188505,-0.0570468189813968,5.95197398270055e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,39587,-0.0709631652102596,0.00754800162571445,-0.0857572483966599,-0.0561690820238593,6.09971318814131e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,37437,-0.100354457893838,0.0106749169237373,-0.121277295064363,-0.0794316207233125,6.2593975642746e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,39750,-0.0591764388365164,0.00629989431197855,-0.0715242316879944,-0.0468286459850385,6.59132406483295e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0528409950492889,0.00562680245398811,-0.0638695278591056,-0.0418124622394722,6.75054938032249e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.115816323327716,0.0123468402648928,-0.140016130246906,-0.0916165164085262,7.44166309988827e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.0467460059596742,0.00499804859902065,-0.0565421812137547,-0.0369498307055937,9.62407172780243e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0759641843011447,0.00812583123791586,-0.0918908135274598,-0.0600375550748296,1.00431708408082e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0527569279428205,0.00565722579776842,-0.0638450905064466,-0.0416687653791944,1.24388163897872e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,39846,-0.0331124801911319,0.0035526995899686,-0.0400757713874703,-0.0261491889947934,1.30751824591988e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0449686430147506,0.00482797649499755,-0.0544314769449458,-0.0355058090845555,1.41611992091479e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.020729711120233,0.00222770983962169,-0.0250960224058916,-0.0163633998345745,1.53660078283415e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.0198735470947305,0.00213615735087348,-0.0240604155024425,-0.0156866786870185,1.56533118429126e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,39771,-0.0496694154298625,0.00534197906412159,-0.0601396943955408,-0.0391991364641842,1.61397775032308e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0872936005694765,0.0094001883752036,-0.105717969784876,-0.0688692313540774,1.83648149887483e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,-0.0316736509836411,0.00341131072432142,-0.0383598200033111,-0.0249874819639711,1.8608883036471e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,37437,0.0330340789504689,0.00356166471354163,0.0260532161119273,0.0400149417890104,2.04265830596241e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,37388,-0.0189479921325644,0.00204454231564778,-0.022955295071234,-0.0149406891938948,2.18757763471116e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,39749,-0.0787306037742663,0.00849785986271869,-0.0953864091051949,-0.0620747984433376,2.20052353265231e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.045452039559975,0.0049167571417245,-0.055088883557755,-0.035815195562195,2.65975764159218e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.0788077979294208,0.00853292339933693,-0.0955323277921212,-0.0620832680667205,2.8834918103167e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.041935102406081,0.00455155096426902,-0.0508561422960482,-0.0330140625161137,3.54518031914129e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0514786593028404,0.00559412539068509,-0.0624431450685831,-0.0405141735370976,3.92360476426621e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0665434182555984,0.00723219485080235,-0.080718520163171,-0.0523683163480258,3.96993103191518e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.0197019015265955,0.00214225375429755,-0.0239007188850187,-0.0155030841681723,4.13474394998165e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0462252338808128,0.00502632217328924,-0.0560768253404597,-0.0363736424211658,4.14769066848867e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,39882,-0.0807537275128692,0.00878437684625406,-0.0979711061315271,-0.0635363488942112,4.28497746296748e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,39790,-0.037967415963212,0.00413610571481575,-0.0460741831642509,-0.0298606487621731,4.85194591115914e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37124,-0.0473646169816993,0.00516933045013211,-0.0574965046639582,-0.0372327292994404,5.79973788627989e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.0275198161993387,0.00300357227195667,-0.0334068178523737,-0.0216328145463036,5.81764863560324e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,39749,0.0290522297640672,0.00317186891906226,0.0228353666827052,0.0352690928454293,5.84598907936703e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.0302066052670482,0.00329819061909708,-0.0366710588804785,-0.0237421516536179,5.88691781212615e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0334293851556582,0.00365183613761085,-0.0405869839853755,-0.026271786325941,6.14500066794618e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0202486953631695,0.00221237900377476,-0.024584958210568,-0.0159124325157709,6.23031711176422e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0484676945688016,0.0052976699539011,-0.0588511276784478,-0.0380842614591554,6.43063499968993e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0742006283827956,0.00812729080391723,-0.0901301183584734,-0.0582711384071178,7.685784882092e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0536636450091785,0.00587705838850105,-0.0651826794506406,-0.0421446105677165,7.72989660501181e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-0.0299102470863894,0.00327833571278583,-0.0363357850834496,-0.0234847090893292,8.109553094626e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0715061919495428,0.00784290751238828,-0.0868782906738238,-0.0561340932252617,8.58971664168684e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.0315883585625704,0.00346933956691183,-0.0383882641137176,-0.0247884530114232,9.83905760685467e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0203436929938919,0.00223735091867945,-0.0247289007945036,-0.0159584851932802,1.07678618664741e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0559808870614608,0.0061670876118164,-0.068068378780621,-0.0438933953423007,1.2398741010483e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37388,-0.0533177968995285,0.00587854385194375,-0.0648397428493383,-0.0417958509497188,1.35336706508585e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37382,-0.0288842471273275,0.00319035316064951,-0.0351373393222005,-0.0226311549324545,1.56990237966801e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.0305894505030968,0.00338545152026952,-0.0372249354828251,-0.0239539655233686,1.84975330951324e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.0270866004134967,0.00299857590984713,-0.032963809196797,-0.0212093916301963,1.89722957976608e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,39931,0.0372953001494224,0.00414404010540119,0.0291729815428361,0.0454176187560088,2.51093546391579e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0461437945414385,0.00513626662405474,-0.0562108771245858,-0.0360767119582912,2.96884931467697e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0398414488830382,0.00443661329609725,-0.0485372109433888,-0.0311456868226876,2.9997200817034e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0852620464080972,0.00949856863523652,-0.103879240933161,-0.0666448518830336,3.10186207184127e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0500760799055912,0.00558633856998184,-0.0610253035027556,-0.0391268563084268,3.47325631033164e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0388457913137417,0.00433352103720914,-0.0473394925466717,-0.0303520900808118,3.47888660999475e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40009,-0.0317688755058147,0.00354724494657085,-0.0387214756010935,-0.0248162754105358,3.72960381520325e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0306927934573738,0.00342903978296934,-0.0374137114319937,-0.0239718754827539,3.99534731070951e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0267023920409533,0.00298554262268541,-0.0325540555814167,-0.0208507285004899,4.15569264049352e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.0170039841914671,0.0019046733058961,-0.0207371438710234,-0.0132708245119107,4.91191346679081e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0384335097961882,0.00431630477149574,-0.0468934671483199,-0.0299735524440566,5.94688007272603e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,39684,-0.0326401071405422,0.00367037954748778,-0.0398340510536183,-0.0254461632274662,6.58927799350604e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.061385154711037,0.00690532094128739,-0.0749195837559603,-0.0478507256661138,6.7741617030528e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0446938321754198,0.00503126091439195,-0.0545551035676281,-0.0348325607832116,7.30333449182367e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0418169605704977,0.00471549936481836,-0.0510593393255417,-0.0325745818154537,8.39641645337041e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0617747732526249,0.00697738166303163,-0.0754504413121669,-0.0480991051930829,9.36580800398941e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0346118160812522,0.00391235374575187,-0.0422800294229259,-0.0269436027395786,9.95022250123031e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39405,-0.099711595846298,0.0112708478691159,-0.121802457669765,-0.0776207340228309,9.95526150187111e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0569974209284276,0.00645257017801601,-0.069644458477339,-0.0443503833795162,1.14386534192912e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0408301477221796,0.00462358986138252,-0.0498923838504893,-0.0317679115938698,1.14762674771591e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0576729276967213,0.00653523653804683,-0.0704819913112931,-0.0448638640821495,1.20575138217666e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39477,-0.0318484175242853,0.00360938123043925,-0.0389228047359462,-0.0247740303126244,1.22189520595993e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0218649209888207,0.00247896622653853,-0.0267236947928362,-0.0170061471848052,1.25955731615178e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0565865886192888,0.00641628609471304,-0.0691625093649263,-0.0440106678736512,1.27252476896759e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,39788,-0.0246421886409854,0.00279568660758148,-0.0301217343918451,-0.0191626428901257,1.32612094993369e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,37056,-0.0381845075924394,0.00433876677056675,-0.0466884904627502,-0.0296805247221286,1.52605531800351e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0389431289298542,0.00442781453594626,-0.0476216454203088,-0.0302646124393995,1.57291444336429e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0313755868522918,0.00356653395893711,-0.0383659934118085,-0.024385180292775,1.575034736587e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,37453,-0.0463839247893171,0.00527909151404648,-0.0567309441568482,-0.036036905421786,1.72816174378137e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,39615,-0.0626270150102439,0.00712934496102315,-0.0766005311338493,-0.0486534988866385,1.73146629823718e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0727724246578068,0.00828699139988831,-0.0890149278015879,-0.0565299215140257,1.77296299647456e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0703756151299237,0.00801493549440646,-0.0860848886989604,-0.0546663415608871,1.78863000330672e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0549744895055744,0.0062865261546587,-0.0672960807687055,-0.0426528982424434,2.45261616599063e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0512703769357377,0.0058651788581985,-0.0627661274978068,-0.0397746263736686,2.53124667017958e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37169,-0.107723986912636,0.0123286373668389,-0.13188811615164,-0.0835598576736315,2.66067331084529e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,39862,0.0180983583823863,0.00207245443309083,0.0140363476935283,0.0221603690712444,2.72607999461284e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0685573625623994,0.00786486525566527,-0.0839724984635033,-0.0531422266612954,3.18890851263347e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.0215561058125993,0.00247523030803879,-0.0264075572163553,-0.0167046544088433,3.37027463076973e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0711116717440355,0.00816624507101769,-0.0871175120832302,-0.0551058314048408,3.38916770905629e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0224377542791091,0.00257657867160271,-0.0274878484754504,-0.0173876600827678,3.43581373680518e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0428377613511418,0.00492124202109228,-0.0524833957124827,-0.033192126989801,3.49125700862369e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0275893642907244,0.00317172973955014,-0.0338059545802427,-0.0213727740012061,3.74663235962658e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,39868,-0.0277744684314049,0.00319422933250268,-0.0340351579231101,-0.0215137789396996,3.79324654746019e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.0253782986765503,0.0029223602861682,-0.0311061248374399,-0.0196504725156606,4.17688313623831e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.0250496621564269,0.00288539288084218,-0.0307050322028776,-0.0193942921099763,4.27210589654548e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,37347,-0.023297897894638,0.00268405206693078,-0.0285586399458223,-0.0180371558434537,4.40261163411482e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.0807095171280427,0.00931074715977204,-0.0989585815611959,-0.0624604526948895,4.7972586599292e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0291766065602388,0.00336626742882044,-0.0357744907207269,-0.0225787223997508,4.84377387032591e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0536338868204632,0.00619975854158509,-0.06578541356197,-0.0414823600789564,5.59733377881885e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0501467933724644,0.00579642744429668,-0.0615077911632858,-0.0387857955816429,5.65791968537949e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39477,-0.0336729327307967,0.00389622687321407,-0.0413095374022962,-0.0260363280592971,6.02875700431342e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.0471619533004667,0.00545958064004016,-0.0578627313549454,-0.0364611752459879,6.2256110148639e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,39730,0.0232163931296961,0.00268765403691421,0.0179485912173442,0.0284841950420479,6.24892498778376e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37388,-0.058537844489567,0.00679029384694681,-0.0718468204295827,-0.0452288685495512,7.37985654929487e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0538483888221923,0.00625431768712678,-0.0661068514889608,-0.0415899261554238,7.98514094051958e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0333432490546542,0.00387929905749992,-0.040946675207354,-0.0257398229019543,9.24258363265295e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,39892,-0.0307991996658036,0.00358768927036725,-0.0378310706357234,-0.0237673286958838,9.93324461076301e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,37453,-0.0156324440755986,0.00182059999347045,-0.0192008200628007,-0.0120640680883965,9.93817867353388e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0446823979178666,0.00520579607045754,-0.0548857582159634,-0.0344790376197698,1.00677251071525e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39421,-0.0378471259555605,0.00441050532594876,-0.0464917163944201,-0.0292025355167009,1.0270782918922e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,39906,0.0314773771314786,0.00367862874587425,0.0242672647895651,0.0386874894733921,1.26380486884886e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0289840628746396,0.00338787666664487,-0.0356243011412636,-0.0223438246080157,1.28047333423046e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0247192733641275,0.00289099257176843,-0.0303856188047936,-0.0190529279234613,1.35594294025964e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.0270452075581775,0.00316391967281799,-0.0332464901169007,-0.0208439249994542,1.36396998827997e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,39660,-0.0305160650522371,0.00358597014596786,-0.0375445665383341,-0.0234875635661401,1.89610508346655e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0510473611126705,0.00600878785004669,-0.062824585298762,-0.039270136926579,2.17589797912683e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,39858,-0.036354054660568,0.00428678138331802,-0.0447561461718713,-0.0279519631492646,2.4358576367632e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0517560501161775,0.00610901369594849,-0.0637297169602365,-0.0397823832721184,2.62303892099539e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0409602276393454,0.0048383974164876,-0.0504434865756611,-0.0314769687030297,2.76475055994472e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0589815548790938,0.00697204330449882,-0.0726467597559115,-0.0453163500022761,2.96043478499544e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37368,-0.0807786063615121,0.00956143513218324,-0.0995190192205913,-0.062038193502433,3.25329305287452e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,39788,-0.0553097453801889,0.00656570982392068,-0.0681785366350734,-0.0424409541253044,3.94443144709663e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0492823410859362,0.00585332503949718,-0.0607548581633507,-0.0378098240085218,4.09660439825659e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,39796,-0.0258766450997128,0.00307405340592978,-0.0319017897753352,-0.0198515004240904,4.16018220035415e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,37437,-0.0451257301545081,0.00536860270761757,-0.0556481914614385,-0.0346032688475776,4.6816025909096e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0249914827302033,0.00297618177028104,0.0191581664604525,0.0308247989999542,4.95216808351244e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.043803762122589,0.00521860873372782,-0.0540322352406956,-0.0335752890044825,5.09977401679736e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.06279457539971,0.00748409269761178,-0.0774633970870291,-0.0481257537123909,5.25516807322177e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37388,-0.0445598924202626,0.00531192643860901,-0.0549712682399363,-0.034148516600589,5.40100354323372e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0447990598491271,0.00534423328133692,-0.0552737570805474,-0.0343243626177067,5.59352833762567e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.0639385588910888,0.00763411675005829,-0.078901427721203,-0.0489756900609746,6.04067333225812e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0300689072103513,0.00359123046942581,-0.0371077189304259,-0.0230300954902767,6.09494285071721e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,37252,-0.0424226209999851,0.00507183688258289,-0.0523634212898475,-0.0324818207101226,6.63811362886832e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0512772584714182,0.00613358952585664,-0.0632990939420972,-0.0392554230007392,6.87322693810328e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.0201806621699767,0.00241805506150411,-0.0249200500905248,-0.0154412742494286,7.63639126915209e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.0907052501162406,0.0108737408668344,-0.112017782215236,-0.0693927180172452,7.9180419145103e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0461064189285803,0.00552907519421385,-0.0569434063092394,-0.0352694315479211,8.11734367760289e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,39913,-0.0233600199928044,0.00280468240435168,-0.0288571975053337,-0.0178628424802751,8.80901186039874e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0549075945843861,0.00659313734861622,-0.0678301437876739,-0.0419850453810983,9.02872657308362e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.0270295739235127,0.0032467422754013,-0.0333931887832993,-0.0206659590637262,9.10037966191175e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.0211985166237405,0.00254859368101903,-0.0261937602385378,-0.0162032730089432,9.68471607186065e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.0871918345820699,0.0104847320354866,-0.107741909371624,-0.0666417597925161,9.95672089750057e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.0202171149178787,0.00243200522495992,-0.0249838451588001,-0.0154503846769572,1.02162086911198e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0260119957623288,0.00312997305154389,0.0198772485813028,0.0321467429433548,1.04401921607771e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37124,-0.0349301624713951,0.00420398231280902,-0.0431699678045008,-0.0266903571382894,1.05976958471133e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39476,-0.0553189457528687,0.00665925181650812,-0.0683710793132246,-0.0422668121925127,1.06063251920858e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0321249792789499,0.00387861371493622,-0.0397270621602249,-0.0245228963976749,1.29990023926322e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.032738131570427,0.00395504722238301,-0.0404900241262977,-0.0249862390145563,1.37733739590318e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0193578022810089,0.00233998862459834,-0.0239441799852217,-0.0147714245767962,1.43197378818472e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0475991424904137,0.00575556294128285,-0.0588800458553281,-0.0363182391254993,1.4416312783325e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,39858,0.0248292890382614,0.00300600527444787,0.0189375187003436,0.0307210593761793,1.57100361117117e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.0169481588146186,0.00205190350492925,-0.0209698896842799,-0.0129264279449572,1.59481438037636e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0341869761774518,0.00414104898752981,-0.0423034321930102,-0.0260705201618934,1.62780853571773e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,37306,-0.0744756967706799,0.00902963370657252,-0.092173778835562,-0.0567776147057978,1.76047534872292e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0419567367375114,0.00509381285708847,-0.0519406099374047,-0.031972863537618,1.90520934317813e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.0209289765193746,0.00254777712380494,-0.0259226196820323,-0.0159353333567169,2.28793932980772e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0228838284834967,0.00278968033537728,-0.0283516019408361,-0.0174160550261572,2.52512524151922e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,39931,-0.0379349273442786,0.0046275324793857,-0.0470048910038746,-0.0288649636846826,2.63449281449657e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,39777,-0.022128127743414,0.00270428314506563,-0.0274285227077426,-0.0168277327790853,2.98556351821555e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0462986546049963,0.00565833104424225,-0.0573889834517111,-0.0352083257582815,2.99476408316915e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0339701548401782,0.00415261793638999,-0.0421092859955026,-0.0258310236848539,3.08362576902233e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0258842178181095,0.00316486930671006,-0.0320873616592612,-0.0196810739769577,3.08437650535418e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0418302714403155,0.00511575495809452,-0.0518571511581807,-0.0318033917224502,3.17927517363385e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0458768215781597,0.00561950784535469,-0.0568910569550549,-0.0348625862012645,3.49106748471272e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0551919476896631,0.00676087260748655,-0.0684432580003367,-0.0419406373789894,3.50112005370036e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.020318908721281,0.00249224926258209,-0.0252037172759419,-0.0154341001666201,3.87401215382935e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0547315414945958,0.00672959167482319,-0.0679215411772493,-0.0415415418119423,4.49674234751302e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0266779786179022,0.00328145029985752,-0.033109621205623,-0.0202463360301815,4.60864369136106e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0151367274524434,0.00186254961813364,0.0114861302009015,0.0187873247039854,4.72366960572461e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0483695246747102,0.00596972758910499,-0.0600701907493559,-0.0366688586000644,5.77118030238185e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0447636560263374,0.00553342615073987,-0.0556091712817876,-0.0339181407708872,6.41098018953065e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0620663037729932,0.00767721806557001,-0.0771136511815105,-0.047018956364476,6.78488297032098e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0388727180938219,0.00481557272355414,-0.048311240631988,-0.0294341955556558,7.3976935022432e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0297191009838656,0.00368208680502109,-0.036935991121707,-0.0225022108460243,7.44265826517046e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.0336937330408879,0.00418419960930808,-0.0418947642751318,-0.0254927018066441,8.67052701407218e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0691261841789155,0.00859038136882702,-0.0859633316618165,-0.0522890366960146,9.08212424641052e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37340,-0.0364848682334925,0.00453962688552211,-0.0453825369291158,-0.0275871995378691,9.9703453924714e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0456680810555008,0.00568655578452961,-0.0568137303931788,-0.0345224317178227,1.03577936692191e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0391310099259457,0.00488414303029286,-0.0487039302653197,-0.0295580895865716,1.20926574852347e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40009,0.0280274302725193,0.00350177230734309,0.0211639565501269,0.0348909039949118,1.28797771890367e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0508079691800655,0.00634906191071792,-0.0632521305250727,-0.0383638078350584,1.30305122590212e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0548026229818794,0.00685204949415564,-0.0682326399904245,-0.0413726059733344,1.34955936590659e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,39587,-0.0377591721065275,0.00472406228482944,-0.0470183341847932,-0.0285000100282618,1.40842754218683e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.021887261471393,0.00273795025242284,-0.0272536439661417,-0.0165208789766442,1.41090566177031e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0379091848520836,0.00475525082023516,-0.0472294764597445,-0.0285888932444227,1.68905476097409e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0198216867714682,0.00248775042141632,-0.0246976775974442,-0.0149456959454922,1.72401772463981e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,39594,-0.0401769366321555,0.00504657775968303,-0.0500682290411343,-0.0302856442231768,1.81904742834304e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.035051671283885,0.00441123667308939,-0.0436976951631402,-0.0264056474046298,2.05443621981334e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0449783191144625,0.0056680709791669,-0.0560877382336296,-0.0338688999952954,2.26269792148908e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.0228288153927903,0.00288203157874998,-0.0284775972871402,-0.0171800334984403,2.50979220928199e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0796405772718885,0.010073764847481,-0.0993851563729512,-0.0598959981708258,2.83691105595122e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,39897,0.0271312351554813,0.00343205826859802,0.0204044009490292,0.0338580693619334,2.8471459770861e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0444858793337735,0.00562789557184114,-0.0555165546545821,-0.0334552040129649,2.86492158918827e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0205410503974693,0.00259938061407084,0.0154462643938905,0.0256358364010482,2.91541218392574e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.0405832192743708,0.00513824583712529,0.0305122574336052,0.0506541811151364,3.01337396647669e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,39836,-0.0690403245325762,0.00874821903432463,-0.0861868338398525,-0.0518938152253,3.16733660607629e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,40052,0.0200485016114007,0.00254152798580394,0.015067106759225,0.0250298964635765,3.2560219573491e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37380,-0.0353942410865123,0.00448767016992784,-0.0441900746195709,-0.0265984075534538,3.3319013289862e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0570108203509165,0.00723159635212912,-0.0711847492010896,-0.0428368915007435,3.42414311672896e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0496547514037887,0.00630646588003555,-0.0620154245286584,-0.037294078278919,3.6646844462135e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0225836731532184,0.00287148337623643,0.016955565735795,0.0282117805706418,3.92834802717323e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0213212480364746,0.00271368040414343,0.0160024344443534,0.0266400616285957,4.23796379832151e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,39868,-0.0203517011946659,0.00259226578967508,-0.0254325421424291,-0.0152708602469028,4.38971523460495e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40052,-0.0416696876021488,0.00531950971935062,-0.0520959266520761,-0.0312434485522216,5.04266473997236e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,39788,-0.07678235418236,0.00980303942219489,-0.0959963114498619,-0.057568396914858,5.0823872170945e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0573327139418198,0.00732326416962117,-0.0716863117142773,-0.0429791161693623,5.23186081166588e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0522313971074883,0.00667471944566465,-0.065313847220991,-0.0391489469939856,5.3827437019574e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0572858623102275,0.00732048942553196,-0.0716340215842701,-0.0429377030361849,5.43261113703122e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0489810203725848,0.00625990729017781,-0.0612504386613333,-0.0367116020838363,5.47827859719245e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0437252625169479,0.0055896557974349,-0.0546809878799203,-0.0327695371539755,5.50438721170436e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,39858,-0.0243507094428466,0.00311327468020532,-0.030452727816049,-0.0182486910696442,5.5405387415012e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.042534528838392,0.00543868835860616,-0.0531943580212601,-0.031874699655524,5.63758588907824e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.0850214733690688,0.0108827911510413,-0.10635174402511,-0.0636912027130278,6.02668144590699e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0630896356446964,0.00807716027066178,-0.0789208697751934,-0.0472584015141993,6.03176372942374e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0397161103606326,0.00509000236907753,-0.0496925150040246,-0.0297397057172407,6.42507926747126e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0720503104496644,0.00923810391307885,-0.0901569941192989,-0.0539436267800298,6.61645361416393e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40058,-0.070177092997363,0.00903558255289449,-0.0878868348010362,-0.0524673511936898,8.53241174691653e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0464080507549144,0.00597689983465676,-0.0581227744308416,-0.0346933270789871,8.77694562601138e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,39868,0.0228711769569505,0.00294614967180527,0.0170967236002122,0.0286456303136889,8.78844740384883e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,39856,-0.02915225999325,0.00375916782775632,-0.0365202289356524,-0.0217842910508476,9.36590684153572e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0556465730992745,0.00717898706604945,-0.0697173877487314,-0.0415757584498175,9.7602937581442e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0442692971071631,0.00571356148790502,-0.055467877623457,-0.0330707165908693,9.99019811917021e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0332002992106264,0.00429152859997569,-0.0416116952665787,-0.024788903154674,1.08642622390607e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0380444341710509,0.00493182083578195,-0.0477108030091835,-0.0283780653329182,1.29195734222173e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37043,-0.0383823844663102,0.00497821838286981,-0.048139692496735,-0.0286250764358854,1.34743688551166e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0524944464309167,0.00681190167263062,-0.0658457737092727,-0.0391431191525607,1.37084984432307e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0440432496114914,0.00571546438397746,-0.0552455598040872,-0.0328409394188955,1.37467591395017e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0141683347019093,0.00183899480483938,-0.0177727645193945,-0.0105639048844241,1.39388361909594e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.0395613155220213,0.00513553777580107,-0.0496269695625914,-0.0294956614814512,1.40216070825873e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40030,-0.019789958612956,0.00257087833078203,-0.0248288801412888,-0.0147510370846232,1.46463592753815e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.040938271893203,0.0053203929785348,-0.0513662421311312,-0.0305103016552748,1.51996393953796e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,39931,-0.0420858634585316,0.00547959481656236,-0.0528258692989938,-0.0313458576180694,1.67604969374131e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,39866,-0.0237569463231583,0.00309560228814097,-0.0298243268079146,-0.017689565838402,1.75719474785004e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0277616445596368,0.00361959235785877,-0.03485604558104,-0.0206672435382336,1.82060978340601e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0219402526456843,0.00286182338777627,0.0163310788056428,0.0275494264857258,1.86782850846045e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.0889635937340635,0.0116193769952527,-0.111737572644759,-0.0661896148233683,2.04372361090668e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,39749,0.018466893327437,0.00242035461134169,0.0137229982892073,0.0232107883656667,2.48356413792569e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,39448,0.0869763526427637,0.0114106451192835,0.064611488208968,0.109341217076559,2.63331399516427e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0124951473157484,0.00163996127771551,-0.0157094714200708,-0.00928082321142599,2.7215971122292e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,39810,-0.0294584563137955,0.0038728531961776,-0.0370492485783036,-0.0218676640492874,2.97523245445982e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,39587,-0.0481856228314761,0.00634060444106999,-0.0606132075359733,-0.0357580381269789,3.13917814600841e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.033551557036205,0.00441655164457544,-0.0422079982595728,-0.0248951158128371,3.20208658021474e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.057595602778488,0.00759264532608204,-0.0724771876176088,-0.0427140179393672,3.49249655013087e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0405007715768703,0.00533984797668081,-0.0509668736111647,-0.0300346695425759,3.51541540028045e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0348923971081676,0.00460442410420978,-0.0439170683524188,-0.0258677258639165,3.74239772857357e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,37124,0.0366682000975738,0.00483893323501022,0.0271838909569538,0.0461525092381938,3.74894859125578e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,39858,0.0138114974835276,0.00182516725225107,0.0102341696691155,0.0173888252979396,4.01912808778084e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0406271545065069,0.00536939703158587,-0.0511511726884152,-0.0301031363245986,4.04442435248928e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.0196953877030202,0.00260362701957963,-0.0247984966613962,-0.0145922787446441,4.10075573627983e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40058,-0.0250898343392691,0.0033176776245157,-0.0315924824833199,-0.0185871861952184,4.16645369940556e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.0422797469955254,0.00559313446256953,-0.0532422905421616,-0.0313172034488891,4.27481642188115e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.0244301826277398,0.00323863211424013,-0.0307779015716504,-0.0180824636838291,4.83016776318176e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.048830486799864,0.00647866274469179,-0.0615286657794599,-0.0361323078202681,5.0603799518428e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37124,-0.039986058149163,0.00530809296230538,-0.0503899203552816,-0.0295821959430445,5.27783314490612e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0532203123487556,0.00707061606872595,-0.0670787198434584,-0.0393619048540527,5.46907265855405e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,-0.0196537955889162,0.00261309918004978,-0.0247754699818138,-0.0145321211960187,5.70912308660372e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0483903620885813,0.00643388431994581,-0.0610007753556751,-0.0357799488214875,5.72354699345921e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,39794,-0.060628298414399,0.00806151936880511,-0.076428876377257,-0.044827720451541,5.73806583428058e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0553470211566715,0.00735980317687436,0.0409218069299978,0.0697722353833453,5.7590400258973e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.0849691076039033,0.0113102486501019,-0.107137194958103,-0.0628010202497036,6.10331467672986e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,37169,-0.0389399007656557,0.0051842297648213,-0.0491009911047054,-0.0287788104266059,6.2307366732495e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0305921459219959,0.00407499910521874,-0.0385791441682246,-0.0226051476757672,6.42391520597416e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.0985793721707799,0.0131346564210147,-0.124323298755969,-0.0728354455855911,6.45291768123142e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,39788,-0.0395713428576272,0.00527367229407659,-0.0499077405540173,-0.0292349451612371,6.53801846976092e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.01660793535673,0.00221669408208831,-0.0209526557576231,-0.0122632149558369,7.12183251046333e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,39846,-0.0273135566588623,0.00364809139910658,-0.0344638158011112,-0.0201632975166134,7.40892974863997e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0403764627711338,0.00539691499425624,-0.050954416159876,-0.0297985093823915,7.74192848862031e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0551466428883481,0.00737205740311419,-0.069595875398452,-0.0406974103782443,7.86042503470097e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37333,-0.0250118036469129,0.00334379219974082,-0.0315656363584049,-0.0184579709354208,7.88745683074794e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0675361706471778,0.00903180277890512,-0.0852385040938319,-0.0498338372005238,7.95994980533345e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,36816,-0.0331363161884548,0.00443199871039056,-0.0418230336608204,-0.0244495987160893,8.1164702551713e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0159714578600745,0.0021427355841443,-0.0201712196049973,-0.0117716961151516,9.53557418103862e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0454458575426121,0.0060973188855508,-0.0573966025582917,-0.0334951125269325,9.55943023729968e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0556206997750887,0.00746437346922273,-0.0702508717747653,-0.0409905277754122,9.78770326958252e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,37220,-0.0235768094570862,0.00317066245684332,-0.0297913078724991,-0.0173623110416733,1.10160437370586e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0501172872690987,0.00674263887879902,-0.0633328594715448,-0.0369017150666526,1.11577394863973e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,39858,-0.0546020190075233,0.00736910171428005,-0.0690454583675122,-0.0401585796475344,1.33012810890468e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0192835365029202,0.00260363271658556,-0.0243866566274279,-0.0141804163784125,1.37456929035568e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.0162111074002266,0.00218950632354551,-0.0205025397943758,-0.0119196750060774,1.38668019333073e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0188483980997209,0.00254796648001404,0.0138543837988934,0.0238424124005484,1.45730568570524e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,37124,-0.0374940516784926,0.00507197471010389,-0.0474351221102962,-0.0275529812466889,1.52842464477704e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0173699660546469,0.00235006787928255,0.0127638330112531,0.0219760990980406,1.54148540607924e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0302979381005319,0.00410074710147441,-0.0383354024194218,-0.0222604737816421,1.55863211654759e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0756413945190605,0.0102468878311013,-0.0957252946680191,-0.055557494370102,1.63762504934552e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0268610635116867,0.00364006044608895,-0.033995581986021,-0.0197265450373523,1.68393335299462e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0372284688224426,0.00504533581327337,-0.0471173270164584,-0.0273396106284268,1.69233163364445e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0446440908324794,0.00605598805524836,-0.0565138274207662,-0.0327743542441926,1.77987319821179e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0285155482335646,0.00386940666191847,-0.0360995852909248,-0.0209315111762044,1.81205872813165e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,37411,-0.0388722619972724,0.00527516758426002,-0.049211590462422,-0.0285329335321227,1.81973310371121e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.030088568140254,0.00408690223131815,0.0220782397668704,0.0380988965136375,1.89709001506788e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.0590652228470766,0.00804714154270585,-0.0748376202707801,-0.0432928254233732,2.25948376527481e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0361005627694445,0.00492135192964511,-0.0457464125515489,-0.0264547129873401,2.31741935120226e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,39868,-0.0300348172127433,0.00409457831930343,-0.038060190718578,-0.0220094437069085,2.31879869013884e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0337514516610473,0.00460426476199731,-0.042775810594562,-0.0247270927275326,2.40561999976495e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,39866,-0.0452665529399254,0.00617665258068867,-0.0573727919980751,-0.0331603138817756,2.43568644583153e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37382,-0.0236388088114436,0.00322695040568831,-0.0299636316065927,-0.0173139860162945,2.51608491719921e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.0768889084764914,0.0105109927795503,-0.0974904543244099,-0.0562873626285729,2.71667701819063e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.0747005133030933,0.0102185732144781,-0.0947289168034704,-0.0546721098027163,2.81575653450034e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.0266145780950754,0.00364538403243205,-0.0337595307986422,-0.0194696253915085,2.9935470596642e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0509434217087737,0.00698191540247968,-0.0646279758976339,-0.0372588675199136,3.11862614430596e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,39766,-0.0365379205924818,0.00501081348976904,-0.0463591150324291,-0.0267167261525345,3.20201707037898e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,39703,-0.031578092540169,0.00433144302414244,-0.0400677208674882,-0.0230884642128498,3.23550962125847e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.0758848353348634,0.0104156708004019,-0.096299550103651,-0.0554701205660758,3.37865979539345e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0186139224735267,0.00255689562115374,-0.023625437890988,-0.0136024070560653,3.49670841850995e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.038568140450402,0.00530028799342326,-0.0489567049175116,-0.0281795759832924,3.61337775831417e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,39858,-0.0181739511348191,0.00249984023271705,-0.0230736379909445,-0.0132742642786937,3.75981290595558e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0679151895765488,0.00934572490375488,-0.0862328103879084,-0.0495975687651892,3.85003905600164e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,39831,-0.0183190913544404,0.00252393626033647,-0.0232660064246998,-0.0133721762841809,4.10494153070455e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0207587093095438,0.00286116828091793,0.0151508194789447,0.026366599140143,4.19406839818981e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.0191091243804833,0.00263961127718938,-0.0242827624837745,-0.0139354862771921,4.71247323842895e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0554516618534881,0.00766010232809004,-0.0704654624165446,-0.0404378612904316,4.76989733482975e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.0443344775591533,0.00613729750900112,0.0323053744415111,0.0563635806767955,5.28343618533331e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,39858,0.017709996965883,0.00245226330527414,0.0129035608875457,0.0225164330442203,5.35744275435996e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0246080296571839,0.00341221355218535,-0.0312959682194672,-0.0179200910949006,5.77140930269985e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.0649712705678097,0.00902249104173467,-0.0826553530096097,-0.0472871881260098,6.24348807841123e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,39788,-0.0616571797205663,0.00856473688434143,-0.0784440640138755,-0.0448702954272571,6.33831992115304e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37382,-0.05768843706205,0.00801665437033982,-0.0734010796279161,-0.041975794496184,6.52361397541303e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0220538643332601,0.00306618045858062,0.016044150634442,0.0280635780320781,6.69875593246657e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,39779,-0.0199251555638433,0.00277952974615266,-0.0253730338663025,-0.0144772772613841,7.91338078335091e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0305240128614708,0.00426162666164837,-0.0388768011183016,-0.02217122460464,8.32971528784163e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0623061683029339,0.00870793847279047,-0.0793737277096032,-0.0452386088962646,8.79154216518123e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37422,-0.0318567127901759,0.00445271487320461,-0.0405840339416569,-0.0231293916386948,8.83220363697356e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0418273874413139,0.00585316619338049,-0.0532995931803396,-0.0303551817022881,9.39632838826737e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,39489,-0.0486734263548869,0.00681643331722672,-0.0620336356566512,-0.0353132170531225,9.70177571785631e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0393306675836269,0.00551070275301087,-0.0501316449795282,-0.0285296901877256,9.93432539894377e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.023367911178569,0.00327805872797883,-0.0297929062854075,-0.0169429160717305,1.05817717356977e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,37420,0.0232158366108581,0.00325803894351837,0.0168300802815621,0.0296015929401541,1.08775669862407e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,40009,-0.0415847469862755,0.00583773153480873,-0.0530267007945006,-0.0301427931780504,1.09706005832533e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0197959315466507,0.0027881616465334,-0.0252607283738562,-0.0143311347194453,1.30996330306823e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0495577146892847,0.00698582669318906,-0.0632499350079352,-0.0358654943706341,1.35710730944574e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,37039,-0.0286193578411868,0.00403492254924156,-0.0365278060377002,-0.0207109096446733,1.38019610773846e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0373495741468297,0.00526740326717606,-0.0476736845504948,-0.0270254637431646,1.40235557049334e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,39866,-0.0621279426348337,0.00876861213670907,-0.0793144224227835,-0.0449414628468839,1.44562212767204e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.0659441210450843,0.00930899417619471,-0.0841897496304259,-0.0476984924597427,1.47069876526551e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,37385,-0.0656367394443889,0.00927126102392136,-0.0838084110512748,-0.047465067837503,1.51712479817107e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37056,-0.0290631017198881,0.00410550819474096,-0.0371098977815804,-0.0210163056581958,1.52485447019471e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,39713,-0.0434446470531843,0.00614114455465751,-0.0554812903803131,-0.0314080037260556,1.56423958167905e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0418310567179694,0.00591527249798227,-0.0534249908140146,-0.0302371226219241,1.5941973108433e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,39858,-0.035375618483844,0.00500440120916868,-0.0451842448538146,-0.0255669921138734,1.62617063058029e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37138,0.0143776842415958,0.00203411932119452,0.0103908103720546,0.0183645581111371,1.64724488863662e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.019090868445084,0.00270291733771505,-0.0243885864270054,-0.0137931504631625,1.69598944402611e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.0954681491490635,0.0135398913034453,-0.122006336103816,-0.0689299621943107,1.86420398093184e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0192391270668062,0.00273006207627524,0.0138882053973067,0.0245900487363056,1.89995942533106e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00604614234167178,0.000859507207338114,0.00436150821528907,0.00773077646805448,2.08083153189169e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0316923712345792,0.0045102033289743,-0.0405323697593688,-0.0228523727097896,2.20027690918505e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0443388157497343,0.00631307176370124,-0.0567124364065888,-0.0319651950928799,2.27234293035773e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0244335526690615,0.00348000581847497,-0.0312543640732724,-0.0176127412648505,2.3085975060571e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.0369298848716225,0.00526342240099124,-0.0472461927775653,-0.0266135769656797,2.37139865456747e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0507317436757343,0.0072327958236437,-0.064908023490076,-0.0365554638613927,2.40821154326132e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0458838968221761,0.00654337007008236,-0.0587089021595375,-0.0330588914848146,2.43865233236112e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0143557732203407,0.00205102095467756,-0.0183757742915087,-0.0103357721491726,2.69324545555151e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0433469675635816,0.00619543730849928,-0.0554900246882402,-0.031203910438923,2.74548866022321e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0386299720423825,0.00552253357364529,-0.0494541378467273,-0.0278058062380377,2.78129481500526e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0200102921724698,0.00286374105315265,-0.025623224636649,-0.0143973597082906,2.9093661409672e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0466791061151714,0.00668746558536358,-0.059786538662484,-0.0335716735678588,3.08738831611359e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0338726569495393,0.00485986153965368,-0.0433979855672605,-0.0243473283318181,3.31910545174468e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0283286701086546,0.00406889591961406,0.020353634106211,0.0363037061110982,3.47840683945835e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,39858,-0.0481912905047671,0.00693188573091435,-0.0617777865373592,-0.034604794472175,3.73750459258763e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0225599979202061,0.0032450937086138,-0.0289203815890892,-0.0161996142513231,3.76594061301623e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0456399289298924,0.00656785016957766,-0.0585129152622646,-0.0327669425975202,3.81956549959677e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0189395338904458,0.00272521066146443,0.0135981209939755,0.0242809467869161,3.82778721390787e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39489,-0.029675211280413,0.00428182105988494,-0.0380675805577875,-0.0212828420030385,4.35713641783676e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0571732807268705,0.00826288997434418,-0.0733685450765851,-0.0409780163771559,4.74365828123646e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,39344,-0.0505231048655015,0.00730863375196007,-0.0648480270193432,-0.0361981827116597,4.93751334052148e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0546604218550918,0.0079065057034464,-0.0701571730338467,-0.0391636706763369,4.94572754183821e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,39585,-0.0494754111710707,0.00717356626695435,-0.0635356010543013,-0.0354152212878402,5.51725284311608e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,39885,-0.019554974470052,0.00283804179364806,-0.0251175363856022,-0.0139924125545019,5.77458460863207e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37368,-0.0321785901567865,0.00467122047773169,-0.0413341822931407,-0.0230229980204324,5.8801183468784e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.0225308492076736,0.00327477687617721,-0.0289494118849809,-0.0161122865303663,6.20597017442165e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,39558,-0.0278123441891165,0.00404260622141362,-0.0357358523830872,-0.0198888359951458,6.21995790060362e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.014594097779114,0.00212195200211922,-0.0187531237032677,-0.0104350718549604,6.30916795836072e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0432534924847443,0.00628844653660467,-0.0555788476964894,-0.0309281372729991,6.32554352917637e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0373354154189168,0.00543007227010429,-0.0479783570683212,-0.0266924737695123,6.44727828281122e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.0182178512919418,0.00265039920218203,-0.0234126337282186,-0.0130230688556651,6.48883394178602e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.0631828837783122,0.00919266575303624,-0.0812005086542632,-0.0451652589023612,6.50812212282715e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0249176036802873,0.0036260680949237,-0.0320246971463377,-0.0178105102142368,6.6173108565413e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0321597762281215,0.00468698085025881,-0.0413462586946288,-0.0229732937616142,7.11012242378866e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0167140246753163,0.00243662130571789,-0.0214898024345233,-0.0119382469161092,7.1620797616061e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0293576539506829,0.00428028039448462,-0.0377470035238728,-0.0209683043774931,7.1988202659108e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,37437,0.0177308992482058,0.00258810222747569,0.0126582188823534,0.0228035796140581,7.65340499813907e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0284038950305824,0.00414677210053074,-0.0365315683476227,-0.0202762217135422,7.68072915786799e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0499567500648349,0.007292918335454,-0.0642508700023247,-0.035662630127345,7.70239658732893e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40017,-0.0393594695728845,0.00574684460336441,-0.0506232849954788,-0.0280956541502903,7.71117309223406e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.0643250824865265,0.00939530865573716,-0.0827398874517713,-0.0459102775212816,7.89310277510439e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0209299130381001,0.00305833891576743,-0.0269242573130043,-0.0149355687631959,8.06038042921887e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,39908,-0.0154465771743882,0.00225881148827443,-0.019873847691406,-0.0110193066573703,8.29920564961105e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0253734211745632,0.00371484886775053,-0.0326545249553542,-0.0180923173937721,8.7823899981202e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0390828797844567,0.00572219126855688,-0.0502983746708282,-0.0278673848980853,8.85097560305049e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0127536709881681,0.00186898452548911,-0.0164168806581268,-0.00909046131820947,9.18185301579237e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0351317179097019,0.00514845848073305,-0.0452226965319387,-0.0250407392874651,9.19627067409578e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.0740904221749768,0.0108662195130405,-0.0953882124205363,-0.0527926319294174,9.53527681185605e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0404612242598336,0.00594065464368537,-0.052104907361457,-0.0288175411582103,1.01084598476268e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37371,-0.0555547017289011,0.00816376657249279,-0.071555684210987,-0.0395537192468153,1.05284136163373e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0194475660659354,0.0028582793226858,-0.0250497935383996,-0.0138453385934712,1.0537124982949e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0148199314120284,0.00217838081833016,-0.0190895578159556,-0.0105503050081013,1.05983852465424e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.039072040950958,0.00574778491543493,-0.0503376993852104,-0.0278063825167055,1.10833748909077e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39489,-0.03326876499632,0.00489837659786167,-0.0428695831281288,-0.0236679468645111,1.14741679018982e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0505547169397037,0.00744707221062367,-0.0651509784725261,-0.0359584554068813,1.17991425513998e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0349805996362617,0.00515891089222064,-0.0450920649850141,-0.0248691342875092,1.24610779413618e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.046837496444698,0.00690924682624713,-0.0603796202241424,-0.0332953726652536,1.25350710310571e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,0.0295020863680188,0.00435232450372553,0.0209715303407167,0.0380326423953208,1.25682897407598e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0192027703360536,0.00283324874254636,-0.0247559378714445,-0.0136496028006627,1.27207567896077e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0167827308866338,0.00248130799626141,0.0119193672139614,0.0216460945593062,1.40053037915254e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0505827703578335,0.00749077956117326,-0.0652646982977331,-0.0359008424179339,1.50126285820256e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0347404423662725,0.00515411583448129,-0.0448425094018559,-0.0246383753306892,1.64537548629224e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0599122608348293,0.00889157073341561,-0.0773397394723239,-0.0424847821973347,1.66047753819048e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0396345617342575,0.00588589417733722,-0.0511709143218384,-0.0280982091466765,1.71966591956465e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37043,-0.0583251309591444,0.00866222017441976,-0.0753030825010071,-0.0413471794172817,1.72755216598945e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0469147853342525,0.00697225807582251,-0.0605804111628646,-0.0332491595056404,1.77965776048469e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,39754,-0.0331690788883489,0.00493521786825876,-0.042842105910136,-0.0234960518665617,1.86753743833322e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,39749,-0.0269635646011008,0.00402197186543623,-0.0348466294573559,-0.0190804997448458,2.09524993938694e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0482343471312476,0.00720333275421482,-0.0623528793295086,-0.0341158149329866,2.22449489477592e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0290028377846311,0.00433255934342028,0.0205110214715273,0.0374946540977348,2.24103586007484e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0273504789204902,0.00408697524740881,0.019340007435569,0.0353609504054115,2.27316238536535e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0445742166824588,0.00666357854273087,-0.0576348306262113,-0.0315136027387063,2.33164783050334e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0213371969875536,0.00319480505152262,0.0150753790865693,0.0275990148885379,2.4905052168962e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0520103552651523,0.0077887235548924,-0.0672762534327414,-0.0367444570975632,2.50797073373741e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0563744962747978,0.00847042823533251,-0.0729765356160495,-0.0397724569335461,2.91655416326005e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0271640562611711,0.00408334355777528,-0.0351674096344107,-0.0191607028879316,2.97579035225212e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0394181058901986,0.00592696045671121,0.0278012633950446,0.0510349483853526,3.01175194719304e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.0185249018065877,0.00278610982692671,-0.023985677067364,-0.0130641265458114,3.04508525830454e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0191482207725488,0.00288226463450545,-0.0247974594561795,-0.0134989820889182,3.16279573313267e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,39489,-0.0496256654322308,0.00747477803222381,-0.0642762303753894,-0.0349751004890721,3.26041119033e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0137759097500516,0.00207632239995428,-0.0178455016539619,-0.00970631784614117,3.37638024939839e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0333584565589871,0.00502893648032531,-0.0432151720604247,-0.0235017410575494,3.38968462477044e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,39913,-0.0446315558791659,0.00673186898117213,-0.0578260190822633,-0.0314370926760686,3.46647098988025e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0277735596066495,0.00419540613225393,-0.0359965556258672,-0.0195505635874318,3.70915183504237e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0297649987098294,0.00449661481846112,-0.0385783637540132,-0.0209516336656456,3.71959306502354e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40058,-0.0313214696189222,0.00473710534243199,-0.0406061960900889,-0.0220367431477555,3.91165129553812e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.029228833679859,0.00442101343969717,-0.0378940200216655,-0.0205636473380526,3.95138141296752e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0500319966669656,0.00756825250944534,-0.0648657715854785,-0.0351982217484528,3.97023982984864e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0304346518445775,0.0046094176574697,-0.0394691104532181,-0.0214001932359369,4.18779981107188e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,39788,-0.0200714843958186,0.0030415460561765,-0.0260329146659245,-0.0141100541257127,4.2669588262246e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37437,-0.0186278392411115,0.00283002660620446,-0.0241746913892723,-0.0130809870929508,4.80518014643044e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37124,-0.0234856294622163,0.00356866867545625,-0.0304802200661106,-0.0164910388583221,4.84654201292503e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.0162493947856099,0.00246916637972181,0.0114098286813551,0.0210889608898646,4.84682724171996e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,39868,-0.0416780876442904,0.00633560653738166,-0.0540958764575585,-0.0292602988310224,4.90314656831838e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0295891250919496,0.00450754160801832,-0.0384239066436655,-0.0207543435402337,5.38490527747398e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0296811550031453,0.00452176912869757,-0.0385438224953926,-0.0208184875108981,5.42685917347918e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0267639368563075,0.00408254064447337,0.0187621571931397,0.0347657165194753,5.744145592042e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,39489,-0.0182345750994986,0.00278321131564207,-0.0236896692781571,-0.0127794809208402,5.86905545805403e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37388,-0.0190134028787334,0.00290339225522298,-0.0247040516989704,-0.0133227540584963,6.01423300564613e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0263586319710013,0.00402850786848853,-0.0342545073932389,-0.0184627565487638,6.21488839375254e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,39715,-0.0453680157802042,0.00693722298525318,-0.0589649728313005,-0.031771058729108,6.34872243362655e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.0185590706961756,0.00284032549982165,-0.024126108675826,-0.0129920327165251,6.59300532895013e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0435705249660975,0.00666896766008749,-0.056641701579869,-0.030499348352326,6.66742736310175e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0272403167164634,0.00417650601699865,-0.0354262685097807,-0.019054364923146,7.17762022494717e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37124,0.0210478787331411,0.00323097780330511,0.0147151622386631,0.0273805952276191,7.56150665904621e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0256071307297375,0.00393289209437764,-0.0333155992347177,-0.0178986622247573,7.72822023731246e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0419799939754907,0.00646699027316817,-0.0546552949109003,-0.0293046930400811,8.7987919119135e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.0141695135062254,0.00219114411692801,-0.0184641559754043,-0.00987487103704654,1.0307668617606e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,39775,-0.0206537718627307,0.00319810519550458,-0.0269220580459197,-0.0143854856795417,1.09078830690624e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0263438653202149,0.00408001331554929,-0.0343406914186916,-0.0183470392217383,1.10015038250398e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0408036996654151,0.00632287716523888,-0.0531965389092833,-0.0284108604215469,1.13130476845734e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,36991,-0.0269157047994428,0.0041708977597332,-0.0350906644085199,-0.0187407451903657,1.13346442793185e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37382,-0.022234968071702,0.00345018445843834,-0.0289973296102412,-0.0154726065331629,1.19856414337413e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,39489,-0.0410359267090059,0.00637909147561371,-0.0535389460012087,-0.028532907416803,1.2884841535326e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.013279446473301,0.00206786028783825,-0.017332452637464,-0.00922644030913801,1.38429382356805e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.0243607328650959,0.00379555979613312,-0.0318000300655168,-0.0169214356646749,1.41824719048079e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.019350785291205,0.00301560546512911,-0.0252613720028581,-0.013440198579552,1.4300628341242e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.0147516812242165,0.00229912841742992,-0.0192579729223791,-0.0102453895260538,1.43663935732212e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0543413527477057,0.00846923965165227,-0.0709410624649442,-0.0377416430304672,1.44257386649379e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0228964694813927,0.00356904623498142,-0.0298918001019563,-0.0159011388608291,1.44499417876255e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0625893765411788,0.00975673079660033,-0.0817125689025155,-0.0434661841798422,1.44809269199398e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37021,-0.024107948509312,0.00376434667131877,-0.0314860679850968,-0.0167298290335272,1.56211348627519e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0507492660963168,0.00792771129355668,-0.0662875802316879,-0.0352109519609457,1.58124107053995e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0315490210073183,0.00493056838573468,-0.0412129350433583,-0.0218851069712783,1.61143696441943e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0289535873296524,0.00452989767886552,-0.0378321867802288,-0.020074987879076,1.6961440994508e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.0152876731031135,0.00239366212034334,-0.0199792508589865,-0.0105960953472406,1.7410231644483e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0470401540541722,0.00736692906653125,-0.0614793350245734,-0.032600973083771,1.76624959809375e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0262505650258673,0.00411488015377373,0.0181853999244707,0.0343157301272638,1.82615116823314e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0277209531901077,0.00435030643766573,-0.0362475538079326,-0.0191943525722829,1.92548101714028e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0350478021823191,0.00550651022674916,-0.0458405622267474,-0.0242550421378907,2.00911669991126e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.0168166385350117,0.00264376873215515,-0.0219984252500358,-0.0116348518199876,2.06076646666676e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0304788150777759,0.00479640614107608,-0.039879771114285,-0.0210778590412668,2.15963267468741e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,39866,-0.0349778213016322,0.00550663807689396,-0.0457708319323443,-0.02418481067092,2.18357598248289e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0360050258498976,0.00567297849574249,-0.0471240637015529,-0.0248859879982423,2.25962975144505e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,37056,-0.0300689242943403,0.00474320198128913,-0.039365600177667,-0.0207722484110136,2.38214202557579e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0408890565153431,0.00645657140938004,-0.053543936477728,-0.0282341765529582,2.47110169129214e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,39868,-0.0409235887667627,0.00646316995115233,-0.0535914018710213,-0.0282557756625042,2.48752246822918e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37124,-0.0419367918799225,0.00662820753514701,-0.0549280786488107,-0.0289455051110344,2.57976515239327e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,37021,-0.0361619094089728,0.0057195239082268,-0.0473721762690974,-0.0249516425488483,2.65612977843291e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0421444813104485,0.00666664058666442,-0.0552110968603108,-0.0290778657605862,2.66993520466949e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0306811693417842,0.00486198628697189,-0.0402106624642491,-0.0211516762193193,2.87132798299882e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,39691,0.0286204976884578,0.00454040418454631,0.019721305486747,0.0375196898901686,2.98677040332832e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0403340004680961,0.00640414765293158,-0.052886129867842,-0.0277818710683502,3.10889669914278e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,39866,-0.0293117775579624,0.00465486620889372,-0.038435315327394,-0.0201882397885307,3.11337682103138e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0317939232191339,0.00505094788838526,-0.041693781080369,-0.0218940653578988,3.16328734694409e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.0757854328554787,0.0120524284830689,-0.0994081926822938,-0.0521626730286637,3.29927794446189e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,39818,-0.0240695337761157,0.00382848107296297,-0.0315733566791231,-0.0165657108731083,3.3214231834704e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,39866,-0.051579375970199,0.00820466310456076,-0.0676605156551381,-0.0354982362852599,3.32915764432894e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0568686856394271,0.00904852918541733,-0.0746038028428451,-0.0391335684360091,3.36668296005797e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37445,-0.0375586430025652,0.00597782447700216,-0.0492751789774895,-0.025842107027641,3.42245278538973e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,37368,-0.0385389493170378,0.00615456369893194,-0.0506018941669444,-0.0264760044671312,3.91959970923174e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0391779984248601,0.00625738976687214,-0.0514424823679295,-0.0269135144817907,3.93888406346106e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.022025873141533,0.00352711920061026,-0.0289390267747291,-0.0151127195083369,4.37617199106022e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0364611453646189,0.00584703115003542,-0.0479213264186883,-0.0250009643105495,4.62869265573985e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,37453,0.0132663818191902,0.00213443704288636,0.00908288521513298,0.0174498784232475,5.26895691655732e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0417469211161251,0.00672588068510593,-0.0549296472589327,-0.0285641949733175,5.53922508204224e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37056,-0.0233227923206758,0.00375830383274188,-0.0306890678328499,-0.0159565168085017,5.6094154275629e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0628616390767611,0.0101359078053201,-0.0827280183751885,-0.0429952597783337,5.71585607560195e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.0187362113567594,0.00302400892433258,-0.0246632688484513,-0.0128091538650676,5.94008591631636e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0368086084869039,0.00594024407157411,-0.0484514868671891,-0.0251657301066186,5.94617853010903e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.0283660381386709,0.0045804312842801,-0.0373436834558599,-0.0193883928214819,6.05447440508657e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.0443194576488594,0.00715749953474311,-0.0583481567369559,-0.0302907585607629,6.11574950448437e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,40042,-0.0190403957836852,0.00308960560956616,-0.0250960227784349,-0.0129847687889355,7.31962846615467e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0338678943210293,0.00549930727159361,-0.0446465365733527,-0.0230892520687058,7.51554428748092e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0500348961573654,0.00812824041752093,-0.0659662473757064,-0.0341035449390244,7.68621067937353e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0332135665394199,0.00540343613782409,-0.0438043013695551,-0.0226228317092847,8.09636377423042e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.0543608505992925,0.00884392237181736,-0.0716949384480545,-0.0370267627505304,8.0991543465001e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.0622966339703821,0.0101447149893497,-0.0821802753495075,-0.0424129925912567,8.40474242099724e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.0142268865836945,0.00231705450961205,-0.0187683134225342,-0.00968545974485493,8.44323645038299e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.0218276755028703,0.00356003410681089,-0.0288053423522196,-0.0148500086535209,8.9204607481634e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.031417205249715,0.00513360943514526,-0.0414790797425997,-0.0213553307568303,9.62850799888866e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0377467182062335,0.00616858661166714,-0.0498371479651012,-0.0256562884473659,9.66474404221602e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,36991,-0.0322424833454353,0.00529018521769435,-0.0426112463721162,-0.0218737203187543,1.12661080074609e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39477,-0.025762498360348,0.00422874112301502,-0.0340508309614574,-0.0174741657592386,1.13955137101245e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0365487971568428,0.00599899280587196,-0.0483068230563519,-0.0247907712573338,1.1426982607366e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0246301786167168,0.00405035688490707,-0.0325688781111346,-0.0166914791222989,1.22724301960802e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,39858,-0.0295475273007123,0.00486124820987116,-0.0390755737920598,-0.0200194808093649,1.24314638522841e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0457038238638053,0.00752352824179882,-0.060449939217731,-0.0309577085098796,1.27027929913195e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.010082724634066,0.00166084624470598,0.00682746599444225,0.0133379832736897,1.30124044625809e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.02128231336697,0.00350527732353325,-0.0281526569210952,-0.0144119698128448,1.30193801095164e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0340229008128251,0.00560609265334056,-0.0450108424133726,-0.0230349592122776,1.32287263489414e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0509108235037546,0.00838904855374234,-0.0673533586690896,-0.0344682883384196,1.32465901708432e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.0204238041400072,0.00336827677863609,0.0138219816538805,0.027025626626134,1.36113151734575e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37382,-0.0333495476547607,0.00550318026636751,-0.044135780976841,-0.0225633143326804,1.3969589137678e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40030,-0.0645239450328062,0.0106486882065853,-0.0853953739177134,-0.0436525161478991,1.39718234589497e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.0171547110929098,0.00283120995963685,-0.0227038826137981,-0.0116055395720216,1.39913349281839e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.023969048220533,0.00395735826126889,-0.03172547041262,-0.016212626028446,1.42510120961756e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.0160163938590651,0.00264776984844032,-0.0212060227620081,-0.0108267649561221,1.49565830305813e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,39585,-0.0268291902504201,0.00443572772231844,-0.0355232165861642,-0.0181351639146759,1.49576104156173e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0350085216328551,0.00579325253101031,-0.0463632965936353,-0.0236537466720749,1.55267862506459e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,39931,-0.0261175720635924,0.00433384226505073,-0.0346119029030919,-0.017623241224093,1.71287491556709e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0219959831018327,0.00365578346939054,-0.0291613187018381,-0.0148306475018272,1.82610912823333e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0449954295457794,0.00748914029801411,-0.059674144529887,-0.0303167145616717,1.92638950936125e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0416564776237455,0.00693771354555349,-0.0552543961730303,-0.0280585590744607,1.96248270902883e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0321053173191194,0.00534642777261499,-0.0425843157534447,-0.021626318884794,1.96392480155628e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,37043,-0.0161819731596533,0.00269629930946415,-0.021466719806203,-0.0108972265131035,2.00573033630366e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0432797188805274,0.00721960162932975,-0.0574301380740137,-0.0291292996870411,2.09088549737102e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37437,-0.02915097275543,0.00486705514145505,-0.0386904008326819,-0.0196115446781781,2.15876078026961e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0333800474392682,0.00557510038114561,-0.0443072441863136,-0.0224528506922228,2.18688123763914e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,39931,0.0154961377136821,0.00259343872813999,0.0104129978065277,0.0205792776208365,2.34759112994026e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0370197335776685,0.00619898634122765,0.0248697203488623,0.0491697468064747,2.39490612194754e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0479653286099141,0.00804196582492655,-0.0637275816267701,-0.0322030755930581,2.50736623299418e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,39585,-0.0255340449268335,0.00428292974054868,-0.0339285872183089,-0.0171395026353581,2.54785049954446e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.038878083226659,0.00654065272149901,-0.0516977625607971,-0.026058403892521,2.85016524744086e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0473584809284603,0.00797050341921209,-0.062980667630116,-0.0317362942268046,2.87900574803954e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0588558429150968,0.00991545447196385,-0.0782901336801459,-0.0394215521500476,2.98514093327034e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0482073532327972,0.00816670463528862,-0.0642140943179628,-0.0322006121476315,3.64355561917722e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0204659792665008,0.00346741059957056,-0.0272621040416591,-0.0136698544913425,3.66870967294541e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0344735830799575,0.0058539507526002,0.0229998396048611,0.0459473265550539,3.97857330694968e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0263769954045767,0.00448099482611508,-0.0351597452637623,-0.0175942455453912,4.02763068619771e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0205717794090944,0.00350135068953046,-0.0274344267605741,-0.0137091320576147,4.32059870926127e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0143188585568975,0.00243747028491408,0.00954141679846595,0.0190963003153291,4.32596750916192e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0267458573491633,0.00455896335961597,-0.0356814255340106,-0.017810289164316,4.55079848180068e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0432743748901063,0.00737965962004436,-0.0577385077453933,-0.0288102420348194,4.62377850329187e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0338853244611758,0.00578123882490832,-0.0452165525579961,-0.0225540963643555,4.68634540007181e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37095,-0.0799143596559507,0.0136356853577572,-0.106640302957155,-0.0531884163547466,4.71955454770642e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,39489,-0.0378509295235243,0.00646515038215859,-0.0505226242725551,-0.0251792347744934,4.87717563122004e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,39866,-0.0532849953763293,0.00910790717253445,-0.0711364934344968,-0.0354334973181617,4.99930950013343e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,39587,-0.0268140378272315,0.00458474548417255,-0.0358001389762097,-0.0178279366782533,5.05764471795104e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37411,-0.0591216042720509,0.0101351757026072,-0.078986548649161,-0.0392566598949409,5.55791212711202e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.0335168652946112,0.00574860244309483,0.0222496045061453,0.0447841260830771,5.65770228213114e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0424269222422885,0.00728138093598845,-0.0566984288768259,-0.0281554156077512,5.77970362440773e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0212999307651297,0.00365679536929821,-0.0284672496889542,-0.0141326118413052,5.82995778380441e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0249773736221447,0.00428822109973318,-0.0333822869776218,-0.0165724602666677,5.83587998233106e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.0192513060024822,0.00330573841428819,-0.0257305532944871,-0.0127720587104774,5.87045627486616e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.017916633152533,0.00307647772768553,-0.0239465294987967,-0.0118867368062694,5.888226654306e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.0639934213117682,0.0109912322205079,-0.0855362364639636,-0.0424506061595728,5.938905010878e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,39868,0.0195710574422497,0.00336674500546121,0.0129722372315457,0.0261698776529537,6.25119679463471e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.0200600370165471,0.00345230652377079,-0.0268265578031379,-0.0132935162299564,6.34214427811106e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0339787444184995,0.00585515754539344,-0.0454548532074707,-0.0225026356295284,6.6551078927809e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0270557950396842,0.0046646080500042,-0.0361984268176924,-0.0179131632616759,6.75042102694469e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37124,-0.0373689305183829,0.00644216852325167,-0.0499955808239562,-0.0247422802128096,6.75548555129184e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39434,0.050334133530239,0.00867814371558997,0.0333249718476827,0.0673432952127954,6.7559132655359e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.0199885050517104,0.00344601525223519,-0.0267426949460914,-0.0132343151573295,6.76327847345205e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.037538973894616,0.00647311563460219,-0.0502262805384363,-0.0248516672507957,6.7868156040102e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,39892,-0.0247572524942085,0.00427371353846356,-0.0331337310295971,-0.0163807739588199,7.0472307829302e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37149,-0.0171484356855077,0.00296162416786114,-0.0229532190545155,-0.0113436523164998,7.18862832742703e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0443787660227248,0.00767448473319338,-0.0594207560997838,-0.0293367759456657,7.52084326381966e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.028680396447769,0.00496810382887078,-0.0384178799523557,-0.0189429129431823,7.93696372683299e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0267940060616381,0.0046458222035965,-0.0358998175806873,-0.017688194542589,8.22988003982917e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0282269156116655,0.00489565732006074,-0.0378224039589845,-0.0186314272643464,8.3095575673381e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,39913,-0.0222340261570778,0.00386155673645026,-0.0298026773605203,-0.0146653749536353,8.67807373530173e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,39866,-0.0218998039632814,0.00380536315208717,-0.0293583157413722,-0.0144412921851905,8.82353403886372e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0221975454045035,0.00385960893540344,-0.0297623789178943,-0.0146327118911128,9.05065351917887e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0306873983539475,0.00533812216394938,-0.0411501177952883,-0.0202246789126067,9.15861427177846e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.04564512628112,0.00794394101312242,-0.06121525066684,-0.0300750018954001,9.34402431573584e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0214205795101709,0.00373775882240459,-0.0287465868020839,-0.0140945722182579,1.02095053083975e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0375533724221171,0.00655408907390188,-0.0503993870069648,-0.0247073578372694,1.02706552322037e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.0139423108345344,0.00243458539714517,-0.0187140982129389,-0.00917052345612985,1.04580999181305e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0429367324224727,0.0075046024176177,-0.0576457531610034,-0.028227711683942,1.07561357658333e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.0269789206604949,0.0047192551285736,-0.0362286607124992,-0.0177291806084907,1.10514020382665e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,39749,-0.0192442122722699,0.00336671136561842,-0.025842966548882,-0.0126454579956578,1.11000599637513e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0358913764767844,0.00628514706516093,-0.0482102647244998,-0.0235724882290689,1.14689368493059e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,39913,-0.0147109956214991,0.00257978700400502,-0.0197673781493489,-0.00965461309364926,1.20206036855573e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,39931,-0.031511647428519,0.00553725717680986,-0.0423646714950663,-0.0206586233619717,1.28619998443607e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.035357725350478,0.00621372601132106,-0.0475366283326672,-0.0231788223682887,1.29542115019344e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0441894751357656,0.0077662131147321,-0.0594112528406406,-0.0289676974308907,1.29805302732757e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0406276334084583,0.00714434103021927,-0.0546305418276881,-0.0266247249892286,1.31804265273965e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,39788,-0.0321835561685436,0.00566032067568676,-0.0432777846928897,-0.0210893276441976,1.32470434979631e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0302836863989174,0.00533259076159632,-0.0407355642916462,-0.0198318085061886,1.38282025304983e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.0122901363060408,0.00216661837056797,-0.016536708312354,-0.0080435642997276,1.43610416610613e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.0158506554989545,0.00279960428878285,-0.0213378799049689,-0.0103634310929401,1.52379986534519e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.017617746432313,0.00311193278938525,-0.023717134699508,-0.0115183581651179,1.52769805423056e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0521615614121734,0.00921573264487958,-0.0702243973961374,-0.0340987254282094,1.53942866102955e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.049645815803958,0.00879442391629519,-0.0668828866798965,-0.0324087449280194,1.67840131519655e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0429621649313064,0.00762354945201068,-0.0579043218572473,-0.0280200080053655,1.78084652215449e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0234118546584038,0.00416394274152134,-0.0315731824317857,-0.015250526885022,1.91412680558696e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0477310080151319,0.00849065344826653,-0.0643726887737343,-0.0310893272565295,1.92950468154896e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0264897122521082,0.00471510658731978,0.0172481033409614,0.035731321163255,1.9701752648398e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0303904167782273,0.00541485329917736,-0.0410035292446149,-0.0197773043118396,2.03446324603447e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.034108112893577,0.00607838981177588,-0.0460217569246578,-0.0221944688624963,2.0401989383503e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0281605137629793,0.00502724754832752,-0.0380139189577012,-0.0183071085682573,2.15994197626442e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,37453,-0.0112584275236328,0.00201165019067528,-0.0152012618973563,-0.00731559314990921,2.22806567805932e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0490058423697812,0.00875792379782333,-0.0661713730135149,-0.0318403117260475,2.24236748610076e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.019634859356503,0.00352332674123448,-0.0265405797693226,-0.0127291389436834,2.54767023748705e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40009,-0.0135318410113963,0.00243387676237048,-0.0183022394656425,-0.0087614425571502,2.74379876482236e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0224722124945947,0.00405093422267802,-0.0304120435710437,-0.0145323814181458,2.95368723596222e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0548052478218946,0.00989626421786068,-0.0742019256889015,-0.0354085699548876,3.11847625161197e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0337519387101556,0.00609614813890031,-0.0457003890624002,-0.021803488357911,3.13204615815158e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,-0.0133743979815286,0.00241809721878785,-0.0181138685303528,-0.00863492743270446,3.23414190944512e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0220119763207338,0.00398395796012281,-0.0298205339225745,-0.0142034187188931,3.34431968602865e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,-0.00826423186989595,0.00149618588911823,-0.0111967562125677,-0.00533170752722422,3.37366853042707e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0242633558732681,0.00439415375497226,-0.0328758972330138,-0.0156508145135225,3.42011131198727e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0139388806839115,0.00253053416566494,0.00897903371920823,0.0188987276486148,3.67977451467742e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0290875455480952,0.00528390746609998,-0.0394440041816512,-0.0187310869145393,3.76049795255471e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0387514572038009,0.00704291767500907,-0.0525555758468187,-0.0249473385607832,3.81900738587643e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0209277487213409,0.00380488829051221,-0.0283853297707448,-0.013470167671937,3.86198797200591e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.021072137191376,0.00383673636733489,-0.0285921404713524,-0.0135521339113996,4.03149729319095e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0239865848617365,0.00436890634031915,-0.032549641288762,-0.015423528434711,4.08495790444781e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0172524506256191,0.00314464550308591,-0.0234159558116674,-0.0110889454395707,4.18017481609134e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0198957062975224,0.0036332614111493,-0.0270168986633751,-0.0127745139316698,4.43050989617216e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,-0.021207691317361,0.00388022046921849,-0.0288129234370292,-0.0136024591976927,4.68303752584214e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0302155381054137,0.00552904207708495,-0.0410524605765002,-0.0193786156343272,4.71590539239269e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0494891154879843,0.00905981156206298,-0.0672463461496277,-0.0317318848263408,4.76570940733646e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0173703439366738,0.00318144758708216,-0.0236059812073548,-0.0111347066659927,4.83447947983216e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0187886291990884,0.00344162646543761,-0.0255342170713461,-0.0120430413268306,4.86648249159731e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,36654,-0.0643843203063719,0.011818417410612,-0.0875484184311713,-0.0412202221815725,5.19412752643842e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37043,0.0341222424174565,0.0062838755648725,0.0218058463103064,0.0464386385246066,5.73118869296684e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0245396717023519,0.00452670822322688,-0.0334120198198765,-0.0156673235848272,6.02811971786206e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.0767645422433588,0.0141848621237313,-0.104566872005872,-0.0489622124808455,6.34852746306773e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,39585,-0.0651944314741912,0.0120672252912146,-0.0888461930449718,-0.0415426699034106,6.66360757862637e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.0211835582280197,0.00392204808271341,-0.0288707724701379,-0.0134963439859014,6.71504745347403e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0122754480165784,0.00227321273477925,0.00781995105641105,0.0167309449767457,6.75722167207422e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.053152671345558,0.00984796784962952,-0.0724546883308319,-0.0338506543602842,6.87833289452767e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40030,-0.0222752955652306,0.00413306259455572,-0.0303760982505598,-0.0141744928799014,7.16290417774573e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39344,-0.0307474579952709,0.00570940532074709,-0.0419378924239352,-0.0195570235666066,7.33366161810353e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0283514640077442,0.00526626288852374,-0.0386733392692507,-0.0180295887462377,7.4259590206827e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,39868,-0.0554500183894395,0.0103075626314153,-0.0756528411470135,-0.0352471956318654,7.5722802333411e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0372910660956591,0.00693829356468182,-0.0508901214824355,-0.0236920107088828,7.7989338784538e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0446654309091902,0.00831025937249215,-0.0609535392792749,-0.0283773225391056,7.79936948325822e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0397692115684014,0.00740007156597795,-0.0542733518377181,-0.0252650712990846,7.82473834089437e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.0113096392700006,0.00210548007413811,-0.0154363802153113,-0.00718289832468994,7.93655291531079e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.0162994832237788,0.00304036560059491,-0.0222585998009448,-0.0103403666466128,8.39108415803285e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.0139634213721912,0.00260552489650282,0.00885659257504567,0.0190702501693367,8.47548219391614e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0231099631402626,0.00431300690474609,-0.031563456673565,-0.0146564696069603,8.54666706600218e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0366335419382462,0.00684427483477482,-0.0500483206144048,-0.0232187632620876,8.82178586633938e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,37453,-0.0105576646045874,0.00197278103107347,-0.0144243154254914,-0.00669101378368335,8.85629984099897e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0169393096612761,0.00316965908375408,-0.0231518414654341,-0.0107267778571181,9.23497159333198e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0208200943018739,0.00390256440175329,-0.0284691205293103,-0.0131710680744374,9.70990927288174e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0441971540357029,0.00829980435904643,-0.0604647705794339,-0.0279295374919719,1.02269332983102e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.0213358190876432,0.0040082993326701,-0.0291920857796766,-0.0134795523956098,1.03753502926978e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.03047137285547,0.00573204205725222,-0.0417061752876843,-0.0192365704232556,1.07778157391775e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0171149422827181,0.00321996483064305,-0.0234260733507785,-0.0108038112146578,1.08226307443656e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0324360718020335,0.00610738848958457,-0.0444065532416193,-0.0204655903624478,1.10546028378105e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0380423387855907,0.00717281249089414,-0.0521010512677433,-0.0239836263034382,1.14997123922498e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37382,-0.0345175062787814,0.00651685580261637,-0.0472905436519095,-0.0217444689056533,1.19795044499447e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,37453,-0.00773364542564285,0.0014621756653811,-0.0105995097297898,-0.00486778112149589,1.24801400218628e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.0134058808459248,0.0025389991204566,-0.0183823191220197,-0.00842944256982988,1.31185684564297e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,39949,0.0139687907372805,0.00264726443286999,0.00878015244885536,0.0191574290257057,1.33244791467163e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.0294439780797615,0.0055816499268617,-0.0403840119364105,-0.0185039442231126,1.34413780754132e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.025563580881761,0.00484709571277714,-0.0350638884788042,-0.0160632732847178,1.35593106270726e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0342923837859097,0.0065063189199821,-0.0470447688690746,-0.0215399987027448,1.37726986117191e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0182570459734783,0.00346652964872997,0.0114626478619676,0.0250514440849891,1.41110452928334e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.01932650313651,0.00367116919146629,-0.0265219947517839,-0.012131011521236,1.42508909912315e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0129804301209782,0.00246847511164913,0.0081422189021459,0.0178186413398105,1.47458722439078e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0263983117455361,0.00502439829502899,-0.0362461324037929,-0.0165504910872792,1.51129863301079e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0363810635793477,0.00693619976946381,-0.0499760151274968,-0.0227861120311986,1.58600285127105e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0342424905118317,0.00653165924908319,-0.0470445426400348,-0.0214404383836287,1.60765536809009e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0142967110066214,0.00272988325698487,0.00894613982293104,0.0196472821903117,1.65165377494609e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0314115911616363,0.00599957502152851,-0.0431707582038322,-0.0196524241194405,1.66875855729718e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0288771483549321,0.00551760356236154,-0.0396916513371607,-0.0180626453727035,1.6875277022738e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.046234022481001,0.00885357475408457,-0.0635870289990067,-0.0288810159629952,1.79184712126899e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,37437,-0.0377708304003215,0.00723717454644069,-0.0519556925113453,-0.0235859682892977,1.82540827891098e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.0149862746642851,0.00287324689634641,-0.0206178385811241,-0.00935471074744617,1.85365531445883e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0339748118514721,0.00652046276233832,-0.0467549188656552,-0.021194704837289,1.91105211811936e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0241479679074106,0.00463723233673201,-0.0332369432874053,-0.0150589925274158,1.93925753459046e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0268172300639224,0.00516253976163085,-0.0369358079967189,-0.0166986521311259,2.07672443538923e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0401316918424508,0.00773062875757593,-0.0552837242072996,-0.024979659477602,2.11898577281729e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37241,-0.0116832029164367,0.00225086123677413,-0.016094890940514,-0.0072715148923594,2.12746054554156e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.0151617243105658,0.00292971692772546,-0.0209039694889077,-0.00941947913222389,2.30529748851159e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37348,-0.0288298816470613,0.00557370450529646,-0.0397543424774424,-0.0179054208166802,2.34315676579946e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0281504263714824,0.00544520287678,-0.0388230240099712,-0.0174778287329936,2.37258888022856e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.0146668988870255,0.00283900907008338,-0.0202313566643889,-0.00910244110966209,2.41747640945949e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,37382,-0.0517487571861666,0.0100160929717936,-0.071380299410882,-0.0321172149614511,2.41832810608697e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.02630415241753,0.00509416967013722,-0.0362887249709989,-0.016319579864061,2.45765806962196e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0335369299930681,0.00649779075224891,-0.0462725998674759,-0.0208012601186602,2.48197955821225e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0336382260013554,0.00652126452386952,-0.0464199044681396,-0.0208565475345711,2.52803559895137e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0103649200482717,0.00201115647229352,0.00642305336257641,0.014306786733967,2.59072619669235e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.0138415041131429,0.0026884794352902,-0.0191109238063117,-0.00857208441997415,2.66431849722109e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0295394576097893,0.00574953766573333,0.018270363784952,0.0408085514346266,2.81976583506832e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0499585270158954,0.00972659662418216,-0.0690226563992924,-0.0308943976324984,2.84110821717149e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0204880667021511,0.00399493984835119,-0.0283181488049194,-0.0126579845993828,2.95460754753299e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,39866,-0.0460663726004266,0.00899584636210455,-0.0636982314701516,-0.0284345137307017,3.07691764632396e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0159142002628316,0.00311672009527142,-0.0220229716495636,-0.00980542887609957,3.32787810552964e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.0194224125750018,0.00380892450116566,-0.0268879045972864,-0.0119569205527171,3.45080644426687e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40058,-0.0296607218990598,0.00582076673660588,-0.0410694247028073,-0.0182520190953123,3.51413464372593e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.00979814425172453,0.00192379441713482,-0.0135687813093088,-0.00602750719414029,3.56175904230758e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0544201036102217,0.0106889892237933,-0.0753705224888565,-0.0334696847315868,3.59822695071713e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,37445,-0.0354380286963081,0.0069674133888641,-0.0490941589384817,-0.0217818984541345,3.70073041112172e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0579605431885389,0.0114032270947385,-0.0803108682942263,-0.0356102180828515,3.76839021296062e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0205906029283754,0.00405589472530337,-0.02854015658997,-0.0126410492667808,3.89134859577411e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0375077385745784,0.00738957709495156,-0.0519913096806835,-0.0230241674684734,3.9120341232526e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0548112852812216,0.0108089931430062,-0.0759969118415137,-0.0336256587209295,4.00368491158636e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0131047101260361,0.00259198215200707,-0.0181849951439699,-0.00802442510810221,4.33162508944488e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0338890442487691,0.00670868669535139,-0.0470380701716578,-0.0207400183258804,4.43265961355059e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.020751148673433,0.00410963528516384,-0.0288060338323542,-0.0126962635145119,4.49152368478584e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0119072954246672,0.00236410991886608,0.00727363998368968,0.0165409508656447,4.78737716738503e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0282254084752916,0.00561064446052097,-0.0392222716179127,-0.0172285453326704,4.94976313262051e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,39931,-0.0096909787617626,0.00192716047001258,-0.0134682132829873,-0.00591374424053794,4.99313750863967e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,39858,-0.0112916610927484,0.00224699128544011,-0.015695764012211,-0.00688755817328575,5.08239486838404e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,39967,0.0196328667659251,0.00391022953641676,0.0119688168745482,0.0272969166573019,5.1979555897002e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.0338625186476264,0.00676275355560303,-0.0471175156166083,-0.0206075216786444,5.59192940561433e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.011928951038762,0.00238425792912605,-0.0166020965798491,-0.00725580549767493,5.70873358598739e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,37043,-0.0248874015352505,0.00497582269560465,-0.0346400140186356,-0.0151347890518653,5.75685270960816e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0122136433640851,0.00244254171895821,-0.0170010251332432,-0.007426261594927,5.79299140571214e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0434505733764474,0.00869657182740314,-0.0604958541581575,-0.0264052925947372,5.91730452922618e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0338705059361387,0.00678268922105902,-0.0471645768094143,-0.020576435062863,5.9866330306551e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.038085955534121,0.00763466813044674,-0.0530499050697966,-0.0231220059984454,6.14734654728263e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.0438630975992226,0.00879584842627892,-0.0611029605147293,-0.0266232346837159,6.2169915697231e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0323470790673457,0.00648988579702505,-0.0450672552295148,-0.0196269029051765,6.2999304682497e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.0171497044201689,0.00344994944918236,-0.0239116053405664,-0.0103878034997715,6.73011955814995e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.0159553952473615,0.00321049280382583,-0.0222479611428602,-0.0096628293518629,6.77237198088878e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0297079530517841,0.00597747300840157,0.0179921059553171,0.0414238001482512,6.78052069783712e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,37437,-0.0204782387483264,0.00412653879392042,-0.0285662547844104,-0.0123902227122424,7.04094816855417e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,37056,-0.00793558499902886,0.00159946547047917,-0.011070537321168,-0.00480063267688969,7.08595867411605e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.0155722620888315,0.00313974386329773,-0.0217261600608951,-0.009418364116768,7.14502621883939e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,37021,-0.0186679890578767,0.00377043776939211,-0.0260580470858852,-0.0112779310298682,7.46919440416451e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0328248890339439,0.00663388350776717,-0.0458273007091675,-0.0198224773587202,7.58575190092355e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0579663295783147,0.0117217564394577,-0.0809409721996517,-0.0349916869569776,7.68645096555655e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.0170634565218804,0.00345056161071614,-0.023826557278884,-0.0103003557648768,7.70313647939328e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0361520001802696,0.0073131409936426,-0.0504857565278091,-0.0218182438327301,7.76949415074325e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0175341121019731,0.00354778219496206,-0.0244877652040987,-0.0105804589998474,7.80161875774159e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0375727300641781,0.00760311821062515,-0.0524748417570034,-0.0226706183713528,7.82116646599927e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,37453,0.0143851964620174,0.00291383551020274,0.00867407886202008,0.0200963140620148,8.03325101357399e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37039,-0.0233892663950184,0.00473779553874229,-0.0326753456509532,-0.0141031871390835,8.04112356632589e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00953359323404593,0.00193622440098182,0.00573859340812157,0.0133285930599703,8.59065768964624e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0336982185588209,0.00684706431827325,-0.0471184646226365,-0.0202779724950053,8.68700582798701e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0405253828883279,0.0082404530145759,-0.0566766707968967,-0.0243740949797591,8.8363943483638e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.0101946520913819,0.00207371266932613,-0.0142591289232611,-0.00613017525950271,8.91480562355205e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0196274846423861,0.00399310948565945,-0.0274539792342786,-0.0118009900504936,8.9529912107043e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0463399618762813,0.00943964503948296,-0.0648416661536679,-0.0278382575988947,9.24291156800024e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0357753472829415,0.00728789260610545,-0.0500596167909082,-0.0214910777749748,9.26671481007824e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0228188178566747,0.0046491680397861,-0.0319311872146555,-0.013706448498694,9.28602735167934e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0391001842508502,0.0079666546925988,-0.0547148274483439,-0.0234855410533566,9.30930282434798e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0205410568797787,0.00419403067908742,-0.0287613570107901,-0.0123207567487674,9.81211875213209e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37368,-0.0152768082521513,0.00311977267531065,-0.0213915626957602,-0.00916205380854247,9.85519153300184e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,37149,-0.0150822358378301,0.00308429883064556,-0.0211274615458954,-0.00903701012976483,1.02012978979853e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.028089318115769,0.00574948457618846,-0.0393583078850984,-0.0168203283464396,1.04152207322556e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0457405311606948,0.00936645762125209,-0.0640987880983489,-0.0273822742230407,1.05257395272399e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37420,-0.0167396839365927,0.0034296336614384,-0.023461765913012,-0.0100176019601734,1.06806858045772e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0386743682880196,0.00792637844121004,-0.0542100700327913,-0.0231386665432479,1.07727163209953e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.0108600439599074,0.00222802657333135,-0.0152269760436368,-0.00649311187617792,1.10253071826561e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.0131814692599132,0.00270586023270696,-0.0184849553160188,-0.00787798320380754,1.12060137687331e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0167048135186127,0.00343433752406529,-0.0234361150657807,-0.00997351197144476,1.16298137538218e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0249063623560894,0.00512175699957936,-0.0349450060752649,-0.0148677186369138,1.17006122687539e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,37368,-0.0305667671975129,0.00628621494520994,-0.0428877484901244,-0.0182457859049015,1.17212879390541e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37382,-0.0143115127753489,0.00294682139810824,-0.020087282715641,-0.00853574283505673,1.20759327360758e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0130598903066427,0.00268948598698931,0.00778849777214371,0.0183312828411418,1.20970120389827e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0376262437388141,0.00775191465488297,-0.0528199964623847,-0.0224324910152435,1.22288408977401e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.0218515657829954,0.00451166581933597,-0.0306944307888939,-0.0130087007770969,1.28893293472975e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0523634283779227,0.0108228887129804,-0.0735762902553643,-0.031150566500481,1.32234027447646e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40012,-0.0134718568816632,0.00279287484882206,-0.0189458915853544,-0.00799782217797195,1.42238769844705e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.0198441462252998,0.00411711072915019,-0.0279136832544341,-0.0117746091961654,1.44957086906301e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0335253954443962,0.00696847765964937,-0.047183611657309,-0.0198671792314835,1.51546742519044e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,39749,-0.0664671867077568,0.0138235868273821,-0.0935614168894257,-0.0393729565260879,1.53655923701278e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,39585,-0.0388299198918086,0.00808976724560475,-0.0546858636931939,-0.0229739760904233,1.6021938181076e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,39868,-0.0560537821772122,0.0117090560636271,-0.0790035320619214,-0.033104032292503,1.70622182789629e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0440725204784198,0.00920766519780393,-0.0621195442661155,-0.0260254966907241,1.71228291218317e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0220850828364899,0.00462615805363468,-0.0311523526216139,-0.0130178130513659,1.82525876202702e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0226472735642205,0.00474448063964136,-0.0319464556179175,-0.0133480915105234,1.83039884438691e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0234117096308971,0.00490760544103026,-0.0330306162953164,-0.0137928029664778,1.85434549010598e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,39587,-0.0235872403621142,0.00495992716209232,-0.0333086975998151,-0.0138657831244132,1.99650261972436e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0185177673894603,0.00390121223661618,0.0108713914056925,0.026164143373228,2.08576461704955e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0183112801868621,0.00387265777647058,-0.0259016894287444,-0.0107208709449798,2.28327888133021e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,39836,-0.0312078696757594,0.00660654732743424,-0.0441567024375305,-0.0182590369139883,2.33471306775454e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37445,0.0108439978018274,0.00229564474541109,0.00634453410082163,0.0153434615028331,2.33879657615351e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.0267485174726938,0.0056653489781859,-0.0378526014699382,-0.0156444334754494,2.36218613134329e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.0396639194002226,0.00842402852062629,-0.0561750153006501,-0.0231528234997951,2.52115509224044e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0120631763020568,0.0025636869613579,-0.0170880027463183,-0.00703834985779534,2.55865237021492e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.027902110966522,0.00594162092012156,-0.0395476879699602,-0.0162565339630837,2.67503866760337e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,39788,-0.0127027600412677,0.00270597757274636,-0.0180064760838506,-0.00739904399868485,2.69705839387039e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0410849230837245,0.00876500010921001,-0.0582643232977761,-0.0239055228696729,2.79487287781328e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.0175074761630877,0.00373919900727802,-0.0248363062173526,-0.0101786461088228,2.86700034435124e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0213549923105547,0.00456611256100405,-0.0303045729301226,-0.0124054116909867,2.9413090101352e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,37437,-0.0210549239724095,0.00450742572018001,-0.0298894783839623,-0.0122203695608567,3.02370897356099e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0178065387183868,0.00381239400256019,-0.0252788309634047,-0.0103342464733688,3.0305725064604e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,39749,0.0186640503094448,0.00400509654504416,0.0108140610811582,0.0265140395377313,3.18660128583183e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0180090271969005,0.0038645922292449,-0.0255836279662205,-0.0104344264275805,3.19304157427106e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.0127357198904193,0.00273451138320229,-0.0180953622014958,-0.00737607757934284,3.22844691313882e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0240337220789568,0.00516546154044607,-0.0341580266982311,-0.0139094174596825,3.30605508887299e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0283565171287493,0.00609617956101895,-0.0403050290683464,-0.0164080051891521,3.327015842021e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0381505784339197,0.00820724617191549,-0.0542367809308741,-0.0220643759369653,3.37681902932024e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.0219220493963044,0.00472071886649195,-0.0311746583746286,-0.0126694404179802,3.44854939664782e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0221187116836557,0.00476898075443271,0.0127715094049676,0.0314659139623438,3.55015729510866e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.0126395067469357,0.00272556668196341,-0.017981617443584,-0.00729739605028744,3.56228609291796e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.01419014076909,0.00306143744898023,-0.0201905581690913,-0.00818972336908879,3.60124374185722e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0288899446748075,0.00623687572449437,-0.0411142210948164,-0.0166656682547985,3.65411811839985e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.0240209532647705,0.00518692053248502,-0.0341873175084412,-0.0138545890210999,3.67169734919178e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0246878263072404,0.00535454706745402,0.0141929140550306,0.0351827385594503,4.04527064392271e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0432561487926969,0.00938988373322462,-0.0616603209098171,-0.0248519766755766,4.12985553574609e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,39868,-0.0304866840092398,0.00661869016117837,-0.0434593167251494,-0.0175140512933302,4.13351500630521e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0410916003972587,0.0089291603753192,-0.0585927547328844,-0.0235904460616331,4.22346694322522e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37388,-0.0477247185718817,0.0103769644775985,-0.0680635689479747,-0.0273858681957887,4.28163631689929e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0299422287385641,0.00651067895971623,-0.0427031594996079,-0.0171812979775203,4.28601837177792e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0327247261438193,0.00713946452557591,-0.0467180766139481,-0.0187313756736905,4.61125501991372e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0214033957452707,0.00467472573960961,-0.0305658581949055,-0.0122409332956359,4.72423355790821e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0389111221290584,0.00850684840243467,-0.0555845449978304,-0.0222376992602865,4.82639995175717e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0287625019721965,0.0062905512957626,-0.0410919825118912,-0.0164330214325018,4.85933319232762e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0204447531789756,0.00448547937418209,-0.0292362927523725,-0.0116532136055787,5.20972222809073e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,39489,-0.0458337490092991,0.0100678532343192,-0.0655667413485647,-0.0261007566700335,5.34159457486821e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0249766051549105,0.00549047649207283,-0.0357379390793732,-0.0142152712304477,5.42817363026657e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,-0.0254654800616724,0.00559964987628299,-0.0364407938191871,-0.0144901663041578,5.46314139794901e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,37289,-0.0188851939235828,0.00415883993621162,-0.0270365201985576,-0.010733867648608,5.64814074312505e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0195931104985938,0.00431788973211464,-0.0280561743735385,-0.0111300466236491,5.72948711855938e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0300015441447412,0.00662736025214207,-0.0429911702389397,-0.0170119180505428,6.03587898131361e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0395371274019851,0.00874479005817904,-0.056676915916016,-0.0223973388879541,6.20063359562218e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.0525542336787795,0.0116248055885753,-0.075338852632387,-0.0297696147251719,6.21220503478431e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37056,-0.0113334560769195,0.00250791770966859,-0.01624897478787,-0.0064179373659691,6.26515822478529e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0573185875893353,0.0126864438349876,-0.082184017505911,-0.0324531576727595,6.29403203658953e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,37056,-0.0181797390913814,0.00403096966810918,-0.0260804396408754,-0.0102790385418875,6.53816361214167e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0157457996473063,0.00349182121311954,-0.0225897692250206,-0.00890183006959201,6.55005301111088e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0347128433416819,0.00770732577228404,-0.0498192018553587,-0.0196064848280052,6.71965821476709e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0403751912262846,0.008966909920301,-0.0579503346700745,-0.0228000477824946,6.75690420524152e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0277550476700495,0.00617668130718991,-0.0398613430321417,-0.0156487523079572,7.05577847583078e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,39908,-0.0220603280964233,0.00491214775857039,-0.0316881377032212,-0.0124325184896253,7.13925481394028e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0402914947779258,0.00897883881860722,-0.057890018862396,-0.0226929706934557,7.26146977026778e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0313268176744627,0.00700028898017705,-0.0450473840756097,-0.0176062512733156,7.70246830516528e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37445,0.0263977165636818,0.00590225363395461,0.0148292994411307,0.0379661336862328,7.79444691310112e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,39885,-0.0135321200572356,0.00304033676347036,-0.0194911801136375,-0.00757306000083366,8.61032168491295e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,37453,-0.00780244466184025,0.00175499488122382,-0.0112422346290389,-0.00436265469464156,8.82384894064493e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.0179322482783343,0.00403836765596041,-0.0258474488840167,-0.0100170476726519,9.04849693736668e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0208626487984689,0.00470429822589189,-0.030083073321217,-0.0116422242757208,9.27686890317624e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0324456132695692,0.00732340870821865,-0.0467994943376777,-0.0180917322014606,9.46835916959526e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,37287,-0.0425214437429641,0.00959855235237437,-0.0613346063536179,-0.0237082811323104,9.4985242439036e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0181280251504702,0.00409781695778747,-0.0261597463877336,-0.0100963039132067,9.77458863095181e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00856098983523206,0.00193615255177208,-0.0123558488367053,-0.00476613083375879,9.87327446607587e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,37249,0.0132899952878703,0.00300905729310369,0.00739224299338704,0.0191877475823535,1.01022023845387e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39478,-0.0235323654432805,0.00533165964348073,-0.0339824183445027,-0.0130823125420582,1.02298302357278e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0139966143201401,0.00317194996846516,-0.0202136362583318,-0.00777959238194834,1.02912711179239e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.0132916732351153,0.00301548835828619,-0.0192020304173563,-0.00738131605287442,1.05108227397084e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0148438072417827,0.00337023902855079,-0.0214494757377422,-0.00823813874582311,1.06925312942172e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37437,0.0245623599189684,0.0055875947808057,0.0136106741485892,0.0355140456893476,1.11166230244649e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.033970798134992,0.00773007275898164,-0.049121740742596,-0.018819855527388,1.11829549652474e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.0102302127289386,0.00232929747852798,-0.0147956357868535,-0.00566478967102377,1.13047398049802e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,37382,-0.0333179009659577,0.00759865971229936,-0.0482112740020644,-0.0184245279298509,1.17018912777008e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.0133824015623319,0.00305403436549983,-0.0193683089187116,-0.00739649420595225,1.18423495812482e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0218837651142055,0.00499441320090934,-0.0316728149879878,-0.0120947152404232,1.18525764164208e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0325107726757531,0.00742906377075122,0.0179498076850807,0.0470717376664255,1.21552870673668e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,39913,-0.0263710494361423,0.00603227426308537,-0.0381943069917896,-0.0145477918804949,1.24080950326068e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,39866,-0.0246671800445608,0.00564470146699943,-0.0357307949198797,-0.0136035651692419,1.25045629799716e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0208623314509266,0.00478891142370018,-0.0302485978413789,-0.0114760650604742,1.33229132230053e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.00786949405813083,0.00180906225638858,0.00432373203560922,0.0114152560806524,1.37106609805337e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0403137101332825,0.00927853682098182,-0.0584996423024068,-0.0221277779641581,1.4024527572556e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0174258685035026,0.00401165730559442,-0.0252887168224677,-0.00956302018453753,1.41052246989126e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0286528506960075,0.00659847182953534,-0.0415858554818968,-0.0157198459101183,1.42021702818843e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,37445,-0.0287323117157971,0.00662019088873271,-0.0417078858577132,-0.015756737573881,1.43445403004622e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0271079908749959,0.00624969661139696,-0.0393573962333339,-0.0148585855166578,1.4516405277396e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0254614954984386,0.00587559975426612,-0.0369776710168002,-0.0139453199800771,1.47697024066923e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,39490,-0.0174784995618519,0.00403632294806814,-0.0253896925400655,-0.00956730658363836,1.49831885345296e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,39868,0.028753844097661,0.00665094998562632,0.0157179821258334,0.0417897060694886,1.5466318639065e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0291550651755812,0.0067497066865015,-0.0423844902811241,-0.0159256400700382,1.57529396847037e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0342686325705036,0.00794141015021472,-0.0498337964649245,-0.0187034686760828,1.60428058234542e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0200942131999413,0.00465880370497113,-0.0292254684616847,-0.0109629579381979,1.61893094606593e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.0129811498585629,0.00301157370886898,-0.0188838343279461,-0.00707846538917971,1.64125609889435e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0368826323785388,0.00857307222275179,-0.0536858539351323,-0.0200794108219453,1.70337646145335e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0321891183290376,0.00751187016967225,-0.0469123838615952,-0.01746585279648,1.8391746208945e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0137313267967311,0.00320586098787714,-0.0200148143329703,-0.00744783926049194,1.8553388068645e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0152450932078924,0.00355999713238398,0.00826749882841983,0.022222687587365,1.8604855509908e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,37453,0.0145619044558923,0.00340246164315623,0.00789307963530609,0.0212307292764785,1.8833030015979e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,39587,-0.0138390247571163,0.00323781397182403,-0.0201851401418914,-0.00749290937234117,1.92964871304676e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40018,-0.00849260513865878,0.0019878164255905,-0.0123887253328162,-0.0045964849445014,1.94548850314446e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0331538752105106,0.00776236145609018,-0.0483681036644473,-0.0179396467565738,1.95635599244885e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0269522844840766,0.00631792957073277,-0.0393354264427128,-0.0145691425254404,2.00182439499557e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.00920922238132198,0.00215895390302314,-0.0134407720312473,-0.00497767273139664,2.00534558630728e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0251759154474891,0.00590601649595517,-0.0367517077795612,-0.013600123115417,2.03283330907788e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,37039,-0.0178484885116343,0.00420257091256929,-0.0260855275002701,-0.00961144952299849,2.18098928161891e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0203439046948971,0.00479139978536754,-0.0297350482742174,-0.0109527611155767,2.19174743877508e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.0140975898741042,0.00332041379000017,-0.0206056009025046,-0.0075895788457039,2.19331998092126e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.0179381643018928,0.00423324683665939,-0.0262353281017452,-0.00964100050204035,2.27346215306708e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0156111190820275,0.00368892023104442,-0.0228414027348746,-0.00838083542918047,2.33261639099983e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0158745870008415,0.00375812989751185,-0.0232405215999647,-0.00850865240171828,2.41507155728866e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.019682816104236,0.00466238142241363,-0.0288210836921667,-0.0105445485163053,2.43887958925653e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0347640176052501,0.00823847621675855,-0.0509114309900969,-0.0186166042204034,2.46252407622434e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,39788,-0.0217993669458385,0.00517205860495615,-0.0319366018115526,-0.0116621320801245,2.51339953610946e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0368227111605251,0.00873880095358374,-0.0539507610295492,-0.0196946612915009,2.52630329805766e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0240149029440232,0.0057080612760337,-0.0352027030450492,-0.0128271028429971,2.602288876738e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0380767894247001,0.00906210790608514,-0.055838520920627,-0.0203150579287733,2.6629559046763e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.0169183728926803,0.0040361980881161,-0.0248293211453879,-0.00900742463997276,2.78677187831457e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0213781839130411,0.0051055615290566,-0.0313850845099921,-0.0113712833160902,2.84208502024685e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.0158227832454333,0.00378056488116395,-0.0232326904125147,-0.00841287607835198,2.8632001775357e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.023681853232913,0.00565897084956924,-0.0347734360980687,-0.0125902703677573,2.87170883172451e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0297548593604738,0.00712284702763788,-0.0437156395346441,-0.0157940791863036,2.96763112917959e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0175296064306543,0.00419989224496295,-0.0257613952307817,-0.00929781763052692,3.01113328785305e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0191660780217069,0.00459455437696769,-0.0281714046005636,-0.0101607514428502,3.04240129304623e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0352481858688789,0.00848271229513305,-0.0518743019673397,-0.0186220697704182,3.26869749981731e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,39749,-0.0166718774242589,0.00401432494811285,-0.0245399543225601,-0.00880380052595769,3.29720026105616e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,37445,-0.0105847505081469,0.00255001166651908,-0.0155827733745243,-0.0055867276417695,3.33243059389779e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.010942173718461,0.00263654094536457,-0.0161097939713755,-0.00577455346554645,3.34213670493896e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,39564,-0.021398160819854,0.00515692531718752,-0.0315057344415416,-0.0112905871981665,3.35099297752494e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,39862,-0.0139166197369785,0.00335912294024177,-0.0205005006998524,-0.0073327387741046,3.44654569914249e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37411,-0.0203603479617653,0.00491521260170289,-0.0299941646611029,-0.0107265312624276,3.4590654703508e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.0110813712976119,0.00267860341574099,-0.0163314339924642,-0.00583130860275952,3.53672775900072e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,39788,-0.016542454470931,0.00400421807257321,-0.0243907218931745,-0.00869418704868756,3.62627138351703e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,39913,0.0149524308101181,0.00362495431952263,0.00784752034385373,0.0220573412763824,3.72828096681211e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0257715702201413,0.00625554243989559,-0.0380324334023367,-0.013510707037946,3.81118546335441e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0184640526592846,0.00450305779788504,-0.0272900459431393,-0.00963805937542989,4.15024295489838e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0144011272010058,0.00351395764798894,-0.0212884841910641,-0.00751377021094749,4.18756076377063e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0119460862733369,0.00291773725041949,-0.0176648512841591,-0.00622732126251472,4.25565874332634e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.010998175236734,0.00268677057005077,-0.0162642455540335,-0.00573210491943451,4.2709290926671e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.0181122160467033,0.00443318015040126,-0.0268012491414898,-0.00942318295191684,4.42200611648449e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0184142346926649,0.00450840609691695,-0.0272507106426221,-0.00957775874270764,4.4403198677815e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0108173047444573,0.00265456011931205,-0.0160202425783089,-0.00561436691060563,4.62864577737002e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0133499105656377,0.00327765749522635,-0.0197741192562814,-0.00692570187499409,4.66742270430117e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00784342672513806,0.00193212933223214,-0.0116304002163131,-0.00405645323396306,4.94162260896269e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0241824367524795,0.00595771116539998,-0.0358595506366635,-0.0125053228682956,4.95646638485852e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0128036987576513,0.00315592064291537,0.00661809429753721,0.0189893032177655,4.99764010860762e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37249,-0.0429638105206617,0.0105992917339499,-0.0637384223192035,-0.0221891987221199,5.07508201683801e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0352555503378489,0.00870485147565818,-0.0523170592301389,-0.0181940414455589,5.14794724206725e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37382,-0.0238374226812011,0.00590463468016537,-0.0354105066543252,-0.012264338708077,5.44212904434806e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.0146134435068775,0.00361991123588832,-0.0217084695292186,-0.00751841748453636,5.444662418568e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,39918,-0.0150827400599486,0.00373650460129571,-0.0224062890784882,-0.00775919104140906,5.44850843252033e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.0278011398998807,0.00690539397290209,-0.0413357120867688,-0.0142665677129926,5.70472994866953e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0362323478188363,0.00901454849250405,-0.0539008628641442,-0.0185638327735283,5.86822615290092e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.00933978687556299,0.00232541305463568,-0.0138975964626489,-0.00478197728847705,5.94218309853012e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0138078935161363,0.00343920811507507,0.00706704561058912,0.0205487414216834,5.97576104383946e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0296587961873654,0.00739015835867971,-0.0441435065703776,-0.0151740858043532,6.02124510273092e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,39477,-0.0262128227782471,0.0065345125658391,-0.0390204674072917,-0.0134051781492025,6.06298994964122e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0185439232680151,0.00462356610300123,-0.0276061128298975,-0.00948173370613267,6.08534004054507e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.042111788542868,0.010511681011769,-0.0627146833259353,-0.0215088937598007,6.19839700820326e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0261306233536085,0.00652406212106883,-0.0389177851109034,-0.0133434615963136,6.22889687941661e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0280539444858437,0.00701333152089475,-0.0418000742667974,-0.01430781470489,6.3600649121722e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37021,0.0140045865442743,0.0035096071905069,0.00712575645088079,0.0208834166376678,6.63313523708491e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0305619194150036,0.00766948936108295,-0.0455941185627262,-0.015529720267281,6.78215168413546e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0439270767348022,0.0110268355961605,-0.0655396745032767,-0.0223144789663276,6.82190818847717e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0195033265706424,0.00490304148206764,-0.0291132878754949,-0.00989336526578979,6.99182051633651e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,39881,-0.0406307024241183,0.0102235517123526,-0.0606688637803295,-0.0205925410679071,7.09179950212814e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37056,-0.0132806972807236,0.00334219641604457,-0.019831402256171,-0.00672999230527625,7.11579640681621e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.0157526374238417,0.00396513321114474,-0.0235242985176854,-0.00798097632999799,7.13494421082487e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0565178758363649,0.0142554612475495,-0.0844585798815618,-0.0285771717911679,7.38240331903004e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40052,-0.0154760451444392,0.00390786078245149,-0.0231354522780441,-0.00781663801083426,7.51965426996849e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,39587,-0.0169513879481571,0.00428266125256243,-0.0253454040031794,-0.00855737189313471,7.58666330904004e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.0166058646463559,0.00419894398812748,-0.0248357948630858,-0.00837593442962608,7.6998732375868e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0411670608882356,0.0104149965129296,-0.0615804540535775,-0.0207536677228936,7.76766650990806e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0321565134182874,0.00814002729928278,-0.0481109669248816,-0.0162020599116931,7.8422574673365e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0167754805176941,0.00424689819278251,-0.0250994009755478,-0.00845156005984035,7.85407266103162e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.0143099520575548,0.00363575744140541,-0.0214360366427094,-0.00718386747240016,8.33131580226836e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0280140287722131,0.00711794835183174,-0.0419652075418033,-0.0140628500026229,8.33720114272677e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,39415,-0.0113584995469,0.00288746406531537,-0.0170179291149181,-0.00569906997888184,8.40014279744369e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0196840978876861,0.00500739981819066,-0.0294986015313398,-0.00986959424403238,8.49575081274507e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.0182531727951495,0.00464357273648889,-0.0273545753586678,-0.0091517702316313,8.50680354784154e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0109470589178411,0.00278540077988129,-0.0164064444464084,-0.00548767338927378,8.52504496466661e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,39788,-0.0156742789830733,0.00399029037123587,-0.0234952481106956,-0.007853309855451,8.5978957554709e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_A,,37411,-0.0121944185809065,0.00310652330598344,-0.018283204260634,-0.00610563290117892,8.70055695451143e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.00613838621800998,0.00156606873219741,-0.0092078809331169,-0.00306889150290306,8.91254187737839e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.033909021775788,0.00867139754310863,-0.0509049609602809,-0.0169130825912951,9.25874679703456e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0267475261724289,0.00684573386006675,-0.0401651645381598,-0.0133298878066981,9.38341122724588e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37124,-0.040974767188542,0.0104995650251702,-0.0615539146378756,-0.0203956197392083,9.56666594380262e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0343294819295445,0.00880296840417751,-0.0515833000017324,-0.0170756638573566,9.67647879034013e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,39858,0.00888005937293411,0.00227814712670182,0.00441489100459855,0.0133452277412697,9.74138625524246e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,39587,-0.0104628077078942,0.00268817549653726,-0.0157316316811072,-0.00519398373468117,9.97657730165917e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0254959630576044,0.00655331350375393,-0.0383404575249621,-0.0126514685902467,0.00010051094662952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0201441110909546,0.00518296507258119,-0.0303027226332137,-0.00998549954869544,0.000102067965175812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.047868138951782,0.0123259058037091,0.0237093635765121,0.0720269143270518,0.000103357025973729
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.00713917765014777,0.00183935128101665,-0.0107443061609404,-0.00353404913935513,0.000104293658246887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0317038228568984,0.00817385958546897,-0.0477245876444176,-0.0156830580693792,0.000105453461186567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0262780264753851,0.00678147651781995,-0.0395697204503122,-0.012986332500458,0.000107072620706415
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,39866,-0.030044957098532,0.0077544005483362,-0.0452435821732709,-0.0148463320237931,0.000107239335400066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0209900183045839,0.00543089331485885,-0.0316345692017073,-0.0103454674074606,0.000111657406758626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0268816203371521,0.00695569410223086,-0.0405147807775245,-0.0132484598967796,0.000111666789339167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.0112766844017651,0.00292191952167193,-0.0170036466642421,-0.00554972213928817,0.000114235155541597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,36991,-0.0238457431492584,0.0061807590793921,-0.0359600309448669,-0.0117314553536499,0.000114836681248177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0116123572055668,0.00301663671062155,0.0056997492527486,0.0175249651583851,0.000118948870307539
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37388,-0.0264894630330353,0.00689139144737036,-0.0399965902698812,-0.0129823357961894,0.000121674134025579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,37437,-0.00966746389189395,0.00251661673731714,-0.0146000326970355,-0.00473489508675235,0.000122864685745513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,39829,-0.0244931725461292,0.00638518950946747,-0.0370081439846855,-0.011978201107573,0.000125568451244428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0212019173955072,0.0055339989959262,0.0103552793634918,0.0320485554275225,0.000128106497901263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0371172329311614,0.00969033807092655,-0.0561102955501774,-0.0181241703121453,0.000128457610477552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,39788,0.0279630303128802,0.00730153296940535,0.0136520256928458,0.0422740349329147,0.000128766154889714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0216898225002146,0.00567029318121847,-0.0328035971354028,-0.0105760478650264,0.000131279840565276
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0214993332636869,0.0056471794225453,0.0104308615954981,0.0325678049318757,0.000141140960233041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,39489,0.0267648901138935,0.00703034233282925,0.0129854191415481,0.0405443610862388,0.000141169304945284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0333072329026494,0.00878370722322142,-0.0505232990601634,-0.0160911667451354,0.000150127669926727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0435129381353738,0.0115086195732474,-0.0660698324989386,-0.0209560437718089,0.000156953128834817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0234943173484242,0.00621730011261916,-0.0356802255691577,-0.0113084091276906,0.000158234010051492
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.020248299032651,0.00536278835126552,-0.0307593642011315,-0.00973723386417062,0.00016024771690474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0190766162446539,0.00505315306135877,-0.0289807962449171,-0.00917243624439074,0.000160473224513732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.0374677654803091,0.00993960379149659,-0.0569493889116424,-0.0179861420489758,0.000164131716592344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,-0.00292856661822223,0.000777283851819193,-0.00445204296778785,-0.00140509026865661,0.000165469897815422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0222690702488578,0.00591358865629273,-0.0338597040151916,-0.0106784364825241,0.000166774689048586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.0217390511225005,0.00578671664299497,-0.0330810157427706,-0.0103970865022304,0.000172779022739531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.0204762923589501,0.00545186731706473,-0.031161952300397,-0.00979063241750321,0.000173378952407549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0374825075823327,0.01000871887693,-0.0570995965811155,-0.01786541858355,0.000181036425459849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0237342159469032,0.00635994153945436,-0.0361997013642337,-0.0112687305295726,0.00019075171355293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0276751605436928,0.00741599879670624,-0.0422105181852371,-0.0131398029021486,0.000190760367958731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0383008119653444,0.0102669866926678,-0.0584241058829733,-0.0181775180477156,0.000191893425467684
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,39847,0.0182712570218371,0.00490199967328792,0.00866333766219281,0.0278791763814814,0.00019420388231157
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,39985,-0.0248526837005003,0.00667276862935169,-0.0379313102140297,-0.011774057186971,0.000196374640324456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0166307310240026,0.00447515956161579,-0.0254020437647695,-0.00785941828323561,0.000202921024359756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37056,0.0106035637525635,0.00285694781277195,0.00500394603953045,0.0162031814655965,0.000206881077031674
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,39477,-0.0206973910169817,0.00558356979686942,-0.0316411878188457,-0.00975359421511761,0.00021058811738609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.01547137690629,0.0041749935212843,0.00728838960457275,0.0236543642080072,0.000211497138829086
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,39903,-0.0192790135727241,0.00522558317328809,-0.0295211565923687,-0.00903687055307945,0.000225569446875869
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0214969115713825,0.00583454605064735,-0.0329326218306513,-0.0100612013121137,0.00023013702088493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,39788,-0.00731310085958468,0.00198919141109825,-0.0112119160253373,-0.00341428569383211,0.000237308150075416
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0129692690596018,0.00353895438961397,-0.0199056196632452,-0.0060329184559584,0.000248556508412171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0309407429519919,0.00844670181193764,0.0143852074005941,0.0474962785033896,0.000250028060341001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37257,0.0378849895642376,0.0103451097622887,0.0176085744301518,0.0581614046983235,0.000251103871969307
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0330742645653088,0.00904113816861926,-0.0507948953758025,-0.015353633754815,0.000254811228774968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.01693907338713,0.00464235465922376,-0.0260380885192086,-0.00784005825505145,0.000264295518534241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0122978089694025,0.00337075309461015,-0.0189044850348384,-0.00569113290396661,0.000264901237344448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0315639708063587,0.00865280325606253,0.0146044764244761,0.0485234651882412,0.000265486447776868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,39713,0.0164945150847365,0.00452200098136103,0.00763139316126888,0.0253576370082041,0.000265534984521529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37169,0.0117866772209249,0.00324041645783432,0.00543546096356966,0.0181378934782802,0.000276449166943955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37437,-0.0273803281940061,0.00752838392037549,-0.0421359606779421,-0.0126246957100701,0.000276910757388829
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,39844,-0.0433303902198141,0.0119150650932077,-0.0666839178025012,-0.0199768626371269,0.000277122857757488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.0186439329976808,0.00513537979202454,-0.0287092773900489,-0.00857858860531271,0.000283931845176431
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39489,-0.0122552864934935,0.00338819907252395,-0.0188961566756404,-0.00561441631134651,0.00029891804797542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0188002872911086,0.00519945027979299,-0.0289912098395029,-0.00860936474271434,0.000300317931026515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0125585723197518,0.00347579261301823,-0.0193711258412675,-0.00574601879823609,0.00030359459007362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37043,-0.0240773276406774,0.00666618567903366,-0.0371430515715834,-0.0110116037097715,0.000305138430862208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,40052,-0.017867921864117,0.00495349181096958,-0.0275767658136173,-0.00815907791461658,0.000310526285663059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.0157105374810111,0.00435656207550307,-0.0242493991489971,-0.0071716758130251,0.000311702072402882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39489,-0.0212171580538934,0.00588512509943557,-0.0327520032487871,-0.0096823128589997,0.000312861657829078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0175252669549125,0.00486557001012637,-0.0270617841747602,-0.00798874973506482,0.00031704086776425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0255956060969879,0.00710736557663921,-0.0395260426272007,-0.0116651695667751,0.000317636854626428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.0115630355831706,0.00321104564146002,-0.0178566850404322,-0.00526938612590892,0.000318135961836015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,-0.0140742272216777,0.00391283135033842,-0.021743376668341,-0.00640507777501443,0.000322950163621848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00811749046041072,0.00225868462265188,-0.0125445123208084,-0.00369046860001303,0.000326739671711217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37437,-0.0291071129351018,0.00812498996040541,-0.0450320932574964,-0.0131821326127072,0.000341618974815897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0281905790876753,0.00787972843287241,-0.0436348468161052,-0.0127463113592454,0.000347959972221444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37021,0.0147372565426612,0.00412273750100848,0.0066566910406846,0.0228178220446378,0.000351980498490887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0338857935640992,0.00948695152230693,-0.0524802185478208,-0.0152913685803776,0.000355719734055509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00855274926497975,0.00239959116055531,-0.0132559479396682,-0.00384955059029134,0.000366151828599926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0163140467878175,0.00458799250518389,0.00732158147765705,0.0253065120979779,0.000378133453912976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0305461158398461,0.00860396518739122,-0.0474098876071329,-0.0136823440725593,0.000385993840000843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0102030598522195,0.00287556934334088,-0.0158391757651676,-0.00456694393927136,0.00038920070453774
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.022389129143255,0.00631985708616104,-0.0347760490321307,-0.0100022092543794,0.000397254445739081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.0108855013127749,0.00307430401324173,-0.0169111371787287,-0.00485986544682114,0.000400294276118524
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0146742856320351,0.00415338601334028,0.00653364904588815,0.022814922218182,0.000412136623668493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.0148575386077807,0.00420709461124316,-0.0231034440458173,-0.00661163316974412,0.000414304002261734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,37453,-0.0065582236736875,0.00185953396920739,-0.010202910253334,-0.00291353709404102,0.000421983978695101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0141864491633273,0.00402561384716902,0.00629624602287598,0.0220766523037785,0.000426413388908942
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,39788,-0.0095264071433577,0.00270726880006758,-0.0148326539914902,-0.00422016029522525,0.000434669919739513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0144798476889763,0.0041171316485187,-0.022549425720073,-0.00641026965787966,0.00043772565448849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0142982278214576,0.00407189812995511,-0.0222791481561696,-0.00631730748674557,0.000447137877005884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.0146364361685911,0.00417371811182602,-0.0228169236677701,-0.0064559486694121,0.00045502014290466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0299949641938161,0.00855997739186815,-0.0467725198818776,-0.0132174085057545,0.000459639458220267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0195229557883529,0.0055805550754576,-0.0304608437362498,-0.00858506784045605,0.000469344324180926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,37124,-0.0262419605065794,0.00750748883245495,-0.0409566386181911,-0.0115272823949677,0.000474830662103104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,39931,-0.0310586380163951,0.0088873361247668,-0.0484778168209381,-0.0136394592118522,0.00047586020437411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.028831216015028,0.00825065734790627,-0.0450025044169242,-0.0126599276131317,0.000476393617231866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.0123300919103346,0.00353500815526124,-0.0192587078946466,-0.00540147592602256,0.000488204903585808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39315,-0.00844162266072219,0.00242549130390041,-0.013195585616367,-0.00368765970507739,0.000502090870112639
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0308721662813249,0.00887154390117996,-0.0482603923276376,-0.0134839402350122,0.00050295236103701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0224763317863591,0.00646111933185192,-0.0351401256767889,-0.00981253789592939,0.000505452943138522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,39559,-0.0180076908700145,0.00518070551422395,-0.0281618736778935,-0.00785350806213559,0.000510489825702291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,39866,-0.0127912278179187,0.0036912012174163,-0.0200259822040547,-0.00555647343178277,0.000530970307699457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0195365883177052,0.00564887893493203,0.00846478560523843,0.030608391030172,0.000544612192818628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0282936862176967,0.00818068927515011,-0.0443278371969909,-0.0122595352384025,0.000544717364768831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,40009,-0.0250366903630294,0.00724395073449156,-0.0392348338026329,-0.010838546923426,0.000549216086440865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.00785552006793493,0.00227511919624501,0.00339628644329471,0.0123147536925752,0.000556243227322152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0239749843122629,0.00694699883088063,-0.037591102020789,-0.0103588666037369,0.000559691560843914
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,37056,-0.0190864012046454,0.00556065195570846,-0.029985279037834,-0.0081875233714568,0.000600092163481385
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.00939822783515127,0.00274287415742841,-0.0147742611837109,-0.00402219448659159,0.000613451301609612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37388,-0.0166871392895658,0.00488103404895148,-0.0262539660255107,-0.00712031255362093,0.000630900427529703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.013609505623339,0.00398188519288426,-0.0214140006013922,-0.00580501064528588,0.000632766586550963
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0237840934502917,0.00697298093784611,-0.03745113608847,-0.0101170508121133,0.0006491439020169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.0128815829096876,0.00377773657444289,-0.0202859465955956,-0.00547721922377951,0.000651889051226099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0282324919348605,0.00828021280605303,-0.0444617090347245,-0.0120032748349966,0.000652438903755595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0227370759409014,0.00667204798758499,-0.035814289996568,-0.00965986188523482,0.000656824502214214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,39642,0.00890426109403506,0.00261520166152574,0.00377846583744461,0.0140300563506255,0.000663752362409012
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,37453,-0.0135669693543906,0.00398685264679684,-0.0213812005421124,-0.00575273816666879,0.00066860320014062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0335002295484384,0.00985092622707131,-0.0528080449534982,-0.0141924141433787,0.000673720047240249
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,39812,-0.0154477650502946,0.00454736303007739,-0.0243605965892463,-0.0065349335113429,0.000682748545606758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.0126295268136896,0.00371892016816577,-0.0199186103432945,-0.00534044328408465,0.000685701371754983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0191267183497848,0.00563523797085443,-0.0301717847726595,-0.00808165192691012,0.000690501192599147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00844234144637994,0.00248941953806301,0.00356307915177644,0.0133216037409834,0.000697692721948041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.024511550155855,0.00722978160040333,-0.0386819220926455,-0.0103411782190645,0.000699707606761332
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0151568062199456,0.00447185405148386,-0.023921640160854,-0.00639197227903725,0.000702188365482336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,-0.00470682177772703,0.00139111302690257,-0.00743340331045608,-0.00198024024499799,0.000717726773147995
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0215490489884254,0.00639557067837523,-0.0340843675180408,-0.00901373045880995,0.000755496863751704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0238718888463411,0.00711865893395255,-0.0378244603568881,-0.00991931733579415,0.000800407041280395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.0177702412745269,0.00532567876672735,-0.0282085716573125,-0.0073319108917413,0.000849676025638149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0387632787951304,0.0116507586871776,-0.0615987658219986,-0.0159277917682623,0.000879942276471606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0179725212530054,0.00540697174055508,-0.0285701858644933,-0.00737485664151743,0.000889512546700667
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0163231174846684,0.00491832071497154,-0.0259630260860126,-0.00668320888332415,0.000906306496364008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.026534933731095,0.00800013848831245,-0.0422152051681874,-0.0108546622940026,0.000912538924538024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,39587,-0.0285994081599757,0.00862878141922506,-0.0455118197416568,-0.0116869965782946,0.000920409206088126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,-0.0134380380618599,0.00405617167794029,-0.0213881345506228,-0.00548794157309691,0.00092512706504184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0229718535672542,0.00694528025103839,-0.0365846028592894,-0.00935910427521896,0.000943231028912358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,39489,-0.0122833874900736,0.00373041401383211,-0.0195949989571845,-0.00497177602296266,0.000994265557257527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,39913,-0.00860880372365022,0.00262516227891935,-0.0137541217903321,-0.0034634856569683,0.00104271114189875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0265945583653436,0.00812595181900079,-0.0425214239305852,-0.0106676928001021,0.00106722833320327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.0127782981668589,0.00391118873528759,-0.0204442280880225,-0.00511236824569518,0.0010892758036359
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40030,-0.0187665905151954,0.00574884610923699,-0.0300343288892999,-0.00749885214109094,0.0010992025125545
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,37039,-0.0122072766692582,0.00374236648425465,-0.0195423149783973,-0.00487223836011903,0.00110944187151774
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,37453,-0.00725887837482882,0.00222610956679006,-0.0116220531257373,-0.00289570362392031,0.00111375374344413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0190711772770255,0.00585303701838247,-0.0305431298330551,-0.00759922472099584,0.00112304363251473
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.023242400681142,0.00715051436718291,-0.0372574088408206,-0.00922739252146355,0.00115465897442152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0147347716460473,0.00453877136862243,-0.0236307635285473,-0.00583877976354736,0.00117111802423217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.00958674867380149,0.00295385431774922,0.00379719421101301,0.01537630313659,0.00117535545607346
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37021,-0.0119645669886448,0.00368654796639259,-0.0191902010027742,-0.00473893297451529,0.00117551492023264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.00899681377975854,0.0027746024947003,0.00355859289014595,0.0144350346693711,0.00118756923579716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.0104164380673196,0.00321743551041268,-0.0167226116677284,-0.00411026446691073,0.0012082961605814
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,-0.00984762272052568,0.00304251285534165,-0.0158109479169953,-0.00388429752405604,0.00121181789462772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0185811070872627,0.00574493023725732,-0.0298411703522871,-0.00732104382223836,0.00122169619939181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.0128088056278367,0.0039606993189326,-0.0205717762929446,-0.00504583496272883,0.00122380413756411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0334074651368898,0.0103455061234165,-0.0536846571387861,-0.0131302731349935,0.00124442445147206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0120358934436156,0.00373022675245507,-0.0193471378784275,-0.00472464900880362,0.00125528911368713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00868104490814112,0.00269231473594464,-0.0139579817905926,-0.00340410802568963,0.00126545009848293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0337915147384664,0.0104849164987599,0.0132410784008969,0.0543419510760358,0.00127213233291064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0136312393654131,0.00423503012259429,-0.0219318984056979,-0.00533058032512832,0.00129041659688658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37411,-0.0237005956273952,0.0073736245008696,-0.0381528996490996,-0.00924829160569076,0.00131096797206397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,-0.0105808205136563,0.00329333771432109,-0.0170357624337256,-0.00412587859358691,0.00131711200397809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0318004454150257,0.0099148422558582,-0.0512335362365078,-0.0123673545935436,0.00134224768122144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.0229265030911491,0.00714937694829641,-0.03693928190981,-0.0089137242724881,0.00134491835695876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0101415034765683,0.0031655210340273,0.00393708224987482,0.0163459247032618,0.00135925775238396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0103985593044724,0.00325389949865791,0.00402091628710289,0.0167762023218419,0.00139752027833899
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0112184513846725,0.00351072830361386,-0.0180994788597557,-0.00433742390958934,0.00139928911366545
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0350842808623186,0.0109896009124574,-0.0566238986507351,-0.013544663073902,0.00141370678630216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,39846,0.0549344956372749,0.0172360372240154,0.0211518626782046,0.0887171285963451,0.00143939643603253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0272201127411566,0.008548239080689,-0.043974661339307,-0.0104655641430061,0.00145386052504107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0195851329316733,0.00615101667762322,-0.0316411256198148,-0.00752914024353182,0.00145505653142754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37021,0.0126602038894193,0.00397964497112787,0.00486009974600867,0.0204603080328299,0.00146986735791731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,39984,-0.0187089292802046,0.00589192704171018,-0.0302571062819565,-0.00716075227845263,0.00149937575035214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0121892553712347,0.00383902354491738,-0.0197137415192728,-0.00466476922319662,0.00150123325372581
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0162395997007451,0.00512140586559914,-0.0262775551973194,-0.00620164420417078,0.00152301386408105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0252142069393958,0.00796736279238558,-0.0408302380124716,-0.0095981758663201,0.00155540645697828
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0299314031865378,0.00947366706115665,-0.0484997906264048,-0.0113630157466707,0.00158434958647587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.00640053177382862,0.00202766145961365,0.00242631531298586,0.0103747482346714,0.00159973191911758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0222178495195833,0.0070399474285468,-0.036016146479535,-0.00841955255963159,0.00160269963718621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0305197901782312,0.00967873195867047,-0.0494901048172253,-0.0115494755392371,0.00161745139087081
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,36962,0.00940808862048611,0.00298356225336807,0.0035603066038847,0.0152558706370875,0.00161796162791209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.0127340001709338,0.00403926368386349,-0.0206509569913062,-0.00481704335056132,0.00162202464164054
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0200653946877965,0.00637241450714419,-0.0325553271217991,-0.00757546225379384,0.00164303915413791
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0332126688194281,0.0105544803921316,0.0125258872508501,0.0538994503880061,0.00165381818410254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0265419872306773,0.00844133060926515,-0.043086995224837,-0.0099969792365176,0.00166849493373627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0100277883297441,0.00320253993274998,0.00375081006155414,0.0163047665979341,0.00174404668011327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0222589123086046,0.00711570918887951,-0.0362057023188084,-0.00831212229840075,0.00176303792684926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40058,-0.0231794189571869,0.00743460125181946,-0.0377512374107531,-0.0086076005036208,0.00182540524877001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00765140050868096,0.00246389812752884,0.00282216017872444,0.0124806408386375,0.00190424374233969
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37186,0.0524873844801977,0.0169202848906888,0.0193236260944476,0.0856511428659478,0.0019259419196015
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0174036586251831,0.00561340616504156,-0.0284059347086645,-0.00640138254170161,0.00193673627081753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.0274275282837553,0.00884682517502311,0.01008775094071,0.0447673056268006,0.00193681282812689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37437,-0.00900713331637125,0.00290794461258466,-0.0147067047570372,-0.00330756187570531,0.00195609545215598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0071064722174293,0.00229500104968916,0.00260827016003854,0.0116046742748201,0.00196159495195806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0257245496828567,0.00831467067686087,-0.0420213042095041,-0.00942779515620943,0.00197972732272257
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.0120235291515811,0.00388888484162609,-0.0196457434411682,-0.00440131486199396,0.00199318818323183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,39455,0.0257549989433755,0.00833388569513287,0.00942058298091509,0.0420894149058359,0.00200242428202946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,37445,-0.00666323746247004,0.00215743348293917,-0.0108918070890308,-0.00243466783590925,0.00201574151631394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0156537537069136,0.00506945535435795,-0.0255898862014552,-0.00571762121237199,0.00202024245310662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0274370473724137,0.00889090786365066,-0.044863226785169,-0.0100108679596584,0.00203311860921675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.0253859125133763,0.00822897193453442,-0.0415146975050637,-0.00925712752168882,0.00204000845215258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,39397,0.0190593559292392,0.00618018548094187,0.00694619238659312,0.0311725194718852,0.00204633222895994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,39456,-0.0105295347547318,0.0034154669343325,-0.0172238499460235,-0.00383521956344013,0.00205353440718716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00767918563424079,0.00249328742618364,0.00279234227892085,0.0125660289895607,0.00207468145081173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0210753599744013,0.00686009056998883,-0.0345211374915794,-0.00762958245722321,0.0021292975407976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37368,0.0115784473542665,0.00377142799313019,0.00418644848773137,0.0189704462208017,0.00214452438990449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0122224911992475,0.00398804675975528,0.00440591955012719,0.0200390628483679,0.00218270095532236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,39585,0.00684104155861983,0.00223395976906651,0.00246248041124948,0.0112196027059902,0.00220018556589768
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0209250808259654,0.00685002926070102,-0.0343511381769394,-0.00749902347499143,0.00225698702213295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0146026585575728,0.00478440254486399,0.00522522956963943,0.0239800875455063,0.00227658216210334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0344839677069616,0.0113008579792737,-0.056633649346338,-0.0123342860675852,0.00228193792417277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.0107908013018595,0.00354059781609988,0.00385122958230369,0.0177303730214152,0.0023102588022992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40030,0.00902031084420736,0.00296284447978517,0.00321313566382843,0.0148274860245863,0.00233460227269158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0214966953759278,0.00708851744419768,-0.0353901895665552,-0.00760320118530033,0.00242833812710187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,39587,-0.014328482942591,0.00474566956159685,-0.0236299952833208,-0.00502697060186117,0.00253786431325387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,37388,-0.0244575878564308,0.00811108123746298,-0.0403553070818582,-0.00855986863100336,0.00257175911503333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.0092419836480159,0.00306730031208402,-0.0152538922597006,-0.00323007503633122,0.00259098861214057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.0080479054725641,0.0026755876378461,0.00280375370238575,0.0132920572427425,0.00263555091362809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0110980741502197,0.00369668545408342,-0.0183435776402233,-0.00385257066021624,0.00268552837179338
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37388,0.0107507774797249,0.00358480018113364,0.00372456912470298,0.0177769858347468,0.00271369469834319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0199137336645794,0.00664335012025445,-0.0329346999002781,-0.00689276742888069,0.00272588866181001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0170369054036809,0.00569062657134549,-0.0281905334835181,-0.00588327732384375,0.00275899831816384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00755767633434032,0.00252433285061144,0.00260998394714189,0.0125053687215387,0.00275922983309774
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0240401702386385,0.00805390351496746,-0.0398258211279748,-0.00825451934930232,0.00284170458285184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0189368380556716,0.00636767096537171,-0.0314174731478001,-0.00645620296354304,0.00294475995107715
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.014702811898332,0.00494623754109632,-0.0243974374788808,-0.00500818631778319,0.00295809123837762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.023826431611674,0.00802360276439766,-0.0395526930298934,-0.00810017019345455,0.00298693417434127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0108363191359189,0.00365202819641464,0.00367834387094619,0.0179942944008916,0.00301061413327843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0136703175822485,0.00460821554261676,-0.0227024200457773,-0.00463821511871963,0.00301727269558621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0250415750735954,0.00844477388367454,-0.0415933318855975,-0.00848981826159327,0.00302900679408474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,37162,-0.00641858966814487,0.00217852399610896,-0.0106884967005184,-0.00214868263577132,0.00322155849395403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0315901444656906,0.0107260864997415,-0.0526132740051839,-0.0105670149261973,0.0032324016146046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,39788,0.0124043011792021,0.00421575767671772,0.00414141613283541,0.0206671862255689,0.00326184272931111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0129691458078509,0.00440849928379016,-0.0216098044040797,-0.00432848721162222,0.00326825089845539
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0132914795683703,0.00451877552383468,-0.0221482795950863,-0.00443467954165432,0.00327222855618531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37267,-0.0116743479757464,0.00397509195249071,-0.0194655282026282,-0.00388316774886464,0.00332101517843975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0189147906859489,0.0064417730966714,-0.0315406659554249,-0.00628891541647299,0.00332752711962796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37411,-0.0103350611399314,0.00352022875852433,-0.017234709506639,-0.00343541277322366,0.00333133795304365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,39788,-0.00815192717726849,0.00277919130269323,-0.0135991421305472,-0.00270471222398976,0.00335964401628353
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00717940311235605,0.0024494168504232,-0.0119802601391855,-0.00237854608552657,0.00338363848281702
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0188164239337181,0.00645449818434125,-0.0314672403750269,-0.00616560749240922,0.00356012197956723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0129005491886339,0.00443603561070811,0.00420591939164595,0.0215951789856218,0.00364209855543854
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,39788,-0.0230535948927773,0.00793441407515014,-0.0386050464800716,-0.00750214330548303,0.00367148645393409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0216266361294509,0.00744370042832485,-0.0362162889689676,-0.00703698328993416,0.00367332214919603
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0171572155252045,0.00590519803101949,-0.0287314036660027,-0.00558302738440632,0.0036734743084372
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.024290343602088,0.00836795109119345,-0.0406915277408272,-0.00788915946334886,0.00370460571919547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37169,-0.0116884210955283,0.00403056359791784,-0.0195883257474472,-0.0037885164436093,0.00373836252568419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.00847991841273945,0.00292822844243141,0.00274059066557388,0.014219246159905,0.00378672562308282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,39764,-0.0187032920624632,0.00647063692727884,-0.0313857404399297,-0.00602084368499665,0.00385165750966809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.00832867059115353,0.00288190715338427,0.00268013257052037,0.0139772086117867,0.00385891570089673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0230191595134241,0.00796799098027035,-0.038636421834754,-0.00740189719209425,0.00387053349042068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40058,0.0108741392839534,0.00376486061965431,0.00349501246943094,0.0182532660984758,0.0038781307176316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,39841,-0.018339158018078,0.00636183070812278,-0.0308083462059987,-0.00586996983015737,0.00394826373081692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00780293190190656,0.00271231055268036,0.00248680321865305,0.0131190605851601,0.00402303441965951
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.0145372945403413,0.00505499094675205,-0.0244450767959753,-0.00462951228470727,0.00403596819113958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0221524843530963,0.00770753961142321,-0.0372592619914858,-0.00704570671470679,0.00405671327625993
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37056,0.0148291424391568,0.0051629023107921,0.00470985391000429,0.0249484309683093,0.00408210779906728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0266241204639801,0.009277816518746,-0.0448086408407223,-0.00843960008723799,0.00411558485366817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.0188275421103244,0.00657643272497213,-0.0317173502512698,-0.005937733969379,0.00420469722928971
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.0145220943879163,0.00507376337010252,-0.0244666705933173,-0.00457751818251539,0.00421375798761785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.0193034695741869,0.00674549836449772,-0.0325246463686025,-0.00608229277977143,0.00422063047051203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,37342,-0.0264590554420317,0.00925960764570059,-0.0446078864276049,-0.00831022445645855,0.00427686055382989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0208311175767356,0.00729066102883924,-0.0351208131932605,-0.00654142196021068,0.00427908093976955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.00730818183283561,0.00255867633672979,0.00229317621284522,0.012323187452826,0.00429366634907849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,36991,-0.0117082987414288,0.00410173984136126,-0.0197477088304969,-0.00366888865236074,0.00431760208373844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0131950111500434,0.00463521138374084,-0.0222800254621755,-0.00410999683791135,0.00442430404140106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0182659944019701,0.00642401865978067,-0.0308570709751402,-0.0056749178288,0.00447031027281563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0182785675498685,0.0064307513896102,-0.0308828402735045,-0.00567429482623248,0.00448479990037941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.0098914649481259,0.00348047511528902,-0.0167131961740924,-0.00306973372215942,0.00449025685685812
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,39585,-0.0293182205861095,0.0103164970027244,-0.0495385547114493,-0.00909788646076972,0.00449064255150208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0185720913421283,0.00653942513006663,-0.0313893645970589,-0.00575481808719767,0.00451691566328992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0132124074882724,0.00465370862879174,-0.0223336764007043,-0.00409113857584064,0.00453067465179243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.0143914392990903,0.00507318719551731,-0.0243348862023042,-0.00444799239587635,0.00456426704223107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.00661988470384644,0.0023339311635535,0.00204537962328158,0.0111943897844113,0.00456866330266794
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.0164681572694578,0.00581342487337467,-0.0278624700212721,-0.00507384451764341,0.00462149821103334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0167037198255336,0.00590071666713324,0.00513831515795246,0.0282691244931148,0.00465029988307728
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0171033505927832,0.00604192549990651,0.00526117661296645,0.0289455245726,0.00465052068207424
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0221425296888535,0.00783152880137851,-0.0374923261395554,-0.00679273323815166,0.00469921729483589
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.0106788095485937,0.00377714107160139,-0.0180820060489324,-0.003275613048255,0.00470128154515174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0182869400467426,0.00649073726749057,-0.0310087850910242,-0.00556509500246111,0.00484859403443073
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,40052,0.00820133063770627,0.00291361436197168,0.00249064648824179,0.0139120147871708,0.00488618702691191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.00841197829392404,0.00299399314447875,0.00254375173074569,0.0142802048571024,0.00496733385192601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,39546,-0.0193550209861521,0.00690193987457421,-0.0328828231403176,-0.00582721883198669,0.00504899651007923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.0201796928605897,0.00720122322289764,-0.0342940903774691,-0.00606529534371031,0.0050820434298444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.00693844367453999,0.00248262289865765,0.002072502793171,0.011804384555909,0.00519923018288821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0360537248854487,0.0129215430613225,-0.0613799492856408,-0.0107275004852566,0.00527485080442733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.00602952289229643,0.00216301708701228,-0.0102690363828405,-0.00179000940175237,0.00531697976260323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37411,-0.0216340778328604,0.00776261980439821,-0.0368488126494809,-0.00641934301623991,0.00532797788926286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,37437,-0.00983621767931073,0.00353380902979332,-0.0167624833777056,-0.00290995198091582,0.00538567743886558
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0340297956644404,0.0122656498849856,-0.0580704694390122,-0.00998912188986869,0.00553680444660642
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,37309,-0.00672265070221982,0.00242366103930196,-0.0114730263392517,-0.00197227506518798,0.00554891478564678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0157816092276562,0.00570158976646231,-0.0269567251699223,-0.00460649328539005,0.00564897683253459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0152002329499389,0.00550340739441975,0.0044135544568762,0.0259869114430016,0.00575200180305329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,36962,0.0129622895868467,0.00470350959764287,0.00374341077546664,0.0221811683982267,0.00586160749069064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.02596218447656,0.00942768850989903,-0.0444404539559621,-0.00748391499715792,0.00589717505963295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.0085248198865847,0.00310426996485362,0.0024404507554716,0.0146091890176978,0.00603795817663356
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0199375087561703,0.00728159094460192,-0.0342094270075901,-0.00566559050475055,0.00618839180452021
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,-0.00682370101435711,0.00251143485208679,-0.0117461133244472,-0.001901288704267,0.00659494915023733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0168974169198901,0.00624263366873317,-0.0291329789106071,-0.00466185492917309,0.00680272904524307
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,39587,-0.0111416564700115,0.00412023403959439,-0.0192173151876165,-0.00306599775240645,0.00685567517060525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.00662409904001661,0.00245411072537161,-0.011434156061745,-0.00181404201828827,0.00695958998933937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0247781253280004,0.00918764014421364,-0.0427859000106591,-0.00677035064534162,0.00700621673728313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37021,-0.0174703460610199,0.00648541310095642,-0.0301817557388945,-0.00475893638314527,0.00707340585283793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.00932987022009563,0.00346628604635192,-0.0161237908709454,-0.00253594956924586,0.00711995705308203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,39788,-0.0478181775859437,0.0177818421788252,-0.0826705882564411,-0.0129657669154462,0.00717071494469734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0062387663961407,0.0023277266433616,0.00167642217515196,0.0108011106171294,0.00736541644135598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,39788,0.00482922045803443,0.00180197362676833,0.0012973521495685,0.00836108876650035,0.00737062874991506
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,-0.00684699866778882,0.00256097734594431,-0.0118665142658397,-0.00182748306973797,0.00751200258004334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0360628975492853,0.0135090139141939,-0.0625405648211053,-0.00958523027746533,0.00760329841479203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0286003438081545,0.0107192404687045,-0.0496100551268154,-0.00759063248949362,0.00763525899446419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,39780,-0.0170599136149191,0.00640529193359112,-0.0296142858047577,-0.00450554142508051,0.00774311247787571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.00902624785829234,0.00339522632831516,0.00237160425479464,0.01568089146179,0.00785639810504498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37437,-0.00843385833450402,0.00317565299270585,-0.0146581382002075,-0.00220957846880056,0.00792159634175677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00861290206394629,0.00324335514432583,-0.0149698781468249,-0.00225592598106765,0.00792736958092334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,-0.00586638739776736,0.00221037431997787,-0.010198721064924,-0.00153405373061075,0.00796172376387942
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0119779344298391,0.00451805261194149,-0.0208333175492444,-0.00312255131043378,0.00803027049668211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.027140079467811,0.0102536995623166,-0.0472373306099516,-0.00704282832567043,0.00813377302793079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,39477,-0.0187267520943235,0.00709442522191029,-0.0326318255292676,-0.00482167865937928,0.00830757831027041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.014580258392582,0.00553383685998077,-0.0254265786381443,-0.0037339381470197,0.00842831966727131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0225165666280259,0.00856495342502125,0.00572925791498428,0.0393038753410676,0.0085738448228515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0181787512472413,0.00692005294543101,0.00461544747419649,0.031742055020286,0.00862466504815691
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0191877380806192,0.00730441123064942,-0.033504384092692,-0.0048710920685463,0.00862585396783536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,39868,-0.00953386894345584,0.0036319708076866,-0.0166525317265216,-0.0024152061603901,0.00867351190901612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.0139285368940418,0.00531530682975548,-0.0243465382803625,-0.00351053550772102,0.0087909947901806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,39788,-0.023711327905907,0.00906437925827531,-0.0414775112521266,-0.00594514455968741,0.00890817888596121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,39866,-0.0159931482489648,0.00612118458062442,-0.0279906700269887,-0.00399562647094096,0.00898999235169888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,39970,-0.0150047607239412,0.00575182978877177,-0.0262783471099338,-0.0037311743379485,0.00909725542792028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37039,-0.017624268461162,0.00676393161680465,-0.0308815744300991,-0.00436696249222489,0.00918099326572668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.020935707736352,0.00804512102029291,-0.036704144936126,-0.00516727053657786,0.00927056293209711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37424,0.00364521323644903,0.00140082888057599,0.000899588630520102,0.00639083784237797,0.0092733085142274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.0124141659466437,0.00477178114330312,0.00306147490576955,0.0217668569875178,0.00928995557284375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37021,-0.0167566714954434,0.00645210522825221,-0.0294027977428177,-0.00411054524806906,0.00941230172146408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.0175359917597753,0.00676184549331074,-0.0307892089266643,-0.00428277459288619,0.00951434970123501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,-0.00699050678574478,0.00269585233562029,-0.0122743773635605,-0.00170663620792901,0.00952150697732832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0110571482086235,0.00426423114496611,-0.0194150412527571,-0.00269925516448996,0.00952455377044679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0244223480012844,0.00942279975476132,-0.0428910355206166,-0.00595366048195223,0.0095571232963965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0125784901600765,0.0048592924275857,-0.0221027033181444,-0.00305427700200847,0.00964887422560585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37056,-0.0218880391617697,0.00845828524647163,-0.0384662782448541,-0.00530980007868527,0.00967072020779684
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.0120939915548274,0.00469390561919916,-0.0212940465684578,-0.00289393654119705,0.00999025361125882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.00737169738483199,0.00286377234254766,0.00175870359343857,0.0129846911762254,0.0100603083873335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,39858,-0.0297562464398616,0.0116628999330758,-0.0526155303086901,-0.00689696257103306,0.0107395893692234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.010693423200422,0.00420486297350423,-0.0189349546284903,-0.00245189177235373,0.010998161666136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0156415026279904,0.00615145200407333,-0.0276983485559741,-0.00358465670000665,0.0110084698350192
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0253399092582343,0.00998896543064456,-0.0449182815022977,-0.005761537014171,0.0111987920656402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40030,0.0109406821262348,0.00431314315084464,0.00248692155057928,0.0193944427018903,0.0112030722879709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,37056,-0.0127898129734735,0.00504208656186048,-0.02267230263472,-0.00290732331222697,0.0112045444137208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0242947247102919,0.00958420440628709,-0.0430797653466146,-0.0055096840739692,0.0112600172412813
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.00940723511365187,0.00371196692054465,-0.0166826902779194,-0.00213177994938437,0.0112784075326745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0107294236884785,0.00423537645752738,-0.0190307615452322,-0.00242808583172485,0.011311352355867
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,37411,0.0109411168089957,0.00432430028199761,0.00246548825628042,0.0194167453617111,0.0114126937209462
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.0139875377523514,0.00554038786017533,-0.0248466979582951,-0.00312837754640778,0.0115911931265459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.0266076256734355,0.0105389390171267,-0.0472639461470038,-0.00595130519986709,0.011591437762009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.00423251087211563,0.00167847171038811,-0.00752231542447632,-0.000942706319754938,0.0116903543618313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.0062970330537697,0.00249808811371905,0.00140078035088036,0.011193285756659,0.0117225035209935
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,37056,-0.0153552773885971,0.00609230071914214,-0.0272961867981157,-0.00341436797907853,0.0117325221803551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.020515727953304,0.00815342743350993,-0.0364964457229834,-0.00453501018362449,0.0118742606058819
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0121364599706081,0.00483221451061591,-0.0216076004114153,-0.00266531952980096,0.012031294750435
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40009,0.00545543147580249,0.00217281027545449,0.00119672333591168,0.0097141396156933,0.0120564321938466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00855582906622862,0.00341169553203666,-0.0152427523090205,-0.00186890582343676,0.0121588138206334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0234612326211982,0.0093562515731556,-0.0417994857045832,-0.00512297953781322,0.0121692142331677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.00769208021659165,0.00307528738959021,-0.0137196435001885,-0.00166451693299483,0.0123870592690675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,39908,-0.0196929447685073,0.00787645062141174,-0.0351307879864743,-0.00425510155054026,0.0124211371801706
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.011133135540846,0.00445313234310548,-0.0198612749333327,-0.00240499614835923,0.0124271045162785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.00787755818346677,0.00315460885987229,-0.0140605915488165,-0.00169452481811708,0.0125314002973598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.0116003072525683,0.00464984398672317,-0.0207140014665457,-0.00248661303859085,0.0126159021677432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.00790324894716673,0.00316888084909735,-0.0141142554113975,-0.00169224248293592,0.0126407680921296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,39749,0.00291989023572666,0.0011739858871261,0.000618877896959507,0.00522090257449381,0.0128869432875218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0183207970781066,0.00736957433465414,-0.0327651627740288,-0.00387643138218454,0.0129289973355707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0206445211845254,0.00830868039068738,-0.0369295347502726,-0.0043595076187781,0.0129786156157023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0185470921790787,0.00747144043590403,-0.0331911154334506,-0.0039030689247068,0.0130605524327781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.0163516659009878,0.00658759810277698,-0.0292633581824307,-0.0034399736195449,0.0130682081861291
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,36991,-0.0176500389576942,0.00712405123772942,-0.0316131793836438,-0.00368689853174448,0.0132420743553524
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00643553856845336,0.0026037167763424,-0.0115388234500845,-0.00133225368682226,0.0134587898066245
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0248267826132408,0.0100670084695053,-0.0445581192134711,-0.00509544601301047,0.0136698543062541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.00895976361919311,0.00363415903252266,0.00183681191544868,0.0160827153229375,0.013695446947948
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,37072,-0.0103672350230956,0.00420670517914799,-0.0186123771742256,-0.0021220928719655,0.0137348172238769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0163143400980376,0.00662563992753391,0.00332808584007112,0.029300594356004,0.0138155340320734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.0198241645313398,0.0080838042574318,-0.0356684208759061,-0.00397990818677347,0.014206273365917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,-0.0141657866892463,0.00578065347468543,-0.0254958674996298,-0.00283570587886291,0.0142766596354412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.00796810422996922,0.0032541516035204,0.00158996708706924,0.0143462413728692,0.0143543863697839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,39866,-0.0131366216283697,0.00537406671548193,-0.0236697923907143,-0.00260345086602514,0.0145181488381805
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0113552251963254,0.0046491871847606,-0.0204676320784562,-0.0022428183141946,0.0146022418083481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0119276113685463,0.0048888460379581,-0.0215097496029442,-0.00234547313414844,0.0147080819528411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39405,-0.0156973210791227,0.00643491665342018,-0.0283097577198263,-0.00308488443841919,0.0147228704142934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,-0.00880206123770366,0.00360920113236223,-0.0158760954571336,-0.00172802701827369,0.0147498068868089
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,39585,0.00885905039146856,0.0036370096139112,0.00173051154820261,0.0159875892347345,0.0148696743014299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0187752708284032,0.00772820564608477,-0.0339225538947294,-0.00362798776207707,0.0151351038622437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37411,-0.0144631609442355,0.0059669402289685,-0.0261583637930137,-0.0027679580954572,0.0153685816713782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39477,-0.0130936842093028,0.00540798855413351,-0.0236933417754045,-0.00249402664320116,0.0154817681718876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00893944454156504,0.00369362680216448,-0.0161789530738074,-0.00169993600932267,0.0155238982518853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,39913,-0.00909755536445272,0.00378989995114983,-0.0165257592687064,-0.00166935146019905,0.0163851759542061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00613211061009154,0.00256537216920833,-0.0111602400617399,-0.00110398115844321,0.0168444975970843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0217137950510985,0.00910258774949031,-0.0395548670400995,-0.0038727230620975,0.0170718028761655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0140596324158429,0.00590298430906099,-0.0256294816616025,-0.00248978317008341,0.017243115716782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0133916768597237,0.00563085657840347,-0.0244281557533945,-0.00235519796605293,0.0174084238893947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0265708958475516,0.0111819835576331,-0.0484875836205124,-0.00465420807459074,0.0175026015721595
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0666440020470436,0.0280791325569614,-0.121679101858688,-0.0116089022353993,0.0176352230903547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.0288388461425219,0.0121639822959914,-0.0526802514426651,-0.00499744084237882,0.0177598169390161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37021,-0.014081082841556,0.00594718462240731,-0.0257375647014743,-0.00242460098163765,0.0179139558091363
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37368,-0.00776917293689402,0.00328339254067412,-0.0142046223166153,-0.00133372355717273,0.0179856230779887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.0135128325280515,0.00572691999824257,-0.0247375957246069,-0.00228806933149602,0.0183103127538042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0270616244880032,0.0114908865487777,-0.0495837621236075,-0.00453948685239903,0.0185346452726167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39489,-0.0155732790574726,0.00661567910518447,-0.0285400101036342,-0.00260654801131107,0.0185851423260557
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0182897049465164,0.00777048048595364,-0.0335198466989855,-0.00305956319404727,0.0185978355900799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00921445127197867,0.00392351490214169,0.00152436206378097,0.0169045404801764,0.0188629588066351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTN,Titin,37021,-0.0154161643304,0.00657097799321466,-0.0282952811971008,-0.00253704746369929,0.0189858280784119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.0116641346333395,0.00498497697800379,-0.0214346895102269,-0.00189357975645204,0.0193035510925323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00867157131067767,0.003712671675394,-0.0159484077944499,-0.00139473482690543,0.0195210918668172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,36962,0.00801097998309418,0.00343180776078729,0.00128463677195109,0.0147373231942373,0.0195933558128061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00748343461036048,0.00321404619809933,0.00118390406208579,0.0137829651586352,0.0199084285805395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.010884084353392,0.00467762861256987,-0.0200522364340289,-0.00171593227275501,0.0199865198590597
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37043,-0.0162588839800668,0.00699919784820135,-0.0299773117625415,-0.00254045619759218,0.0201962311522213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,39947,-0.00560027020589839,0.00243696353385133,-0.010376718732247,-0.000823821679549773,0.0215715662395692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,39985,-0.00658448623919048,0.00287190748666943,-0.0122134249130626,-0.000955547565318397,0.0218768129721975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0168818586883123,0.00736941476221922,-0.031325911622262,-0.00243780575436266,0.0219882158786861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00962461924581609,0.00421341110964759,-0.0178829050207254,-0.00136633347090681,0.0223679909346864
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0130611077266654,0.00576442922209206,-0.0243593890019658,-0.00176282645136498,0.023479124069662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.0214263173767616,0.00945986993171029,0.00288497231060948,0.0399676624429138,0.0235278189519541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.0148068048218052,0.00653982145211473,-0.0276248548679501,-0.00198875477566033,0.0235840338725606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,39889,-0.00639410766318299,0.00282479773534147,-0.0119307112244523,-0.0008575041019137,0.0236143162532174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.00606306286043644,0.00267953575599284,-0.0113149529421824,-0.00081117277869047,0.0236657498710172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,39799,-0.00766336578048509,0.00339030352020071,-0.0143083606800785,-0.00101837088089169,0.0238112644382974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.013312602228634,0.00590454163243531,-0.0248855038282072,-0.00173970062906075,0.0241719828786821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0250348328758097,0.0111321390816624,-0.0468538254758681,-0.00321584027575136,0.0245361960228794
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0158518609000503,0.00706792889928611,-0.0297050015426511,-0.00199872025744957,0.0249269276953719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0157496124543752,0.00704270948573131,-0.0295533230464086,-0.00194590186234185,0.0253488789800424
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.012068592850095,0.00541410368732033,-0.0226802360772429,-0.00145694962294719,0.0258238899845558
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,-0.00535138636977037,0.00240353529967955,-0.0100623155571423,-0.000640457182398457,0.0259994177329276
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,37453,-0.00553277626789602,0.00248645789579993,-0.0104062337436639,-0.000659318792128153,0.0260865853118511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,40052,-0.00569432188859913,0.00256131802130017,-0.0107145052103475,-0.000674138566850802,0.026216075319022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.00541031527759586,0.00243663211784993,0.000634516326609995,0.0101861142285817,0.0264076494676511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0103033246770728,0.00465076796896114,-0.0194188298962366,-0.00118781945790895,0.0267494531070698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37368,-0.0171617265043603,0.00774807365505121,-0.0323479508682607,-0.00197550214045992,0.0267789588577027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,39788,0.00318344242168682,0.00143733666786228,0.000366262552676757,0.00600062229069689,0.0267864990751182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,39587,0.00603085791110773,0.00272822971104934,0.000683527677451013,0.0113781881447644,0.0270821231629683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0111897891952722,0.00507464608837193,-0.0211360955284812,-0.00124348286206325,0.027468500551529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.00685899434505713,0.00311294285863996,0.000757626342122814,0.0129603623479915,0.0275847448095437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,37388,-0.00804879763879546,0.00365398034241435,-0.0152105991099276,-0.000886996167663324,0.0276293210395543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.00775789189341046,0.00352355170474541,0.000851730552109454,0.0146640532347115,0.0277020265742299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.00922135963213415,0.00418872487864637,0.00101145886998727,0.017431260394281,0.027717236513849
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37021,-0.0131341435554223,0.00598520279755656,-0.0248651410386332,-0.00140314607221145,0.0282215036931953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.00893396244518252,0.00407854690870524,-0.0169279143862448,-0.000940010504120244,0.0285043939834076
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0137007148641409,0.00625613683661409,-0.0259627430639045,-0.00143868666437732,0.0285414781669794
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37106,0.00761124969489979,0.00348482578723866,0.000780991151912007,0.0144415082378876,0.0289714975814444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00497095172781195,0.00229888930545281,-0.00947677476649945,-0.000465128689124449,0.0306103769440134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,37453,-0.00553515888450844,0.00256174080757451,-0.0105561708673545,-0.000514146901662404,0.0307357678435769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00816247744805663,0.00378216947574292,-0.0155755296205128,-0.0007494252756005,0.0309315909741356
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,36962,0.00911235873414262,0.00423058851573349,0.000820405243304978,0.0174043122249803,0.0312644502296567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0167903976907518,0.00779730145903515,-0.0320731085504607,-0.00150768683104288,0.0313084740695809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.00529167888332968,0.0024574851673703,0.000475007955283901,0.0101083498113755,0.0313107639939525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0103662291148264,0.00481650836001163,-0.0198065855004492,-0.000925872729203588,0.031396963631609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37169,-0.00470152434922571,0.00218474326109149,-0.00898362114096503,-0.0004194275574864,0.0314168397514386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,39585,-0.00997999911468837,0.00463950522866873,-0.0190734293628791,-0.000886568866497663,0.0314841851626263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,39749,0.0114836077883132,0.00534089650962748,0.00101545062944334,0.0219517649471831,0.0315601847977203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,-0.00711201850112965,0.00330966823729674,-0.0135989682462313,-0.000625068756028038,0.0316603355133907
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0163034243354315,0.00759312853364303,-0.0311859562613719,-0.00142089240949118,0.0317983719603973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.00482817964805672,0.00224872109437874,-0.00923567299303906,-0.000420686303074383,0.0318021907485402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,-0.0089540829402734,0.0041703800217258,-0.017128027782856,-0.000780138097690831,0.0318061587286866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,35640,-0.0208599310428654,0.00971828142090141,-0.0399077626278322,-0.00181209945789867,0.0318564215545013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,37169,0.00598580893340455,0.00278993061722255,0.000517544923648357,0.0114540729431608,0.0319305619060165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00814709579006301,0.00379771629788175,0.000703571846214776,0.0155906197339112,0.0319496375794011
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00896791730151028,0.00418420049958234,0.000766884322328906,0.0171689502806917,0.0321089029359981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.0125877389245543,0.00589666420353637,-0.0241452007634856,-0.00103027708562303,0.0327994770007995
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.00660498125899135,0.00309716160456511,-0.012675418003939,-0.000534544514043741,0.0329737828835339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37021,0.0110875693545959,0.00520567813281999,0.000884440214268679,0.021290698494923,0.0331984397049678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0204616998340334,0.00962458694444505,-0.0393258902451457,-0.00159750942292115,0.0335228066602955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0104608744874784,0.00494765224775686,0.000763476081874912,0.0201582728930818,0.0345070038904264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00946571526090667,0.00448257024255022,-0.0182515529363051,-0.000679877585508235,0.0347334424332931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00735241149278001,0.00348468923728694,-0.0141824023978624,-0.000522420587697618,0.0348841401484665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00740728058542103,0.00351107080134489,0.000525581814785043,0.014288979356057,0.0349036586308143
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.0209382312587068,0.00994556859588464,-0.0404315457066407,-0.00144491681077288,0.0352851221086475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0242002958307228,0.0115277856375801,-0.0467947556803797,-0.00160583598106591,0.0358087950135191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,39587,-0.0124827009181774,0.00594931334693216,-0.0241433550781644,-0.000822046758190339,0.0359055953635516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,39866,-0.0130702873813765,0.00623008859189571,-0.025281261021492,-0.000859313741260867,0.0359270009380345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.00984218698108431,0.004700901154109,-0.019055953243138,-0.000628420719030666,0.036308016888352
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37043,-0.0173162312124183,0.00827427716096389,-0.0335338144479075,-0.00109864797692906,0.0363879807818601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37056,-0.00554226367672276,0.00265136966515025,-0.0107389482204173,-0.00034557913302827,0.036606370729462
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.010738068635603,0.00514103768484179,-0.0208145024978929,-0.000661634773313075,0.0367537044294895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.0113800011102066,0.00545894633759185,-0.0220795359318867,-0.000680466288526606,0.0371202556627727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.0207075033789408,0.00996045707493274,-0.040229999245809,-0.00118500751207264,0.0376392915583583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0184871531397803,0.00890470745527749,-0.0359403797521241,-0.0010339265274364,0.0379031074484312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40009,-0.00557406980598333,0.00268909862565052,-0.0108447031122583,-0.000303436499708318,0.0382030443808331
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,39585,0.00429280631702707,0.00207256219826375,0.000230584408430113,0.00835502822562402,0.0383511758305927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,37021,0.00946179573736063,0.0045906773114069,0.000464068207003102,0.0184595232677182,0.0393141242199862
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00607260563095834,0.00295902248292015,0.000272921564434851,0.0118722896974818,0.0401630410574042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.0101757594015804,0.00497810728765148,-0.0199328496853773,-0.000418669117783467,0.0409642590639781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,40052,-0.0173709874613151,0.00850257793764083,-0.0340360402190911,-0.000705934703539045,0.0410660240794775
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,37382,-0.0203377438939758,0.00996376364934519,-0.0398667206466924,-0.000808767141259228,0.0412532216795762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,37208,-0.00542382692723709,0.00265845241070667,-0.0106343936522222,-0.000213260202252017,0.0413480905907765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,39858,-0.00557190476223161,0.00273182901141781,-0.0109262896246105,-0.000217519899852697,0.0414041566502059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0162054015596719,0.00796535332746594,-0.0318174940815051,-0.000593309037838621,0.0419224471593235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.0131677342346344,0.00647249315761318,-0.0258538208235562,-0.000481647645712579,0.0419262648347304
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.0126133923247264,0.00620724126880451,0.000447199437869562,0.0247795852115832,0.0421691633660712
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0190937612498485,0.00942465920252527,-0.037566093286798,-0.000621429212898952,0.0427908776216639
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00422957165124484,0.00209062849787622,0.000131939795407459,0.00832720350708223,0.0430813535708813
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,39587,-0.0075482186373959,0.00374234019660833,-0.0148832054227482,-0.000213231852043583,0.0437147463069013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0206316682073161,0.01022886646892,-0.0406802464863993,-0.000583089928232774,0.0437150990032601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,36991,-0.0216168930307366,0.0107284714180721,-0.042644697010158,-0.000589089051315193,0.0439345331182865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37235,-0.0066258233164337,0.00329409852290142,-0.0130822564213205,-0.000169390211546916,0.0443008886006243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.0100695380745169,0.00501255796897205,-0.0198941516937022,-0.000244924455331705,0.0445719106704227
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0125400059376904,0.00624341267947496,-0.0247770947894613,-0.000302917085919445,0.0446049037053955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.00647364467497987,0.00323893239741975,0.000125337176037152,0.0128219521739226,0.0456610428748273
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.0123518477915535,0.0061889885349158,-0.0244822653199884,-0.000221430263118529,0.04597865427259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00899828630265707,0.00451893825859718,-0.0178554052895075,-0.000141167315806601,0.0464719916386947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.0109815925979273,0.00552373876508087,-0.0218081205774858,-0.000155064618368818,0.0468238041550984
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.00418291478779513,0.00210430297251988,5.84809616561727e-05,0.00830734861393408,0.0468548354425549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,39524,-0.00890150141387189,0.0044808808591424,-0.017684027897791,-0.000118974929952786,0.0469894952845879
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,39866,-0.00589235613983208,0.0029761348651917,-0.0117255804756078,-5.91318040563393e-05,0.0477353895738917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,39858,0.00868526466980203,0.00438764756514991,8.54754421082127e-05,0.0172850538974958,0.0477789984496184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37021,-0.020913836113487,0.0106021149636199,-0.0416939814421821,-0.000133690784791952,0.0485609308251685
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.00780434996582298,0.00397706956575562,9.2936169419711e-06,0.015599406314704,0.0497437830162548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40052,-0.00436897130126095,0.00223814878601082,-0.00875574292184215,1.78003193202622e-05,0.0509498538870556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,36991,0.00658878656729075,0.00338509230579656,-4.5994352070514e-05,0.013223567486652,0.051626487559318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,39587,0.00551946418928993,0.00283653000326919,-4.01346171176944e-05,0.0110790629956975,0.051690453345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.0124345781602839,0.00640041266437263,-0.0249793869824543,0.000110230661886397,0.052064308436118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.00653297790850021,0.00336625821587521,-6.48881946151919e-05,0.0131308440116156,0.0523130605073654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00734565869270041,0.00378648930151423,-0.0147671777236683,7.58603382674866e-05,0.0524049779672952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37056,-0.00869148180345376,0.00448535017560372,-0.017482768147637,9.98045407295291e-05,0.0526751873683151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.0103329695476127,0.00533560334505267,-0.0207907521039159,0.000124813008690584,0.0528146877351852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,39866,-0.00981453512293195,0.00506886277293599,-0.0197495061578865,0.000120435912022595,0.0528558895239064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37021,0.00750582888696845,0.00388643207518533,-0.000111577980394806,0.0151232357543317,0.0534685991171756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,36962,0.00670922674795217,0.00348085278663808,-0.000113244713858467,0.0135316982097628,0.0539431255411499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.00677215980990576,0.00352341180122415,-0.000133727320493576,0.0136780469403051,0.0546209401089917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,39489,-0.0111414991390932,0.00579803759858458,-0.022505652832319,0.000222654554132546,0.0546744874916409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.0079629881595035,0.0041704989068797,-0.00021118969798071,0.0161371660169877,0.0562366285251434
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00508086227515061,0.00266136558281468,-0.000135414267166156,0.0102971388174674,0.0562682893830177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.0085789611498831,0.00449670538052705,-0.0173925036957161,0.000234581395949923,0.0564311760984001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,39788,-0.023888562486909,0.0125503917228805,-0.0484873302637549,0.000710205289936806,0.0570048529243663
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00490199345423022,0.00257575338009977,-0.00995047007922577,0.00014648317076534,0.0570413050920443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00727897621270367,0.00384202441137229,-0.0148093440589934,0.000251391633586026,0.0581675363289665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.00969607250348514,0.00511851520048236,-0.0197283622964306,0.00033621728946028,0.0582046402561426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.01091020167128,0.00576066306082968,-0.0222011012705062,0.000380697927946172,0.0582548592238629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.00848188977698914,0.00448244610540507,-0.0172674841435831,0.000303704589604806,0.0584794951699118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.00939931174474229,0.00497975063033438,-0.000360999490713099,0.0191596229801977,0.0591142139599368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.0117494862565761,0.00624059205404525,-0.0239810466825048,0.000482074169352567,0.0597554081956648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0259858530055644,0.0138037901783076,-0.0010695757439185,0.0530412817550472,0.0597873703302051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37411,-0.00690098565547056,0.00367311542373429,-0.0141002918859898,0.00029832057504864,0.0602956201037248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00624940836469926,0.0033291970360458,-0.00027581782595051,0.012774634555349,0.0605194375187398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0159358429922944,0.00849891435460115,-0.0325937151273127,0.00072202914272386,0.0608081308319041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0127823936281073,0.00684138957364992,-0.0261915171924611,0.000626729936246555,0.0617291709050695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00732274192816031,0.00392616482767231,-0.000372541134077415,0.015018024990398,0.0621878726344023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.00902342456819482,0.00484231165264144,-0.018514355407372,0.000467506270982404,0.0624206277021653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0118041446688085,0.00633733464274385,-0.0242253205685865,0.000617031230969435,0.0625357955938616
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,36991,0.00953448900669098,0.00512189124498703,-0.000504417833483602,0.0195733958468656,0.0626934912377362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,39587,-0.0256789719496992,0.0137949395862005,-0.0527170535386522,0.00135910963925373,0.0626953936253817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0107958871253233,0.00580224670964883,-0.022168290676235,0.000576516425588421,0.062817417328964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.0100789601340085,0.00544288302301234,-0.0207470108591127,0.000589090591095694,0.0640778986072158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00514034810664974,0.00277640155021008,-0.000301398931762004,0.0105820951450615,0.0641282594159548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0266528755440109,0.0143965661054487,-0.0548701451106904,0.00156439402266864,0.0641396466269626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.00708698024202032,0.00383101647886977,-0.000421812056564433,0.0145957725406051,0.0643470329901983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,39866,-0.00877404354432181,0.00474872187377662,-0.018081538416924,0.000533451328280353,0.0646693704524771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0212936550262311,0.0115326558661836,-0.00131035047148886,0.043897660523951,0.0648560858138326
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00531750697299336,0.00288775127857566,-0.0109774994790017,0.000342485533014933,0.0655847159159873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.00502045809860717,0.00272728343525791,-0.0103659336317127,0.000325017434498329,0.0656692217153732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0223442693380714,0.0121784031965127,-0.0462139396032364,0.00152540092709357,0.0665658038625454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37411,-0.00446060853196229,0.00243599100456675,-0.00923515090091313,0.000313933836988547,0.067103556285125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0419452210592988,0.0229799153528347,-0.0869858551508548,0.0030954130322572,0.0679779291498388
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,39489,0.00558789217619156,0.00306486674821331,-0.000419246650306523,0.0115950310026896,0.0682908580155988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37430,-0.00660051919691677,0.00362815060402324,-0.0137116943808023,0.00051065598696877,0.0688950636963042
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,36962,0.0078612856573199,0.00432494483021886,-0.00061560620990906,0.0163381775245489,0.0691387164910811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37056,0.010258274022024,0.00565924339186478,-0.000833843026030965,0.021350391070079,0.0699072671208791
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37437,-0.012543690341843,0.00692352316214821,-0.0261137957396535,0.00102641505596743,0.0700469803410912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,39785,-0.0151735211554309,0.00838435746122636,-0.0316068617794345,0.0012598194685728,0.070354700048869
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39477,-0.016282425004257,0.00901143445429143,-0.0339448365346682,0.00137998652615414,0.0708029244148428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.0127026242424222,0.00703083066568106,-0.026483052347157,0.00107780386231271,0.0708311452563002
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.0156007311846653,0.00864437283986676,-0.0325437019508042,0.00134223958147353,0.0711402344328951
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,37169,0.00614344721882557,0.00340880759340604,-0.00053781566425027,0.0128247101019014,0.0715322168078683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.0123120157090504,0.00684020943978647,-0.0257188262110319,0.00109479479293106,0.071891839295722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0162883007205072,0.00907444891969346,-0.0340742206031064,0.001497619162092,0.0726785356864048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.00461229407617154,0.00257051319998718,-0.00965049994814641,0.000425911795803339,0.0727861573986585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.0133887070566426,0.00752525343064984,-0.0281382037807162,0.00136078966743113,0.075234895069178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00708859601986953,0.00398487743785458,-0.0148989557980645,0.00072176375832545,0.0752833884605287
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0200982361239645,0.0113030133598834,-0.042252142309336,0.00205567006140692,0.075405419045937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00509959352706232,0.002881456047006,-0.000548060325069447,0.0107472473791941,0.0767802638571132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.0105002151647438,0.00594707959036153,-0.0221564911618524,0.00115606083236482,0.0774847643073724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37021,0.00881402294313676,0.00499295551877475,-0.000972169873661739,0.0186002157599353,0.077537939458722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39489,-0.00632040145207407,0.00358631581595169,-0.0133495804513394,0.000708777547191256,0.078027004787158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,40030,0.00487922312251928,0.00277100840088109,-0.000551953343207665,0.0103103995882462,0.0782892332598211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,39587,-0.00883256450480332,0.00503980792030855,-0.0187105880286081,0.00104545901900144,0.0796970903429233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37039,-0.0101146799953925,0.00578877119560166,-0.0214606715387717,0.00123131154798676,0.0806097994433637
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00774315284261962,0.00444089578826713,-0.0164473085876232,0.00096100290238395,0.0812516801774095
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.00849766867055556,0.00487776758410267,-0.00106275579428566,0.0180580931353968,0.0815103708356101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,39587,-0.00812793473282225,0.00466837488446283,-0.0172779495063694,0.0010220800407249,0.0816920927876259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0166650257802664,0.00959427402926489,-0.0354698028776256,0.00213975131709277,0.082414819020922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,39858,-0.00557266672125965,0.0032219952789875,-0.0118877774680751,0.000742444025555849,0.083726399291681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,37368,-0.0182297289039591,0.0105515490191042,-0.0389107649814034,0.0024513071734852,0.084067979791513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.00783436163574814,0.00453896912486192,-0.0167307411204775,0.00106201784898122,0.0843631915571928
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.0121187030810417,0.00702393924621919,-0.0258856240036313,0.00164821784154791,0.0844884528890395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00790099767240295,0.00458194161771561,-0.00107960789831966,0.0168816032431256,0.0846624964217736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.00943727027934546,0.00548186668430312,-0.0201817289805796,0.00130718842188865,0.0851757609759309
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00427780902485583,0.00248922307434752,-0.00915668625057698,0.000601068200865322,0.0857190907517476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37021,-0.0124573210234763,0.00726930932954267,-0.02670516730938,0.00179052526242728,0.0866097705854188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0160451989453866,0.00937875118625499,-0.0344275512704464,0.00233715337967317,0.0871403812071455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.00712019070225485,0.00417394357767936,-0.00106073870999669,0.0153011201145064,0.0880564927407837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37021,0.0057979604656144,0.00340234986598796,-0.000870645271722,0.0124665662029508,0.0883851299698479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00602527590810725,0.00353689986879018,-0.000907047834721493,0.012957599650936,0.0884892866740622
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.00634236831458437,0.00374736930200962,-0.0136872121465232,0.00100247551735449,0.0905726757919949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,39477,0.0135971013587321,0.00804590975679519,-0.00217288176458646,0.0293670844820507,0.0910594728046697
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.0115460482847598,0.00688137947424459,-0.00194145548475957,0.0250335520542792,0.0933966156128432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,36991,-0.00939327136437003,0.00559918165242629,-0.0203676674031256,0.00158112467438549,0.0934460734438059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37056,-0.00471581359263156,0.00281304665787346,-0.0102293850420635,0.000797757856800419,0.0936820134927934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37039,-0.00685147575984718,0.00409342446679528,-0.0148745877147659,0.00117163619507158,0.094198355094939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0127183332162637,0.00760524903240786,-0.00218795488725573,0.0276246213197831,0.0944871627195919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0155277353096655,0.00928617035882861,-0.0337286292129696,0.00267315859363857,0.0945213325080079
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,37453,-0.00350992420135191,0.00210031825248409,-0.00762654797622072,0.000606699573516905,0.0947172021364258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39246,-0.00751416000548548,0.0044971711242982,-0.01632861540911,0.001300295398139,0.0947689400378002
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.00736004899606669,0.00442717630426132,-0.0160373145524189,0.0013172165602855,0.0964416862434461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,37169,0.00526757634441502,0.00316863862307332,-0.000942955356808686,0.0114781080456387,0.0964541557510498
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.0109600035690556,0.00661669875986523,-0.0239287331383915,0.00200872600028024,0.0976612410355409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,37056,0.00544653378726645,0.00329511340157462,-0.00101188847981981,0.0119049560543527,0.0983724825219579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0134615451905981,0.00815729222847882,-0.0294498379584166,0.0025267475772204,0.0989125829094178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00590709402970245,0.00358519300555772,-0.00111988426119067,0.0129340723205956,0.0994512047102882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERVV_1,,37021,0.00759084836776876,0.00462218825052996,-0.00146864060326997,0.0166503373388075,0.100559419135977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00344814754121189,0.00209966858798571,-0.000667202891240112,0.00756349797366388,0.100565307394464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,37039,-0.00945200254463779,0.00576844205721971,-0.0207581489767884,0.00185414388751285,0.101326482421947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00744224352469031,0.00454647190429941,-0.0163533284571172,0.00146884140773654,0.101669557872155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,36931,0.00637621991272862,0.00389606521073013,-0.00126006790030243,0.0140125077257597,0.101742465510289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.00884116965704999,0.00541556651586627,-0.0194556800281479,0.00177334071404789,0.102588120132986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39477,-0.0138353535892534,0.00847992263954333,-0.0304560019627583,0.0027852947842515,0.102796077602781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,39725,0.00764041361519295,0.00469317784627279,-0.00155821496350173,0.0168390421938876,0.103548353276489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39315,-0.00540721976975944,0.00332168116555244,-0.0119177148542422,0.00110327531472333,0.103575733104868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.0068136081481846,0.00418634729788044,-0.0150188488520303,0.00139163255566106,0.103637998215147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.00752493248671561,0.00463990827326501,-0.016619152702315,0.00156928772888382,0.104869492461533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,37169,-0.025714441913316,0.0158695409544668,-0.0568187421840709,0.00538985835743896,0.105177676857316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.0121985003115293,0.00752916374080134,-0.0269556612434999,0.00255866062044134,0.105219742701722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.0149004629862682,0.00920006856797873,-0.0329325973795065,0.00313167140697015,0.105341379366804
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.0100100181273658,0.00618566159513862,-0.0221339148538375,0.00211387859910589,0.105630180098796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37021,-0.00800681379468798,0.00494987495888844,-0.0177085687141093,0.00169494112473337,0.10577732198113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,37021,-0.0058310432305465,0.00360712565239786,-0.0129010095092463,0.0012389230481533,0.10600275762013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.00433979411441818,0.00268993644816562,-0.00961206955282279,0.000932481323986436,0.106693623306924
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,38832,-0.00740698077218734,0.00460448043018262,-0.0164317624153453,0.0016178008709706,0.107714770970066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00815086366709272,0.00506708107684813,-0.00178061524352962,0.0180823425777151,0.107729839730633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00508040655820475,0.00316290086717491,-0.00111887914145807,0.0112796922578676,0.108243295490661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00855683529077771,0.00533035982942451,-0.0190043405564498,0.00189066997489433,0.108450793889026
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.0154174875302064,0.00962220584248121,-0.0342770109814696,0.00344203592105675,0.109117255551741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37437,-0.0035217294851694,0.00219911932929511,-0.00783200337058782,0.000788544400249021,0.109305599478403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,-0.00603513168918353,0.00378359042900604,-0.0134509689300354,0.00138070555166831,0.110717573061289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.00946395468949831,0.00593676241597037,-0.00217209964580362,0.0211000090248002,0.110931606301156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.012752729037846,0.00802777607903008,-0.028487170152745,0.00298171207705294,0.112180374285593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00560166700480731,0.00353934131158136,-0.00133544196589215,0.0125387759755068,0.11351701083356
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,39695,-0.00398431325700258,0.00251852466252489,-0.00892062159555136,0.000951995081546203,0.113668885654489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39477,-0.0153345353446446,0.00973283382959599,-0.0344108896506528,0.00374181896136355,0.115150536977501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39489,-0.00791100451187999,0.00502922592640785,-0.0177682873276394,0.00194627830387939,0.115737580800831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.0117610051056873,0.00747942598988472,-0.0264206800458614,0.00289866983448673,0.115866911695193
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,39866,-0.0102589913498879,0.00652906537501852,-0.0230559594849242,0.0025379767851484,0.116137337228179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.0116108992824871,0.00738957003140582,-0.0260944565440425,0.00287265797906834,0.116147391141908
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00555789494756202,0.00354668831701137,-0.0125094040489043,0.00139361415378026,0.117123256047229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37021,0.00525653550683403,0.00335761667083025,-0.00132439316799326,0.0118374641816613,0.11747673876154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00496868676087062,0.00317673065331363,-0.0012577053196241,0.0111950788413653,0.117820912055002
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0129993313554229,0.00831433941974804,-0.0292954366181291,0.00329677390728324,0.117963097302848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00425362877562738,0.00273253350940671,-0.00960939445406454,0.00110213690280977,0.119574382473852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.00520774344429344,0.00334942993206137,-0.0117726261111337,0.00135713922254684,0.120013462550912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.0043677574282405,0.00281020694613425,-0.00114024818618263,0.00987576304266364,0.120149346256501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00560152877122439,0.00360683463440955,-0.0126709246546671,0.00146786711221832,0.120435667034208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00465463690930936,0.00300209045517917,-0.0105387342014605,0.00122946038284181,0.121050011072113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37411,0.00667418144742944,0.00430787441286342,-0.00176925240178286,0.0151176152966417,0.12133343977874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00778845745227071,0.00504426469562147,-0.00209830135114736,0.0176752162556888,0.122606732262168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.00450811242782402,0.00291978585422273,-0.00121466784645253,0.0102308927021006,0.122611658823516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.00833146373173237,0.00540188396951203,-0.00225622884851121,0.0189191563119759,0.123018650764007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.00580954038329814,0.0037724490258702,-0.0132035404740037,0.00158445970740746,0.123586372356358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00504313563549768,0.00327563614157627,-0.00137711120199181,0.0114633824729872,0.123683704235188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,37039,-0.00617693947913305,0.00402816713629903,-0.0140721470662791,0.00171826810801305,0.125192286181029
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,39682,0.00978750821248401,0.00638902353977367,-0.00273497792547238,0.0223099943504404,0.125560808100317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00829185760879162,0.00542269940345557,-0.0189203484395645,0.00233663322198129,0.126263432959453
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37382,-0.00664884985256289,0.00435141200135822,-0.015177617375225,0.00187991767009922,0.126542072506216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.0122832747354901,0.00806890228099081,-0.0280983232062321,0.00353177373525188,0.127958158089749
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.0085846864098446,0.00565595012671104,-0.0196703486581982,0.00250097583850904,0.129085040833351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.00477882115152603,0.00315883772322351,-0.00141250078599204,0.0109701430890441,0.130339559904283
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00494534577964089,0.0032706025622215,-0.00146503524231324,0.011355726801595,0.130542783538537
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37021,0.00716599729220001,0.00474401231153578,-0.00213226683841012,0.0164642614228101,0.130930937914625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0148668666695981,0.00984543586479056,-0.0341639209645876,0.00443018762539135,0.13106069098889
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,39868,-0.0110252056001899,0.00734366694444394,-0.0254187928113,0.00336838161092026,0.13329213151094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,36962,0.00673744907777333,0.0045009019437251,-0.00208431873192787,0.0155592168874745,0.134440537753701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.00779786608930964,0.0052254164470935,-0.0180396823256129,0.00244395014699362,0.135641848185315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.0050680682522309,0.00339826619803084,-0.0117286700003714,0.00159253349590955,0.135888821454897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00660639387939598,0.00445980176517264,-0.0153476053391344,0.00213481758034239,0.138545241694061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,39971,0.0160857366485757,0.0109070609300002,-0.00529210277422473,0.037463576071376,0.140285782882745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.0110140360875257,0.00748156270697703,-0.0256778989932007,0.00364982681814928,0.141002315319313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.00566465899895377,0.00384799361620982,-0.00187740848881747,0.013206726486725,0.141011807798923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.00846126436749912,0.00576029257414607,-0.00282890907782718,0.0197514378128254,0.141885136293316
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.00673907861009842,0.00460703214173968,-0.00229070438771135,0.0157688616079082,0.143551157630422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00550943807953657,0.0037680583199515,-0.0128948323866415,0.00187595622756838,0.143725319394912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.00397573132437088,0.0027284879861092,-0.00137210512840316,0.00932356777714492,0.145107243706295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,37388,-0.0121693394448583,0.00836398608808226,-0.0285627521774995,0.00422407328778295,0.145701080391528
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37021,-0.00596584918460236,0.00410874697575051,-0.0140189932570734,0.00208729488786865,0.146528922820439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39477,-0.00552488704315795,0.00381122000680135,-0.0129948782564886,0.00194510417017269,0.147179742782211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00408546446089494,0.00282046505003867,-0.00961357595897073,0.00144264703718086,0.14749898476286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.01466162604889,0.0101353545362822,-0.034526920940003,0.00520366884222306,0.148037772295425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37368,-0.00385135901888162,0.00266364874212304,-0.00907211055344278,0.00136939251567953,0.148229578774101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.00630957369785891,0.00438461061055656,-0.0149034104945498,0.00228426309883195,0.150166549630351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,39868,0.0158186436882096,0.0110013661416139,-0.00574403394935372,0.0373813213257728,0.150487669878793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,37388,0.00310194580694214,0.00216667953485003,-0.00114474608136391,0.00734863769524819,0.152264597096339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.0054594877348749,0.00381403947781592,-0.0129350051113941,0.00201602964164431,0.152333974547439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,39858,-0.0122316729198872,0.00856899523314198,-0.0290269035768455,0.00456355773707106,0.153474429258686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,36991,-0.00852127820302012,0.00597199343670632,-0.0202263853389645,0.00318382893292427,0.153640184261784
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00640206257640317,0.00449220947251789,-0.0152067931425382,0.00240266798973189,0.154134442585403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37391,0.00325530377279292,0.00228623118121236,-0.0012257093423833,0.00773631688796914,0.154506181091542
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37169,-0.00993544450025634,0.00699099890051963,-0.0236378023452748,0.00376691334476213,0.155288836338891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,39866,0.00455787749231058,0.00321613156584275,-0.00174574037674121,0.0108614953613624,0.156446121860497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,39731,0.00388875754688364,0.00274788597016525,-0.00149709895464025,0.00927461404840752,0.157034890912704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0172932032390229,0.0122401649066135,-0.0412839264559853,0.00669751997793961,0.157730338461843
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00436521995603341,0.00311861341216465,-0.0104777022438761,0.00174726233180931,0.161613727032883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.019377205939027,0.0138462510157987,-0.0465158579299924,0.00776144605193839,0.161700242681495
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37411,-0.00931760869294179,0.00666983964977675,-0.0223904944065042,0.00375527702062065,0.162443538416629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.00828629892263418,0.00593329054140509,-0.0199155483837882,0.0033429505385198,0.162563547578084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00371635642350045,0.0026717405994568,-0.00152025515143487,0.00895296799843577,0.1642528235546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.00745910203670991,0.00536283236434398,-0.00305204939740429,0.0179702534708241,0.164282141103491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37021,-0.00802513571284705,0.00578406470701499,-0.0193619025385964,0.00331163111290233,0.165326228281413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.00487325254046923,0.00351720520155896,-0.0117669747355248,0.00202046965458633,0.165908197429334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37169,0.00527457221952145,0.00382262024509085,-0.00221776346085661,0.0127669078998995,0.167661679355763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37056,0.00628831857023677,0.0045786318014175,-0.00268579976054152,0.0152624369010151,0.169649621799189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.00338278038362489,0.00246565729063988,-0.00821546867327906,0.00144990790602928,0.170095420754361
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40031,-0.00535567647298262,0.00390422205922447,-0.0130079517090626,0.00229659876309734,0.170155533286201
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.00545869079116908,0.00398394647205059,-0.0132672258763882,0.00234984429405008,0.170656636416117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37031,-0.00920639081985862,0.00672542854434503,-0.0223882307667749,0.00397544912705763,0.17105612614264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00520556507855249,0.00380376126727518,-0.00224980700530687,0.0126609371624118,0.171169256820456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0115522684985735,0.008488989916638,-0.028190688735184,0.00508615173803698,0.17358322885008
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00454505960211814,0.00334304262018543,-0.0020073039334453,0.0110974231376816,0.173989535461796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00563002629736264,0.00414697559832483,-0.0137580984700793,0.00249804587535403,0.174603061764748
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,37368,-0.0141561042199956,0.0104431381147876,-0.0346246549249793,0.00631244648498812,0.175267847007381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00601165602911452,0.00444160091215826,-0.00269388175871567,0.0147171938169447,0.17592295108097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,39952,-0.00507889242378784,0.0037692712731299,-0.0124666641191224,0.00230887927154676,0.177855355380575
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00391366560582298,0.00291152601763834,-0.00962025660039412,0.00179292538874816,0.178904083590451
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.00602021743506646,0.00448023150782392,-0.00276103632026841,0.0148014711904013,0.179059108781981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0113634555666202,0.00847296255705156,-0.0279704621784412,0.00524355104520089,0.179893050598056
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.00994386398468995,0.00741879299842307,-0.0244846982615992,0.00459697029221927,0.180150967722563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,36962,-0.00922807080010341,0.00689189357495846,-0.022736182207022,0.00428004060681518,0.180602154611101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00657649565645009,0.00491776544276598,-0.0162153159242714,0.00306232461137123,0.181149938399727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37124,0.01204067622169,0.00900941547086343,-0.00561777810120232,0.0296991305445823,0.181423601409161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,37382,0.0147439567247331,0.0110344754522952,-0.00688361516176552,0.0363715286112317,0.181515557656732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00961170586672897,0.00722624401509936,-0.0237751441363237,0.00455173240286577,0.183504839089454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00325650431926961,0.00245255461205219,-0.00155050272035268,0.00806351135889191,0.184266199107038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,36991,-0.0115705903429881,0.0087141461278714,-0.028650316753616,0.00550913606763988,0.184269273299357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37100,-0.00722868589119924,0.00546313296715963,-0.0179364265068321,0.00347905472443364,0.185799737538996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37056,-0.00803773738451153,0.00607722865523204,-0.0199491055487663,0.00387363077974327,0.185991641456973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0111414028077534,0.00842794450629196,-0.0276601740400856,0.0053773684245789,0.186200393685161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.0048105907986819,0.0036393447791638,-0.00232252496847915,0.0119437065658429,0.186248135157328
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,39858,0.00601161558227377,0.00455336876101767,-0.00291298718932085,0.0149362183538684,0.186768217956811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.00850569809945672,0.00644829756886766,-0.0211443613344373,0.00413296513552389,0.187167911448036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39520,-0.0112406010888756,0.00854272885837755,-0.0279843496512956,0.00550314747354443,0.188257357602549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.0101389448933718,0.00773291054108419,-0.00501755976715322,0.0252954495538968,0.189832723178652
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00587444258354409,0.00449934599104742,-0.00294427555890884,0.014693160725997,0.191703435793509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0138295768113846,0.0106134662205611,-0.0346319706036845,0.0069728169809152,0.192586560579677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,37039,-0.00938966350495568,0.00722224435833024,-0.023545262447283,0.00476593543737159,0.193588313763108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37039,-0.00839765633267882,0.0064801318725871,-0.0210987148029495,0.0043034021375919,0.195029792496385
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00906877638751943,0.00701750696812293,-0.0228230900450404,0.00468553727000152,0.196273329365506
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00562684419986478,0.00435515891896858,-0.0141629556810432,0.00290926728131363,0.196380927591737
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,39964,-0.004097788911361,0.00318585182136825,-0.0103420584812428,0.00214648065852077,0.198375741021296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00366794893483453,0.00285669059576987,-0.00926706250254347,0.00193116463287441,0.199169617249633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.00563355898159614,0.00439380110196755,-0.0142454091414525,0.00297829117826025,0.199808872395697
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00406247035453991,0.00317679957173188,-0.0102889975151344,0.00216405680605457,0.200988365131102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.0102168696799528,0.00799088284476665,-0.0258790000556954,0.00544526069578983,0.201072570926953
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.00563793061721974,0.00441381943609919,-0.00301315547753467,0.0142890167119741,0.201506109620009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37039,0.00597958440213277,0.00468372872839267,-0.00320052390551685,0.0151596927097824,0.201740634843457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,36962,0.00513968551094955,0.00402756356854032,-0.00275433908338948,0.0130337101052886,0.201932995331891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37437,-0.0121048880760232,0.00949048481784004,-0.0307062383189897,0.00649646216694329,0.202162544616078
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.00577755927065519,0.00453215588040669,-0.0146605847962523,0.00310546625494192,0.202404479629107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37124,-0.00400101983160631,0.00314512570968191,-0.0101654662225828,0.00216342655937022,0.203347985851447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0145954168516174,0.0115456155336547,-0.0372248232975806,0.00803398959434577,0.206193763456205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.01065731516392,0.00845927048315622,-0.0272374853109062,0.00592285498306618,0.207746302531627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37043,0.00758889470399159,0.00602706882467758,-0.00422416019237647,0.0194019496003597,0.208003784719145
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0141779206376813,0.011270837167136,-0.0362687614852678,0.00791292020990527,0.208435763249779
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00493000481730685,0.00392097189155876,-0.00275510009014832,0.012615109724762,0.208651894407189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00405852031796062,0.00323054489768132,-0.00227334768149476,0.010390388317416,0.209031106360845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00519080369181507,0.00413295209156106,-0.0029097824076446,0.0132913897912747,0.209154359704428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00596024923891449,0.00475971321984186,-0.0152892871498045,0.00336878867197556,0.210508782449944
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.00741394741782799,0.00594417301285249,-0.00423663168736289,0.0190645265230189,0.212323251679856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,36991,0.00572491067828292,0.00460053873820724,-0.00329214524860328,0.0147419666051691,0.213374571930269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,37169,0.00502949998540999,0.00405686428449398,-0.0029219540121982,0.0129809539830182,0.215089508946362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00429933594276535,0.00347100191276525,-0.0111024996917852,0.00250382780625453,0.215495826108757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.00638713215271708,0.00515894986363421,-0.0164986738854401,0.00372440958000598,0.215708994379362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39456,0.00729497217850788,0.00593296364293321,-0.00433363656164122,0.018923580918657,0.218878103280574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00510840284499313,0.00417233250553114,-0.00306936886584791,0.0132861745558342,0.220841456365296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,36991,-0.00447247006863057,0.00365330008052934,-0.0116329382264681,0.00268799808920694,0.220888418492816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,39720,0.0146279815381152,0.0119933380036956,-0.00887896094912811,0.0381349240253585,0.222606017777532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37056,-0.00374964176155937,0.00308604159991947,-0.00979828329740154,0.00229899977428279,0.224375321531281
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.00891734186597676,0.00734650233815717,-0.0233164864487648,0.00548180271681129,0.224837081353634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39489,0.00405312221480188,0.00334035361184418,-0.00249397086441271,0.0106002152940165,0.2250024547116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.00446152525985863,0.00367788545926599,-0.00274713024030271,0.01167018076002,0.225121642330909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.0065890523763357,0.00543414004744868,-0.0172399668693351,0.00406186211666371,0.225328166134344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,37437,-0.0104773456172654,0.00866884609654425,-0.0274682839664922,0.00651359273196129,0.226829702916871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00449344975638534,0.00374394632527611,-0.00284468504115583,0.0118315845539265,0.230086867359848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00320376711859099,0.00267030826857062,-0.00203003708780742,0.00843757132498939,0.230248564733384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,-0.00395448858242564,0.00329888145096066,-0.0104202962263085,0.00251131906145726,0.230651884670918
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00617958908028457,0.00515580493265456,-0.0162849667482875,0.00392578858771836,0.230713667238528
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,39908,-0.00995628394525613,0.00834719049380354,-0.0263167773131111,0.00640420942259881,0.232976837183009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.00678310711444993,0.00569873767716433,-0.017952632961692,0.00438641873279216,0.233956649669762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.0034351731724872,0.00289390993693951,-0.00223689030391424,0.00910723664888864,0.235235181405119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,40052,-0.00824763762476937,0.00698361823808582,-0.0219355293714176,0.00544025412187884,0.237620952466476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37437,-0.0119680244170017,0.0101363242254508,-0.0318352198988854,0.00789917106488194,0.237740001830317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00501538986742736,0.00426142001852756,-0.00333699336888665,0.0133677731037414,0.239244794079246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00434815258452892,0.00369578193900784,-0.0115918851849843,0.00289558001592645,0.239409343931512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.00385366949223006,0.00328222352218366,-0.01028682759571,0.00257948861124992,0.240370910647977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.00713716410249516,0.00608006126273977,-0.0190540841774651,0.00477975597247479,0.240470410972123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,39587,0.00349423723839465,0.00297944016415774,-0.00234546548335453,0.00933393996014382,0.240900537556727
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37411,-0.017592801309713,0.0151250141643479,-0.0472378290718349,0.0120522264524089,0.244785346414852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.00995671039605441,0.00861748708966546,-0.0268469850917987,0.00693356429968988,0.24794434864098
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00802666600643652,0.00695767605859661,-0.0216637110812859,0.00561037906841284,0.248668046847515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00667429209126202,0.00579008948315027,-0.0180228674782366,0.00467428329571251,0.24904709435723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00710130279968818,0.00617180508885964,-0.0191980407738531,0.00499543517447672,0.249912845217844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40052,0.00314577761490955,0.00274532595719408,-0.00223506126119086,0.00852661649100995,0.251867242882194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00540124478073053,0.00472691204420388,-0.0146659923873701,0.00386350282590906,0.253198037370085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.00807207887423739,0.00707066010258405,-0.0219305726753021,0.00578641492682735,0.253628515072196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37043,-0.0033401715017262,0.00292855097077026,-0.0090801314044359,0.0023997884009835,0.254076149728184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,39587,-0.00517487463321703,0.00453747781192677,-0.0140683311445935,0.00371858187815943,0.254106322666786
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0186846914765365,0.0163928213804625,-0.0134452384291699,0.050814621382243,0.25438302906636
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,36962,0.00653303585900666,0.00575115240812775,-0.00473922286092372,0.017805294578937,0.255997229173156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.00533843030633209,0.00470546031868179,-0.0145611325309484,0.00388427191828421,0.256597912335293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,37388,-0.0149153226782621,0.0131985683308916,-0.0407845166068097,0.0109538712502855,0.258466236746323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.00752472772143398,0.00668235603690386,-0.00557269011089758,0.0206221455537656,0.260161090552505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.00629240775940813,0.0055950357140987,-0.0172586777590416,0.00467386224022533,0.260758482351386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00467720429513032,0.00416098030457648,-0.0128327256921002,0.00347831710183957,0.261003534936469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.00467020230793948,0.0041611178781807,-0.0128259933491736,0.00348558873329469,0.261736477854947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,37056,-0.00439471528587968,0.00391643484998625,-0.0120709275918527,0.00328149702009337,0.261831250833758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,-0.00426122280909799,0.00380195243427047,-0.0117130495802681,0.00319060396207214,0.262394068421069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,-0.00314134056918268,0.00280350621487762,-0.00863621275034281,0.00235353161197745,0.262518771168947
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,39931,0.00504435661757122,0.00450377996923442,-0.00378305212212824,0.0138717653572707,0.262718857144815
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00522130614482476,0.00466892775318225,-0.00392979225141245,0.014372404541062,0.263455345134873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.0107933830058,0.00966373662695056,-0.0297343067946231,0.00814754078302315,0.26405941234137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,36818,0.00420242130197604,0.00376317096772835,-0.00317339379477153,0.0115782363987236,0.264133290082013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.00288557055516199,0.00258425135331521,-0.00217956209733582,0.00795070320765981,0.264186061996827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,39885,0.00345129674472784,0.00309573599878449,-0.00261634581288976,0.00951893930234544,0.264929283727895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,39856,0.00655090967594662,0.00590053557002371,-0.00501414004129985,0.0181159593931931,0.266919678632447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00366835702722094,0.00330858303120441,-0.0028164657139397,0.0101531797683816,0.267562739652937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,39830,0.00836306425353698,0.00755208672886556,-0.0064390257350395,0.0231651542421135,0.268144376437946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00218473557426811,0.00197967001074232,-0.00606488879532306,0.00169541764678685,0.269789556390588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.00292271395704351,0.00264848643575988,-0.00226831945704586,0.00811374737113288,0.269808723982302
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.00823244037961158,0.00746718362663541,-0.022868120287817,0.00640323952859383,0.270268485884887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00335515262703707,0.0030464414114356,-0.00932617779345084,0.0026158725393767,0.270770479277156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.00511431274956851,0.00464551777729169,-0.0142195275930602,0.00399090209392319,0.270954432427842
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.00514840458076149,0.00468685316010448,-0.0143346367745663,0.0040378276130433,0.272012341947673
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00363218721563187,0.00332062809725432,-0.00287624385498659,0.0101406182862503,0.274051599677796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.00382810902282068,0.00349996292581756,-0.0106880363574231,0.00303181831178172,0.2740810623876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.00500386659957196,0.00458107304299623,-0.0139827697638446,0.00397503656470066,0.274725041702137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00729022760153054,0.0066908932603233,-0.0204043783917642,0.00582392318870313,0.275917359415583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39123,-0.00292405189087079,0.00268436168000539,-0.00818540078368136,0.00233729700193977,0.27604263519668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00665559422581779,0.00611695957653635,-0.00533364654419346,0.018644834995829,0.276590335639693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,37056,-0.0109608373965301,0.0101019684634108,-0.0307606955848152,0.00883902079175506,0.277932637538465
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.00683981601973341,0.00630457584884779,-0.00551715264400825,0.0191967846834751,0.277987107304052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.00734875056695005,0.00677499234488001,-0.00593023442901477,0.0206277355629149,0.278079355184623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,36962,0.00742912646423264,0.00686412216108997,-0.00602455297150371,0.020882805899969,0.279133531433381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00452277737511402,0.00418828124468922,-0.00368625386447685,0.0127318086147049,0.280222235952961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37056,-0.00615815404698607,0.00571725680621215,-0.0173639773871619,0.00504766929318975,0.281447724851577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00306070087856951,0.00284541737660367,-0.00251631717957368,0.00863771893671269,0.28209857904961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,-0.00647349553927202,0.00603987009973534,-0.0183116409347533,0.00536464985620924,0.283832340651695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00451163012503572,0.00421399226994923,-0.0127710549741362,0.00374779472406476,0.284354861684178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.00903540563585524,0.00845093292822209,-0.00752842290346005,0.0255992341751705,0.285013410211762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37021,-0.00605437171327089,0.00567540548722831,-0.0171781664682384,0.00506942304169659,0.286093732680686
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37056,-0.00695326775182448,0.0065395039922357,-0.0197706955766065,0.0058641600729575,0.287678334905011
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37039,0.00370159653750146,0.0034948489778603,-0.00314830745910473,0.0105515005341077,0.289547333912344
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.00869540353620033,0.00833211983926004,-0.02502635842115,0.00763555134874934,0.296686070368591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39489,-0.00728406211412544,0.0069887481780728,-0.0209820085431481,0.00641388431489725,0.297309300486546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00597560237846379,0.00574862879602328,-0.0172429148186694,0.00529171006174185,0.298596104513236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37083,-0.00825432974761526,0.007945107599098,-0.0238267406418473,0.00731808114661683,0.298861024734824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40052,-0.00317428362045694,0.00305817775776988,-0.00916831202568591,0.00281974478477202,0.299301523218246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,0.00529789914796838,0.00511578138249854,-0.00472903236172875,0.0153248306576655,0.300405196726927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,37169,-0.00428895633449667,0.0041462183450565,-0.0124155442908074,0.00383763162181408,0.300955818841809
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,39720,0.00308861830161593,0.00299291544864175,-0.00277749597772189,0.00895473258095375,0.302098879480569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00609945715191751,0.0059422995478094,-0.0177463642656239,0.00554744996178891,0.304696198525677
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.00291600800050464,0.00285084095411727,-0.00267164026956521,0.00850365627057449,0.306393456512548
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0053541723271476,0.00523934378286639,-0.00491494148727052,0.0156232861415657,0.30683913804734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37039,-0.00265545117178967,0.00260272174408481,-0.0077567857901959,0.00244588344661655,0.307624208935881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37088,-0.00302279229465938,0.00296492913396803,-0.00883405339723672,0.00278846880791796,0.307976769929757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,-0.00273949198186919,0.00268941760810714,-0.00801075049375919,0.00253176653002081,0.308399255670052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,39868,-0.00439381055608124,0.00433300731940046,-0.0128865049021061,0.00409888378994367,0.310582536297549
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.0029024339830449,0.00286749740869719,-0.00852272890409139,0.0027178609380016,0.311468291504086
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.002947193503078,0.00291264492134345,-0.00276159054275516,0.00865597754891116,0.311622336831724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.00312442567486656,0.00309580949847533,-0.00919221229187821,0.00294336094214509,0.312876497608547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00758932665890059,0.00754126567048251,-0.0223702073730463,0.00719155405524512,0.314254440721315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.00217945465807594,0.00216870153847311,-0.00643010967348324,0.00207120035733136,0.314931936878182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00269625235876233,0.00269006656004788,-0.00796878281645618,0.00257627809893151,0.316216893055022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.00699763519375678,0.00699534364481609,-0.0207085087375963,0.00671323835008276,0.317170436426969
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00444366848952656,0.00445006370725463,-0.0131657933557456,0.00427845637669251,0.318024841892713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37039,-0.00649596611551069,0.00653108132367619,-0.019296885509916,0.00630495327889464,0.319937737897061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37382,-0.0242726274370824,0.0244183856736385,-0.0721326633574138,0.0235874084832491,0.320225660163375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0114334915580455,0.0115267893897732,-0.034025998762001,0.01115901564591,0.321258315671658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00568597294111037,0.00573279150229802,-0.0169222442856145,0.00555029840339375,0.321296930868277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40030,-0.00430795656855599,0.00434839137723599,-0.0128308036679385,0.00421489053082654,0.321846327648233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00391574703161159,0.00395549046842342,-0.00383701428649831,0.0116685083497215,0.322215615968265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00283583761168307,0.00286512935221204,-0.00845149114201867,0.00277981591865254,0.322301061554703
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00252026648128294,0.00254892369836855,-0.0075161569300853,0.00247562396751941,0.322796912140295
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00616451697776665,0.00628974806570928,-0.0184924231865568,0.00616338923102354,0.327056944006503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00591149119746655,0.00603214101734135,-0.0059115051965225,0.0177344875914556,0.327104746381513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.0038028356916245,0.00388290395568176,-0.0114133274447607,0.00380765606151175,0.327410411587235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,37445,-0.00864471175948836,0.00882706868422437,-0.0259457663805681,0.00865634286159141,0.327428875014671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37043,-0.00167317001078966,0.00171452598781896,-0.00503364094691481,0.0016873009253355,0.329142306246904
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00281791142349409,0.00289417684027575,-0.00849049803043456,0.00285467518344638,0.330246081920048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00233955971657409,0.00240830964594282,-0.00238072718947384,0.00705984662262202,0.331337260085666
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37021,0.00315922625104988,0.00325233481407274,-0.00321534998453269,0.00953380248663245,0.331381028546573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37021,-0.0056794022067789,0.00585752527989487,-0.0171601517553728,0.00580134734181505,0.332268353740573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.00189329226781531,0.00196005264664271,-0.0019484109196044,0.00573499545523501,0.334089122368403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.00343528649335144,0.00355982838236653,-0.00354197713608697,0.0104125501227898,0.33455507415802
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0111688044228231,0.0115863048688627,-0.033877961965794,0.0115403531201477,0.335077773730156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,39587,-0.00432805431000339,0.00451475353560465,-0.0131769712397885,0.00452086261978173,0.337751413028221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00434950306299648,0.0045456959768747,-0.00456006105167794,0.0132590671776709,0.33866566974315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00547641173420489,0.00573180562562293,-0.0167107507604258,0.00575792729201605,0.339371506493517
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00278390739774393,0.00292690271399293,-0.00852063671717006,0.00295282192168221,0.341545750768544
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.0087011037688525,0.00921422417097044,-0.0267609831439546,0.00935877560624957,0.345027363017242
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00323225170980752,0.00344173712839055,-0.009978056481453,0.00351355306183796,0.347676469016836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.00554150557108932,0.00591783752935624,-0.0171404671286275,0.00605745598644891,0.349077961398769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,39858,-0.00253389633593751,0.00272423023806482,-0.00787338760254454,0.00280559493066953,0.352316281719151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.00727043365219661,0.00783041953236252,-0.0226180559356271,0.00807718863123392,0.353172714378803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,36962,0.00300796637228042,0.00324279355240862,-0.00334790899044048,0.00936384173500131,0.353640013962284
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00692964578245058,0.00750611707133395,-0.0216416352422651,0.00778234367736397,0.35591999421272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0067037150706214,0.00733503694056194,-0.0210803874741228,0.00767295733288001,0.360767018397427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,39749,0.0028896504212673,0.00316904192836419,-0.00332167175832651,0.0091009726008611,0.36186824123796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.00601694604421256,0.00661544495659902,-0.00694932607072152,0.0189832181591466,0.363083931162153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00413093243555354,0.00455737913557984,-0.00480153067018295,0.01306339554129,0.364726410627671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,36903,0.0029804807547133,0.00330067384298526,-0.00348883997753781,0.00944980148696442,0.366547028971689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37056,0.00227258255626383,0.0025177609525559,-0.00266222891074574,0.0072073940232734,0.366743837635966
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00324151287780226,0.00360882320001098,-0.00383178059421926,0.0103148063498238,0.369082992269731
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00419481478021726,0.00467850839159107,-0.0133646912277358,0.00497506166730123,0.369941515364934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.00313680741189457,0.00349874030938041,-0.00999433841828017,0.00372072359449103,0.369973267405798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00586636435332544,0.00654462469889384,-0.00696110005650649,0.0186938287631574,0.370074732458919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00342122838511156,0.00381760091643327,-0.00406126941109765,0.0109037261813208,0.37017711160431
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00296477799892732,0.00332130214247911,-0.00354497420033174,0.00947453019818637,0.372058167001723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,-0.00396513535296787,0.0044429938152518,-0.0126734032308614,0.00474313252492565,0.372166824969995
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,39585,-0.00994791114738457,0.0111827410139509,-0.0318660835347282,0.0119702612399591,0.373706575727772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.00545943477208184,0.00614815190361712,-0.00659094295900771,0.0175098125031714,0.374567911404676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0022820390623467,0.00257363010516354,-0.00276227594377384,0.00732635406846724,0.375253460453766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.00526721168190884,0.00594736907176735,-0.0169240550625728,0.00638963169875517,0.375829177488043
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00437598629977183,0.00494454249062704,-0.0140672895814008,0.00531531698185718,0.376165557142409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00460067009672729,0.0052005254921666,-0.00559235986791924,0.0147937000613738,0.376358795667053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,40052,0.00143039897386146,0.00161921640775065,-0.00174326518532982,0.00460406313305274,0.377038910257543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00675681528958064,0.0076806713186737,-0.0218109310741811,0.00829730049501982,0.379028807801387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37056,0.00322115922973804,0.00367260473448403,-0.00397714604985066,0.0104194645093267,0.380460474497913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00299725051085541,0.00342757809053048,-0.00372080254658434,0.00971530356829515,0.381885821058639
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.00276277767792779,0.0031631389984902,-0.00343697475911301,0.0089625301149686,0.382442397979994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,-0.00262375558254156,0.00300647613381037,-0.0085164488048099,0.00326893763972677,0.38283933507445
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,0.00790690968109977,0.00908227196925742,-0.00989434337864476,0.0257081627408443,0.383992646012571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,-0.00366965561951149,0.00426748806043568,-0.0120339322179654,0.00469462097894244,0.389853921479602
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0211512164654002,0.0248192839588467,-0.0697970130247396,0.0274945800939393,0.394113599134916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00306288137570612,0.00360486010485423,-0.0101284071812204,0.00400264442980817,0.395533269472803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37445,-0.00208287677076002,0.00246787330972499,-0.00691990845782101,0.00275415491630096,0.3986861470288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,39587,0.00324322032862739,0.00385822638816572,-0.00431890339217742,0.0108053440494322,0.400585531507288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.00356015817474886,0.00426088142835433,-0.00479116942482562,0.0119114857743233,0.403423282493061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,37056,0.00460958586382041,0.00552579844232842,-0.00622097908314329,0.0154401508107841,0.404186980111719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00297544678603304,0.00357207155097416,-0.00402581345387631,0.00997670702594238,0.404873935815835
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.0038860695900661,0.00468009602133378,-0.0130590577918803,0.0052869186117481,0.406359423708153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00767090230057395,0.00925651800937172,-0.0258136775989425,0.0104718729977946,0.40728766917017
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.004970900655422,0.00601487952135495,-0.00681826320643371,0.0167600645172777,0.40857278535334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,36868,-0.00346182109222042,0.004194958785791,-0.0116839403123708,0.00476029812792994,0.409254093689335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0059527961516171,0.00724344268123114,-0.00824435150359593,0.0201499438068301,0.41119504954183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37056,-0.00170631016343323,0.00209436192841878,-0.00581125954313404,0.00239863921626758,0.415249597849733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,36962,0.00466027365407372,0.0057342096766794,-0.0065787773122179,0.0158993246203653,0.416396702259587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,39477,-0.0127538717816373,0.0157512776133829,-0.0436263759038677,0.0181186323405931,0.418122680983286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37021,-0.00362976617178285,0.00451529046551862,-0.0124797354841994,0.00522020314063365,0.421478949510509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.00282269635305608,0.0035145793778363,-0.00971127193361524,0.00406587922750307,0.42190880565113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.0039486041327175,0.00497231990273852,-0.00579714287665,0.013694351142085,0.427141596673169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,36962,0.00313722856038363,0.00396568856552165,-0.00463552102803881,0.0109099781488061,0.428904029500286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.00422815747310428,0.00537216258943208,-0.0147575961483912,0.00630128120218259,0.431267170383946
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00540818866445177,0.00688167992898375,-0.00807990399635637,0.0188962813252599,0.431950745347178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,37056,0.00769888547782428,0.00981440093672187,-0.0115373403581506,0.0269351113137991,0.432791466043839
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,40030,-0.00186593220171209,0.00237940338036051,-0.00652956282721869,0.00279769842379452,0.432933248723035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37039,-0.00263053395690537,0.00337947168833676,-0.00925429846604542,0.00399323055223468,0.436355375603587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,37388,0.00200664342147551,0.00258182185961679,-0.00305372742337339,0.00706701426632442,0.43704261244053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.00320779426847411,0.00412770865136851,-0.00488251468820818,0.0112981032251564,0.437092067593593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37437,0.00372965860663494,0.00480120393268656,-0.00568070110143072,0.0131400183147006,0.437280061202574
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0041964245623441,0.00540526904309791,-0.00639790276212781,0.014790751886816,0.437551543282486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37021,-0.00315041951836574,0.00407543141619953,-0.0111382650941168,0.00483742605738535,0.439520139785763
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,37453,0.00165813436629154,0.00217665111146955,-0.00260810181218877,0.00592437054477186,0.446203141725939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00434710629355707,0.00571527084161551,-0.0155490371431235,0.00685482455600933,0.446902224354817
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.00292086472383129,0.00384069726582514,-0.00460690191718598,0.0104486313648486,0.446967150870173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37388,0.00269204497397777,0.00356004752484864,-0.00428564817472556,0.00966973812268111,0.449553062681651
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0019463003339866,0.00257422630799175,-0.00309918322967724,0.00699178389765043,0.449619194481668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,0.00337156750623201,0.00446838258969197,-0.00538646236956424,0.0121295973820283,0.450539359142662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,-0.00354624271867145,0.00473590394578757,-0.0128286144524151,0.00573612901507219,0.453991446557396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.0019045909433653,0.00255371948464959,-0.00310069924654791,0.0069098811332785,0.455795161383617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0038332706119981,0.00514580221366524,-0.013919042950782,0.00625250172678577,0.456325972573571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00369951455152967,0.00497262175830069,-0.013445853197799,0.00604682409473968,0.456903856390403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37039,0.00423480377903544,0.00570042489141602,-0.00693802900813996,0.0154076365662108,0.45755991475842
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.00264812169809692,0.00361061430691532,-0.0044286823434571,0.00972492573965095,0.463311136619418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,-0.00419853048719463,0.00573186181920074,-0.0154329796528281,0.00703591867843882,0.463880265105905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,-0.00204620367781927,0.00282077858112068,-0.00757492969681581,0.00348252234117727,0.468216857661692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37388,-0.00671005620972579,0.00926139831556399,-0.0248623969082312,0.0114422844887796,0.468759884857306
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00339754314224665,0.00471302602459006,-0.00583998786594988,0.0126350741504432,0.470993970711707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00275911884974341,0.00383761951990121,-0.0102808531087498,0.00476261540926296,0.472174519130194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,40030,0.00303523827130829,0.00423512585948518,-0.00526560841328266,0.0113360849558992,0.473580714945955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.00493335780776498,0.00688482619140272,-0.00856090152738436,0.0184276171429143,0.473661328618769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00396672313280915,0.00553894526348226,-0.00688960958361609,0.0148230558492344,0.473910662486585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37169,-0.0030825554219261,0.00431191881009983,-0.0115339162897218,0.00536880544586957,0.474688440478359
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,37169,-0.00286746900663859,0.00401768972836852,-0.0107421408742409,0.00500720286096371,0.475418471724893
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00280320665985352,0.00394177017535921,-0.00492266288385054,0.0105290762035576,0.47700121768788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.00496540441166821,0.00700934542159578,-0.0187037214379959,0.00877291261465952,0.478708715136882
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.000919258245306643,0.00129805192079252,-0.00346344001005998,0.0016249235194467,0.478844000784617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00445942970611409,0.00630703745463397,-0.0168212231171967,0.0079023637049685,0.479543955456445
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.00310095301802991,0.00439050510531681,-0.00550443698839103,0.0117063430244509,0.480020569627301
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.00208815644203812,0.00296258492461181,-0.00371851001020102,0.00789482289427726,0.480920448474735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.0043448239500841,0.00618234781733578,-0.0164622256720622,0.00777257777189403,0.482205846760913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,37039,-0.00298970938561268,0.00425550475733638,-0.011330498709992,0.00535107993876662,0.482347978135141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.0051414687744885,0.00732183574308396,-0.0194922668309331,0.00920932928195606,0.482560444282779
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00225787847464286,0.00322301283330818,-0.00857498362792689,0.00405922667864117,0.483596888526831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.0058861112232318,0.00843268406773955,-0.0224141719960013,0.0106419495495377,0.485180337662107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,0.0022787522848574,0.00329787929862405,-0.00418509114044574,0.00874259571016054,0.489591496016175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00453759428589148,0.00657560059060128,-0.01742577144347,0.00835058287168702,0.490165212067507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00526718217332728,0.00767015733391509,-0.0203006905478009,0.0097663262011463,0.492276954509351
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,37039,0.00228846716404687,0.00333442461003269,-0.0042470050716172,0.00882393939971094,0.492526275334271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00323795015672527,0.00471831183510382,-0.0124858413535288,0.00600994104007821,0.492566404934086
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.00295852296882218,0.00431474153706588,-0.0114154163814713,0.00549837044382695,0.492928031623114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,-0.00220986912285531,0.00322325042049491,-0.00852743994702533,0.00410770170131472,0.492975420175099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00223192823291056,0.00326305681032469,-0.00416366311532584,0.00862751958114695,0.493987744242324
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,36962,0.00390477814200015,0.00574491913412983,-0.00735526336089431,0.0151648196448946,0.496711227751678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,36991,-0.00344565460261138,0.00510671495449341,-0.0134548159134185,0.0065635067081957,0.499859097883269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00574686070079429,0.00852514511351842,-0.0224561451232904,0.0109624237217018,0.50025507635733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00120679665460083,0.00179177253131471,-0.002305077506776,0.00471867081597767,0.500627263995108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,-0.00536180797719438,0.00797249462606651,-0.0209878974442847,0.010264281489896,0.501252900618501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.00191962253531972,0.00287586398081341,-0.00755631593771399,0.00371707086707456,0.504466105916987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,37056,0.00261496802075078,0.00391768973694328,-0.00506370386365805,0.0102936399051596,0.504479131142866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,-0.00228292944257024,0.00343198454270471,-0.00900961914627147,0.00444376026113098,0.505938891245292
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,36962,0.00343591479967752,0.00517444188468854,-0.00670599129431201,0.0135778208936671,0.506691433916614
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00345792948941606,0.00520998884284414,-0.00675364864255846,0.0136695076213906,0.506886605971246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.00266263436549222,0.00401408525032711,-0.00520497272514893,0.0105302414561334,0.507135491823865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00331303775752063,0.00499538845523258,-0.0131039991297765,0.00647792361473523,0.507201634539472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00302765451782015,0.00456819396464153,-0.00592600565287725,0.0119813146885175,0.507490513654254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.00382076990945357,0.00576996473884242,-0.0151299007975847,0.00748836097867757,0.507865503053881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00581104399852216,0.0087890174125679,-0.0114154301301109,0.0230375181271552,0.508514241333983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00303958465853484,0.00464465205243279,-0.00606393336423343,0.0121431026813031,0.512848351399938
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,36991,-0.00487005181561747,0.00745968522861709,-0.019491034863707,0.00975093123247203,0.513864733727055
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,39709,-0.00172094163707621,0.0026416226853325,-0.00689852210032791,0.00345663882617549,0.51475167723182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37445,0.00332399063126391,0.00510327167863827,-0.0066784218588671,0.0133264031213949,0.514834805823428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,39862,-0.0013756587112945,0.00211840937797941,-0.00552774109213415,0.00277642366954515,0.516100269277928
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00242039016133491,0.00374739982378793,-0.00492451349328943,0.00976529381595925,0.518364952779248
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00276327937558952,0.00428734655349507,-0.00563991986926083,0.0111664786204399,0.519249736700327
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.00322868996715456,0.00501166599129351,-0.0130515553100898,0.00659417537578072,0.51943259948389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.00231696047336163,0.00362305110985445,-0.00478421970195308,0.00941814064867635,0.522505096196932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37388,0.00348633705213816,0.00545883831328102,-0.00721298604189264,0.014185660146169,0.523055502948619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,36991,-0.00394638429129356,0.00618203915204228,-0.0160631810292964,0.00817041244670932,0.523248624127934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,39931,0.00183516764880834,0.00287513445479962,-0.00380009588259891,0.0074704311802156,0.523294450498387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.00687502924638877,0.0107718053189166,-0.0279877676714653,0.0142377091786877,0.523324867270349
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,-0.00255714270592438,0.00400782134154472,-0.010412472535352,0.00529818712350326,0.523460031086194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,37411,-0.00132189014478992,0.00207993489858189,-0.00539856254601043,0.00275478225643059,0.525084411552626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.00151895474763237,0.00239664188005229,-0.00621637283253485,0.00317846333727011,0.526230425939924
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00163144792595913,0.00257737992913751,-0.0034202167351504,0.00668311258706865,0.526752847996892
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00428531039784179,0.00677955769547695,-0.00900262268529304,0.0175732434809766,0.527335111656387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00247418570356337,0.00392236519699776,-0.010162021489679,0.00521365008255224,0.528189302691181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.00386341562464835,0.00613170424828853,-0.0158815559512939,0.00815472470199716,0.528658338118137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00274700727645972,0.00439425477468587,-0.011359746634844,0.00586573208192459,0.531892548440588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,39866,-0.0032893889808356,0.00528534046072935,-0.0136486562838651,0.00706987832219393,0.53371348314519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.0045688205057526,0.00737059763517453,-0.00987755085918948,0.0190151918706947,0.535353106059341
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37021,0.00284156460000515,0.00458762698721492,-0.0061501842949361,0.0118333134949464,0.535665262073998
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.00246621264759698,0.00399542840997345,-0.0102972523311449,0.00536482703595098,0.53707471238381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,-0.00445388512407978,0.00723974249592957,-0.0186437804161017,0.00973601016794217,0.538433715728285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00133089106750305,0.00216686162086549,-0.00291615770939331,0.00557793984439941,0.539092340999203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00171322164686776,0.00281550035138734,-0.00723160233558695,0.00380515904185143,0.542868534703618
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37056,0.00254730406374737,0.00419759484588402,-0.00567998183418531,0.0107745899616801,0.543961909925512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00348621382442946,0.00575879942068137,-0.0147734606889649,0.00780103304010604,0.544942578524618
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00327088414843544,0.00540846264894738,-0.00732970264350142,0.0138714709403723,0.545341249205207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37021,0.00232053090716936,0.00386843192399433,-0.00526159566385953,0.00990265747819824,0.548607572388074
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,37453,0.000846085509162064,0.00141267116867914,-0.00192274998144904,0.00361492099977317,0.549232205382005
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40030,0.00113547137566677,0.00195735228381971,-0.00270093910061986,0.0049718818519534,0.561851368423658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,36962,0.00227384678431047,0.00392324482212322,-0.00541571306705105,0.00996340663567198,0.562205690930025
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00302733191346075,0.00522541565935539,-0.0132691466057973,0.00721448277887581,0.562364487693926
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.0028237324493515,0.00487816946067057,-0.00673747969356282,0.0123849445922658,0.562699649862573
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,36703,0.00387606337067351,0.00673524772831783,-0.00932502217682944,0.0170771489181765,0.564970470449356
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00468178298060798,0.00821980261503445,-0.0114290301448595,0.0207925961060755,0.568976647560571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00273702167715894,0.00481906299750895,-0.0067083417979586,0.0121823851522765,0.570073698105572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37056,0.00265499236799331,0.00473073404042925,-0.00661724635124802,0.0119272310872346,0.574655686831116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00214255580852465,0.00381945223588369,-0.00962868219085668,0.00534357057380738,0.574834845527007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,37299,-0.00153135219721832,0.00273640870365822,-0.00689471325638843,0.00383200886195179,0.575747199124271
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37056,-0.0014028920997417,0.00250874583356057,-0.00632003393352041,0.00351424973403701,0.576034334239633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37368,0.00239858487009904,0.00433785308478995,-0.00610360717608925,0.0109007769162873,0.580311691119629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,39749,0.00322962694032299,0.00585937377221878,-0.00825474565322582,0.0147139995338718,0.581511335631457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.00172179704809014,0.00315497619226824,-0.00790555038493588,0.00446195628875561,0.58525227318154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.0030573834864566,0.00563532666936164,-0.00798785678549221,0.0141026237584054,0.587456542851448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37169,0.00307167289847046,0.00566334758999093,-0.00802848837791176,0.0141718341748527,0.587567485791647
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.00281541008507449,0.00519662034230661,-0.00736996578584646,0.0130007859559954,0.587981236606616
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37169,-0.00275753208749103,0.00508991588212403,-0.0127337672164541,0.00721870304147207,0.58799031263896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39489,0.0025959725042921,0.00480987025377288,-0.00683137319310275,0.0120233182016869,0.589399364293617
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,39749,-0.0017061986512364,0.003194120949572,-0.00796667571239753,0.00455427840992473,0.593232465416197
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,39587,-0.00394590107104789,0.00741041165685679,-0.0184703079184872,0.0105785057763914,0.594400638951093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00301492332750252,0.00574734696659404,-0.0142797233820268,0.0082498767270218,0.599886214087125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,36991,-0.00239535713008869,0.00456828807439793,-0.0113492017559086,0.00655848749573125,0.600047740268199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,-0.00731092794847543,0.0140216833788912,-0.0347934273711023,0.0201715714741514,0.602095586142767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,-0.00384077678503531,0.00738592065828088,-0.0183171812752658,0.0106356277051952,0.603062972228419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,39657,0.00521293915182691,0.0100817129262279,-0.0145472181835798,0.0249730964872337,0.605115375361638
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,-0.00344559584431257,0.00666824024528084,-0.016515346725063,0.00962415503643788,0.605360496319057
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37039,-0.0029971570274305,0.00580231478522722,-0.0143696940064758,0.00837537995161484,0.605482444667373
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,39858,0.00118387371897354,0.00230149486465185,-0.00332705621574408,0.00569480365369117,0.606984093359965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00211493286935259,0.00412120509180134,-0.0101924948492832,0.00596262911057805,0.607831837630844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37187,0.00123416976803216,0.00240645164443352,-0.00348247545505754,0.00595081499112187,0.608058634495648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37437,-0.001430985683961,0.00279184502018539,-0.00690300192352437,0.00404103055560237,0.608268079193041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00235930547984447,0.00461431924339711,-0.0114033711969028,0.00668476023721386,0.609148747498225
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40009,-0.00318965729809409,0.00632688537444548,-0.0155903526320072,0.00921103803581905,0.614167511478237
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.00421302936400836,0.00837218720214828,-0.020622516280219,0.0121964575522023,0.614819930630484
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00302390975188635,0.00610413745039189,-0.0149880191546545,0.00894019965088176,0.620335345471442
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,39453,-0.00162815400631776,0.00328938613315125,-0.0080753508272942,0.00481904281465869,0.620626865358975
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00313363150451472,0.00636132220952886,-0.00933456002616186,0.0156018230351913,0.622298575751189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,36991,0.00455914729192321,0.00926792092355006,-0.0136059777182349,0.0227242723020813,0.622778658407726
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00284430179581355,0.00578569804700376,-0.0141842699679409,0.00849566637631381,0.62300388760246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00208790958332763,0.00426446004790652,-0.00627043211056914,0.0104462512772244,0.624420166977538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.0025522836762365,0.00522783059409638,-0.00769426428819241,0.0127988316406654,0.62540866236962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37039,-0.00310005360047975,0.00635692641883523,-0.0155596293813968,0.0093595221804373,0.625794915670053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.0028404798383946,0.00583218889737271,-0.0142715700772451,0.00859061040045591,0.626241662155209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,-0.00405781243021979,0.00834225577684974,-0.0204086337528453,0.0122930088924057,0.626679896352831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.00503214560391031,0.0103856141332027,-0.0253879493049875,0.0153236580971669,0.628017362529706
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,39585,-0.00124576821664891,0.00260768278430629,-0.00635682647388924,0.00386529004059142,0.632849051120112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0018555224615775,0.00390187771612928,-0.00579215786203589,0.00950320278519089,0.634404324962664
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.00190095229563967,0.00402509700909214,-0.00979014243346027,0.00598823784218093,0.636738412814687
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37021,0.00321260784687078,0.0068253197344525,-0.0101650188326561,0.0165902345263977,0.637870125802455
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00226236449570533,0.00481095589294076,-0.0116918380458692,0.00716710905445856,0.638182342830158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0055065109478279,0.0117100136240196,-0.0284581376509062,0.0174451157552505,0.638190323508355
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37382,0.00506644189983468,0.0109530459740537,-0.0164015282093106,0.0265344120089799,0.643687166243369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00260222334168129,0.00562889648248669,-0.00843041376399262,0.0136348604473552,0.643875833967936
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,36962,-0.00321343685530424,0.00695501840752438,-0.016845272934052,0.0104183992234435,0.64406647840736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00293184429749177,0.00639386625126052,-0.00960013355497885,0.0154638221499624,0.646572040051872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.00240257550497469,0.00524090209783459,-0.0126747436167305,0.0078695926067811,0.646651462651479
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00400399973544685,0.00883619106999484,-0.013314934761743,0.0213229342326367,0.650458019406491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0028086105819098,0.00620831552410448,-0.0149769090091546,0.00935968784533499,0.650991931602785
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00244225761131832,0.00541090287117281,-0.0081631120161804,0.013047627238817,0.65173856150984
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,39587,-0.00229566267526114,0.00510558957206151,-0.0123026182365017,0.00771129288597943,0.652978302757913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00276524686863414,0.00620638799203321,-0.0149297673330192,0.00939927359575094,0.655930680966395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00329333633483431,0.00743912657762318,-0.0178740244269757,0.0112873517573071,0.657986405249163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00334597720979284,0.00765396816705312,-0.018347754817217,0.0116558003976313,0.662005507054118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.00192045220109291,0.00445768563845367,-0.0106575160524621,0.00681661165027629,0.666607604315888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.00170078910050336,0.00396948288354091,-0.00607939735123683,0.00948097555224354,0.66831876370393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00209140928650525,0.00488134277020402,-0.00747602254309463,0.0116588411161051,0.668330873648264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37445,0.000924882696976928,0.00218072350073239,-0.00334933536445857,0.00519910075841242,0.671486940076529
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00128619691600166,0.00304308748442019,-0.00467825455346192,0.00725064838546524,0.672548915530097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00127767208011207,0.00303535610640906,-0.00467162588844968,0.00722697004867382,0.673812038484403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-0.000988173130053417,0.0023567559798824,-0.00560741485062292,0.00363106859051608,0.675007068043317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00291546735213729,0.00696559591344456,-0.0165680353424886,0.010737100638214,0.675549988304265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,37437,0.00175824046109405,0.00427588689753622,-0.00662249785807694,0.0101389787802651,0.680933103943362
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00119423988281386,0.00293522825037697,-0.00455880748792499,0.00694728725355272,0.68411302326858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,39585,-0.00205864382942743,0.00512448363304546,-0.0121026317501965,0.00798534409134166,0.687890354597216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.00178083456088736,0.0044446075893065,-0.0104922654359281,0.00693059631415339,0.688667336560867
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37411,-0.00135384856293824,0.00339090702637845,-0.00800002633464001,0.00529232920876352,0.689709010327211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37368,0.00308525968366502,0.0077454546614455,-0.0120958314527682,0.0182663508200982,0.690392033760332
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.00117196213815104,0.0029464764027864,-0.00460313161131031,0.00694705588761239,0.690819432981059
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.000890260475807176,0.00224228000129939,-0.00350460832673964,0.00528512927835399,0.691347969979339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00119246882695329,0.00302068901116603,-0.00472808163493213,0.00711301928883871,0.693019931587749
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00122806698041345,0.00312437502364483,-0.00489570806593042,0.00735184202675732,0.694281515958879
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00215373682985437,0.00556107816431987,-0.00874597637221257,0.0130534500319213,0.698549552683935
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,37021,-0.00238092048391801,0.00618845331741882,-0.0145102889860589,0.00974844801822287,0.700439271856745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00229399446228272,0.00599914815399891,-0.00946433591955513,0.0140523248441206,0.702180729011538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,37169,0.00206707889371757,0.00551328108149246,-0.00873895202600766,0.0128731098134428,0.707720603181881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.00119172620714446,0.00319525295156632,-0.00745442199221445,0.00507096957792553,0.709177496334443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,0.00174374750075697,0.00469205248082645,-0.00745267536166287,0.0109401703631768,0.710168005224334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.00247975572145319,0.00669563173141658,-0.0106436824721233,0.0156031939150297,0.711123487969563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,39585,-0.00251093542746437,0.00680014162030145,-0.0158392130032552,0.0108173421483265,0.711948210599221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,39857,-0.00206560499790191,0.00560976742391141,-0.0130607491487683,0.00892953915296445,0.712717202386121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.00143414323073171,0.00393595428503603,-0.0062803271679389,0.00914861362940232,0.715587662301571
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,39587,-0.0016965922754564,0.00466106598091348,-0.0108322815980468,0.00743909704713403,0.715868628606349
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,39585,-0.0011221006174127,0.00309485092480567,-0.00718800843003181,0.0049438071952064,0.716930871714399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,39699,0.00233289230342956,0.00645729219358058,-0.0103234003959884,0.0149891850028475,0.717894755862753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.0012185359446241,0.00338979196572582,-0.0054254563081985,0.00786252819744671,0.719247637284749
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37169,-0.00256642336808036,0.00714335925270141,-0.0165674075033751,0.0114345607672144,0.719395810216721
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.00314325380931436,0.0089155508881031,-0.0206177335499964,0.0143312259313677,0.724425078106933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.000970431251830654,0.00275704154369087,-0.00443337017380346,0.00637423267746477,0.724855727109743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.00189894236316763,0.00543719551262118,-0.00875796084156989,0.0125558455679051,0.72690697958967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00386253237910559,0.0111160206154588,-0.0256499327854049,0.0179248680271937,0.728240543607403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.00106873686369184,0.00308847006379355,-0.00498466446134351,0.00712213818872719,0.72931752488409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00176869730440973,0.00511304807920936,-0.0117902715396601,0.00825287693084062,0.729409577403968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39238,-0.00100998824225165,0.0029414360115041,-0.00677520282479969,0.00475522634029638,0.731328052214905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37437,0.00259417871167802,0.00756341961633148,-0.0122301237363317,0.0174184811596877,0.731611152406884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.00306261193883521,0.00895539264849937,-0.0144899576522236,0.020615181529894,0.732367460006165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.00164019161657898,0.00485853125626393,-0.0111629128788563,0.00788252964569833,0.735677555289028
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37056,-0.00151350392461495,0.00450703154600651,-0.0103472857547877,0.00732027790555781,0.737019878895852
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00135293349330586,0.00403100304784844,-0.0092536994670888,0.00654783248047708,0.737153755276195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37056,0.000946907021402628,0.00284645285248881,-0.00463214056947544,0.00652595461228069,0.739394635665483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,37368,-0.00159443023716228,0.0047965116092812,-0.0109955929913534,0.00780673251702887,0.739581413123307
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,36962,0.00294457536490221,0.00886927048552014,-0.0144391947867173,0.0203283455165217,0.739896479818031
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37351,0.00159784858393845,0.00484202755952928,-0.00789252543273895,0.0110882226006158,0.741408286538313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37056,-0.00172037946465877,0.00522851410802453,-0.0119682671163869,0.00852750818706931,0.742132239721949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0026709672798639,0.00816293946512306,-0.0186703286315051,0.0133283940717773,0.743516828866448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,39866,-0.00131082356310251,0.0040362905532405,-0.0092219530474539,0.00660030592124888,0.745367369013877
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37368,0.00108206122497368,0.00333360216950132,-0.00545179902724891,0.00761592147719627,0.745494766082268
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.00261130623470375,0.00812339753570983,-0.0133105529352875,0.018533165404695,0.747869994317418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,36991,0.00198782379613598,0.00619103870711492,-0.0101466120698093,0.0141222596620812,0.748154253406134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,39783,-0.00221837933001031,0.00692311590294084,-0.0157876864997744,0.0113509278397537,0.748646011073743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00142660066620499,0.00448701619486637,-0.0102211524081431,0.0073679510757331,0.750535707831795
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,39587,-0.00197321324757008,0.00623875867795062,-0.0142011802563533,0.0102547537612131,0.751791918611988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.000996448603052437,0.00323808811804906,-0.00535020410832373,0.0073431013144286,0.758294592546111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00341594060095052,0.0111312619810346,-0.0252332140837784,0.0184013328818773,0.758941008943413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,37021,0.00228784461726921,0.00796357557751594,-0.013320763514662,0.0178964527492005,0.773895860459825
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.000884395550468694,0.00314567507882086,-0.0052811276040202,0.00704991870495759,0.778602453833319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,39992,0.00113679134836283,0.00404390201348099,-0.00678925659805992,0.00906283929478557,0.778627729970218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,-0.00225030290741719,0.0080647883243024,-0.0180572880230499,0.0135566822082155,0.780227562816445
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39477,0.00366922522110594,0.0132007680360072,-0.0222042801294682,0.0295427305716801,0.781050248490743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,36962,0.00121226282508,0.00439240482711718,-0.00739685063606966,0.00982137628622967,0.78255957221939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,-0.00120981337626802,0.00439485630032761,-0.00982373172491014,0.00740410497237409,0.783105148156865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.000930771061272095,0.00339111155755889,-0.00757734971408752,0.00571580759154333,0.783724127884024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000943379555505021,0.00344891273967972,-0.00770324852527727,0.00581648941426723,0.784450465514527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37039,-0.000594576073482655,0.00217840970156565,-0.00486425908855134,0.00367510694158603,0.784903286385888
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.00220517663742801,0.00809360108503997,-0.0180686347641063,0.0136582814892503,0.785273065596577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00160250908298397,0.00590823931816522,-0.0131826581465878,0.00997763998061986,0.786215444439583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,39788,0.00218202802096001,0.00804527594299191,-0.0135867128273041,0.0179507688692241,0.786226466581099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37021,-0.00126033478032555,0.00468562034271406,-0.0104441506520451,0.00792348109139401,0.787949844683233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00140486384261383,0.00527231346280605,-0.00892887054448604,0.0117385982297137,0.78988867841615
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37169,0.00131462783864943,0.00494045403617294,-0.00836866207224953,0.0109979177495484,0.790170522710174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00128106753660959,0.00488153541801236,-0.00828674188269463,0.0108488769559138,0.792993075132901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0015305834308275,0.0058810967020112,-0.00999636610511445,0.0130575329667695,0.794670611782173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37124,0.0027821675295841,0.0108785671301954,-0.0185398240455989,0.0241041591047671,0.798149696636701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00188152701570321,0.00740641900775865,-0.0126350542395038,0.0163981082709102,0.799468584613541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.000983605202754218,0.00388879265600245,-0.00663842840301059,0.00860563880851902,0.800323697980398
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37043,0.0017068621770484,0.00682460005196124,-0.0116693539247956,0.0150830782788924,0.802510547295476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,39891,-0.0006678698095931,0.00267259008152278,-0.00590614636937774,0.00457040675019154,0.802670909620459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.000953358157968906,0.00381896793232932,-0.00843853530533437,0.00653181898939655,0.802871497725788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37437,-0.00206446170800742,0.00831180488735508,-0.0183555992872234,0.0142266758712085,0.803846433203565
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,40012,-0.00106742849665225,0.00430040133838824,-0.00949621511989321,0.0073613581265887,0.803970428896106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.00060636406568876,0.00245493221699014,-0.00541803121098944,0.00420530307961192,0.804913295848977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,-0.000820821687681465,0.00333237595042743,-0.00735227855051922,0.00571063517515629,0.805439778221929
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.00159350027272305,0.00649039284518005,-0.0143146702492759,0.0111276697038299,0.80606015486743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37424,0.000515284916485884,0.00217273179438066,-0.00374326940050021,0.00477383923347198,0.812536303795454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,-0.000802110977733713,0.0034064146914475,-0.00747868377297082,0.00587446181750339,0.813847042890934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39489,0.00124490176798854,0.00533191288038657,-0.00920564747756913,0.0116954510135462,0.815390773214226
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37056,-0.000679410331114482,0.00296053147896676,-0.00648205202988933,0.00512323136766037,0.818492183802846
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.00152093504033929,0.00676190073335939,-0.0147742604777237,0.0117323903970451,0.822039442116761
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37056,0.000581303319393218,0.00258733939484627,-0.00448988189450546,0.0056524885332919,0.822237745862778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.000867550330693226,0.00400655864665528,-0.00698530461675112,0.00872040527813758,0.828576008636269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,36962,-0.00126832726495719,0.00586644945413597,-0.0127665681950637,0.0102299136651493,0.828835100667394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39489,0.000910096705975185,0.00425274121760432,-0.00742527608052929,0.00924546949247966,0.830547999512425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00236118323125535,0.011229568098094,-0.0243711367035197,0.019648770241009,0.833464245350564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.000797985029466953,0.00379673569018774,-0.00664361692330102,0.00823958698223493,0.833533103946586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,0.000846168216199474,0.00410224647427371,-0.00719423487337699,0.00888657130577594,0.836583628218361
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00105228258614333,0.00526329567696792,-0.00926377694071378,0.0113683421130005,0.84153963665933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,36962,-0.000999530557359152,0.00510801398237992,-0.0110112379628238,0.0090121768481055,0.844864534970084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,-0.000492735462291685,0.00252389384012304,-0.00543956738893285,0.00445409646434948,0.845217265231967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,36991,-0.000907094645236413,0.00468586978753403,-0.0100913994288031,0.00827721013833029,0.84650709010104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.00157974170358102,0.00816998138923058,-0.0144334218193109,0.017592905226473,0.846680588761397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.00122378088718278,0.006330033330557,-0.0136306462150745,0.0111830844407089,0.846703986664761
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000667309712528108,0.00347040968204999,-0.0074693126893461,0.00613469326428988,0.847521400316919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.000532843614352387,0.00277329015302472,-0.00490280508557607,0.00596849231428085,0.847639728602304
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00155146286922604,0.00810442065354556,-0.0174361273501753,0.0143332016117233,0.848187954680799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00156767892024427,0.00875021129967281,-0.018718093067603,0.0155827352271144,0.857815623312956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.000832776905882706,0.00488157820194473,-0.00873511636992897,0.0104006701816944,0.86454419605873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.000499195002024526,0.00292925071429607,-0.00524213639799577,0.00624052640204482,0.864684530594534
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.000949013636830897,0.00566085619813284,-0.0101462645115095,0.0120442917851713,0.866865232423874
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,39868,-0.000542590468780324,0.00324748733875516,-0.00690766565274044,0.00582248471517979,0.867309144004607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.000646329770834206,0.00387206814710165,-0.00823558333915344,0.00694292379748503,0.867434716095121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.000602532786921708,0.00370214486747363,-0.00665367115332661,0.00785873672717002,0.870715855972612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00102659772719668,0.00631684989669615,-0.0134076235247211,0.0113544280703278,0.870900931144058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.000935067149788843,0.00580580623363952,-0.0104443130681446,0.0123144473677223,0.87205079276662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.000487359294877413,0.00305893891545891,-0.00550816097942205,0.00648287956917688,0.873416849977391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.000454835037710521,0.00285946869363842,-0.00514972360182079,0.00605939367724183,0.873621846853418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.000548414736915302,0.00350028846235862,-0.00631215064930759,0.00740898012313819,0.875501805124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.0012899490633023,0.00824463614879328,-0.0174494359149371,0.0148695377883325,0.87567346071354
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.00147670101888122,0.00953228814351286,-0.0201599857801664,0.017206583742404,0.876890094336138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,39858,0.00277782935349977,0.0180790706415758,-0.0326571491039888,0.0382128078109883,0.877888514468061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.000618880148214724,0.00403716213079445,-0.0072939576281424,0.00853171792457185,0.878167327367069
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.000470219571757104,0.00307187447220499,-0.00555065439376467,0.00649109353727888,0.878343425457244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.000774734147567643,0.00508759102767416,-0.010746412561809,0.00919694426667371,0.87896909667808
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37169,-0.00128429487315,0.00843920121589936,-0.0178251292563127,0.0152565395100127,0.879045664253206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,-0.000472069539852042,0.00312044679661666,-0.00658814526122069,0.00564400618151661,0.879755049785982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.000835933946644172,0.00566659709229885,-0.0102705963542616,0.0119424642475499,0.882724201757198
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.000651483617419813,0.00443526806359941,-0.00804164178723503,0.00934460902207465,0.883223334467536
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.000572661742170105,0.0039049572749408,-0.00708105451671387,0.00822637800105408,0.883410578045556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.000851007598545961,0.00588380193531088,-0.0123832593917553,0.0106812441946634,0.885000695447756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,-0.000938218918331285,0.00656203317218729,-0.0137998039358184,0.0119233660991558,0.886310639823702
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.00145781706969137,0.0105312049810633,-0.0220989788325755,0.0191833446931927,0.889904081370036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.000841245222224961,0.00608739654765968,-0.0127725424556379,0.011090052011188,0.890088727534474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0014490988900977,0.0104862912467512,-0.02200222973373,0.0191040319535346,0.890092129616954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.000627048587526989,0.0046551758362631,-0.00975119322660267,0.00849709605154869,0.892851741212834
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.000227681095868567,0.00169301567169199,-0.00309062962064773,0.00354599181238486,0.893022985332386
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,36962,0.000371803601206771,0.00288495407318791,-0.00528270638224154,0.00602631358465508,0.897457125765838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,-0.0006103991913325,0.00474527040799407,-0.00991112919100088,0.00869033080833589,0.897649572171382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,-0.000586964493811017,0.00456593286903414,-0.00953619291711792,0.00836226392949589,0.897713312520554
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.000621954641166098,0.0048998305815413,-0.00898171329865485,0.0102256225809871,0.89899462706234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.000629743234483879,0.00505053804261592,-0.00926931132904332,0.0105287977980111,0.900772133511996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,36962,0.000641042329454803,0.00523288927594574,-0.00961542065139885,0.0108975053103085,0.902502897994885
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.000413842148255637,0.00343432949287629,-0.00631744365778189,0.00714512795429316,0.904087610436514
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.000282864813014589,0.00235655566349731,-0.00490171391346932,0.00433598428744014,0.904458657298556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,37411,-0.000398560563631817,0.00338918744048679,-0.00704136794698593,0.00624424681972229,0.906388190001387
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00060746703950896,0.00523009571612938,-0.00964352056410463,0.0108584546431226,0.907536445463941
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.000726578410464538,0.00633700491881696,-0.0116939512304167,0.0131471080513458,0.908719200645241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.000805145500273653,0.00706566682893057,-0.0130435614844303,0.0146538524849776,0.909277739369952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37124,0.000359756760591595,0.00348145875410188,-0.00646390239744809,0.00718341591863128,0.917698610330175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37368,0.0005097444228841,0.00505073162540754,-0.00938968956291468,0.0104091784086829,0.919611599906527
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.000647006700061298,0.00651109506339778,-0.0121147396241984,0.0134087530243209,0.920846114366497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.00113163522007449,0.0114690459852891,-0.0213476949110922,0.0236109653512412,0.921402599429841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.00173141364006425,0.0178406381382253,-0.0332362371108574,0.0366990643909859,0.922688810829631
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,37161,0.000900271008797555,0.00940810806656658,-0.0175396208016729,0.019340162819268,0.923767452584024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.000842447338840204,0.00951894293067561,-0.0194995754829644,0.017814680805284,0.929478872609294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37039,-0.000249981980574453,0.00301419454960207,-0.00615780329779452,0.00565783933664561,0.93390454793651
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,37453,0.000253050234003786,0.00306424919716411,-0.00575287819243788,0.00625897866044545,0.934185543676963
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.00031832269543074,0.00394241900814457,-0.00804546395139409,0.00740881856053261,0.935647545913423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37039,-0.000353740647575873,0.00464329435124976,-0.00945459757602541,0.00874711628087366,0.939274568883658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,-0.000172084410141248,0.00243299877995028,-0.0049407620188438,0.00459659319856131,0.943614246509572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.000526377217638069,0.00747207699853063,-0.0151716481347581,0.014118893699482,0.943839824864437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,36991,0.000309393307025574,0.00454334948405659,-0.00859557168172535,0.0092143582957765,0.945708607793003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,-0.000234290570161177,0.00350761705548809,-0.00710921999891783,0.00664063885859548,0.946745889699868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.000328235995278591,0.00495462291792297,-0.00938282492385043,0.0100392969144076,0.94718104521144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.000334283257308691,0.00530296316044618,-0.0100595245371658,0.0107280910517832,0.949737940560725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.000453847243672636,0.00739843595647521,-0.014954781718364,0.0140470872310188,0.951086443026049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.000372244936047515,0.0061191088556148,-0.0123656982930525,0.0116212084209575,0.951492982140461
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00028783297139308,0.00482080531099321,-0.0091609454381536,0.00973661138093977,0.952390378172282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.000900288549378395,0.0163855957974867,-0.0312154792136955,0.0330160563124523,0.956183968655505
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,-0.000141722494093891,0.00269019131523445,-0.00541449747195341,0.00513105248376563,0.957986576959836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37388,0.000316895118754261,0.00696945666975748,-0.0133432399539704,0.0139770301914789,0.963734052701902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,-0.000120959286494176,0.00303832721299746,-0.00607608062396919,0.00583416205098084,0.968244182011173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.000144645877735851,0.00381597690418177,-0.00762396060993213,0.00733466885446043,0.969763735381739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,37056,0.000276282967090055,0.00735025550386785,-0.0141302178204909,0.014682783754671,0.970016574784857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.000298783132635536,0.00803362794215337,-0.0160446938992561,0.0154471276339851,0.970332745380324
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00016387622711747,0.00447738546555083,-0.00893955173959709,0.00861179928536215,0.970803785884631
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.000198501987909751,0.00550870432454193,-0.0105985584881924,0.0109955624640119,0.971255587502205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37437,-0.000170159225457641,0.00475995769382861,-0.00949967630536171,0.00915935785444643,0.971483778871119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.00016843225394941,0.00481800463568989,-0.00927485683200278,0.00961172133990159,0.972113027939949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,36991,0.000157471988871631,0.00451139728851077,-0.00868486669660947,0.00899981067435273,0.972155729620906
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.000199188259787536,0.00572001831380197,-0.0114104241548394,0.0110120476352643,0.972221386288753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,36991,0.000305717938640148,0.00908221891748425,-0.017495431139629,0.0181068670169093,0.973147870370999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.000186111988123214,0.00612620947393981,-0.0121934825570452,0.0118212585807988,0.975764751552712
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37064,9.8352173111985e-05,0.00325943242670115,-0.00629013538322227,0.00648683972944625,0.975928236313625
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,-0.000169093018660709,0.00561965734815511,-0.0111836214210447,0.0108454353837233,0.975996077806564
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.000151777033706453,0.00603056127632444,-0.0119716771353024,0.0116681230678895,0.979921350459282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.000151253292647707,0.00612753911597598,-0.0118587233746652,0.0121612299599606,0.980307187060499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.000233268586057558,0.0096240825999543,-0.019096470481968,0.0186299333098529,0.980663063588368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,37311,0.000165188733555036,0.00693005260777461,-0.0134177143776832,0.0137480918447933,0.980983317574668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-3.63363168882357e-05,0.00184291034975404,-0.00364844060240614,0.00357576796862967,0.984269568743692
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,37368,-6.31523734561794e-05,0.00361827860417084,-0.00715497843763102,0.00702867369071866,0.986074921702781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.000117455610064163,0.00833014512378277,-0.0162096288325501,0.0164445400526784,0.988750357803684
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,40009,-3.39870497160747e-05,0.00282581254052979,-0.00557257962915446,0.00550460552972231,0.990403939315799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,39701,-5.35920962257513e-05,0.00601827110018125,-0.011849403452581,0.0117422192601295,0.992895124618317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,3.48193988363051e-05,0.00418550334934961,-0.00816876716588893,0.00823840596356154,0.993362563822091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37368,2.75257900420277e-05,0.00421547922057775,-0.00823481348229036,0.00828986506237442,0.994790191290974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,1.60969687787132e-05,0.0050785995027719,-0.00993795805665422,0.00997015199421165,0.997471102648093
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,2.47563301324467e-06,0.00283707171775227,-0.00555818493378121,0.0055631361998077,0.999303778037483
